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(vi)ABSTRACr
Seventy, GP-referred, sleep-onset insomniacs were randomly assigned to
either progressive relaxation, stimulus control, paradoxical intention,
placebo or no treatment control groups. Following baseline assessment
of sleep pattern and quality subjects received 8 weeks of treatment,
comprising 4 weeks under counterdemand and 4 weeks under positive
demand instruction to control for demand characteristics and expectancy
effects. A further 14 patients were allocated consecutively to a
tailored therapy condition as a development of the main study. Measures
of treatment process and outcome were obtained from self-report
instruments validated against objective monitoring via the "Somtrak"
Sleep Assessment Device. Follow-up data were collected at 6 weeks, and
3, 6 and 17 months post-treatment.
Stimulus control was rapidly effective in reducing sleep latency and
increases in sleep duration also emerged after a number of weeks.
Changes in sleep satisfaction did not, however, parallel sleep pattern
change for this group. By contrast, relaxation was associated with
marked improvement in qualitative measures and was only modestly
effective in altering sleep pattern. Paradox exhibited an initially
variable response but, by the fourth week, subjects demonstrated
significant sleep latency reduction and some increment in subjective
satisfaction. The tailored therapy group did not compare favourably
with the randomly allocated groups, suggesting that selection according
to individual presentation is less important than the "power" of the
treatment applied. Placebo and no treatment subjects did not improve
significantly although between group statistical analyses did not
always achieve statistical significance. Time within treatment group
sub-effects of the MANOVA programme proved particularly useful in data
analysis. Treatment effects were maintained at lengthy follow-up,although a proportion of initially drug-dependent patients resumed
medication.
Results are discussed with reference to the literature and to measures
of clinical as opposed to statistical significance. The selective
impact of the treatments is related to a hypothesised model of
differential treatment effect. Guidelines for clinical practice are
presented and some suggestions are made for further research.LIST OF ABBREVIATIONS 
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WASO	 Wake Time After Sleep Onset
ZAS	 Zung Anxiety Scale
ZUG	 Zung Depression ScaleINTRODUCTION
Insomnia is a common complaint at the GP's surgery. Traditional medical
management involves the prescription of hypnotic drugs, but these are
often ineffective in the long-term and may pose problems upon
withdrawal. The literature on insomnia, however, contains a number of
alternative models for the aetiology, maintenance, and management of
chronic insomnia. Various behavioural approaches have been investigated
and been reported as useful, particularly in the reduction of lengthy
sleep-onset latency, and a recent review paper has concluded that "most
psychological treatments are helpful, and no one treatment emerges as
superior, although stimulus control has an edge" (Lichstein and
Fischer, 1985; p. 346).
Most of the research upon psychological therapies has been conducted in
the USA using subjects solicited by means of media advertisement.
Problems of generalizability to spontaneously presenting clinical
populations are, therefore, substantial and the practising clinician
remains uncertain of the applicability of psychological procedures to
his/her patients, most of whom have chronic and severe sleep problems.
In addition, sleep complaints generally reflect both quantitative and
qualitative concerns and there is need to investigate the impact of
such treatments upon overall sleep pattern and its perceived quality.
The present study was conducted to provide systematic and controlled
evaluation, using physician-referred subjects, of three promising
psychological treatments for initial insomnia; namely, progressive
relaxation, stimulus control and paradoxical intention therapies. The
positive selection of the patient group permitted valid assessment of
the clinical usefulness of the treatments. Methodological protocols for
the management of chronic drug-using patients were also developed based
upon the pharmacological and psychological literature.
1CHAPTER 1
NORMAL SLEEP AND THE PROBLEM OF INSOMNIA
NORMAL SLEEP PATTERNS
Extensive sleep laboratory studies, employing all—night
polysomnographic monitoring, have revealed that there is a typical
"architecture" of sleep comprising a number of different sleep stages
which present at various times during the night and conform to a common
pattern. These stages of sleep fall into two distinct categories; that
of orthodox sleep (also known as non—REM sleep) and that of paradoxical
sleep (usually termed REM sleep). Within orthodox sleep four separate
stages of sleep pattern have been identified, and REM sleep, so called
because of the presence of rapid eye movements which are peculiar to
this sleep phase, alternates regularly with orthodox sleep
approximately five times during the night. These sleep stages have been
recognised for at least the past 20 years and the reader is referred to
any major textbook on sleep research for detailed description (A recent
book by Kales and Kales, 1984, is an excellent source). A brief summary
of normal sleep is, however, provided below.
During waking life, the electroencephalogram (EEG) is characterised by
high—frequency, low—amplitude brain activity called beta waves. When
the eyes are closed, and as relaxation continues, the frequency of this
activity reduces and a state of drowsiness is associated with the
development of alpha rhythms. The onset of sleep is commonly defined as
the point at which these alpha rhythms disappear, although this has
been an issue of some dispute (see Chapter 4). Stages 1 and 2 of
orthodox sleep then develop with further slowing of EEG frequency and
increases in wave amplitude. Theta waves predominate during both of
these early stages, although it is possible to discriminate stage 2sleep by identifying the appearance of either sleep spindles (short
bursts of rhythmic, high—frequency waves of uniform amplitude) or K
complexes (sudden high—amplitude bipolar spikes of approximately two
seconds duration). As sleep deepens further still, larger and even
slower delta waves appear within sleep stages 3 and 4 which taken
together are known as slow—wave sleep (SWS) (Rechtschaffen and Kales,
1968).
The stages described thus far constitute non—REM sleep. Approximately
1.5 hours after sleep—onset, however, the EEG trace changes and closely
resembles that of the waking state except for the presence of regular,
low—amplitude, saw—toothed waves, accompanied by electromyogram (EMG)
records which indicate an absence of muscle activity. The individual is
functionally paralysed. Rapid, darting eye movements are, however,
commonly observed, and if subjects are wakened from REM sleep they
frequently report vivid and detailed dreams (Dement and Kleitman,
1957). Physiological correlates of REM sleep include increases in
blood pressure, heart and respiration rate, body temperature and oxygen
consumption. Penile erections also occur in conjunction with REM sleep
(summary from Kales and Kales, 1984). The loss of muscle tone and the
increased levels of autonomic and neuronal activity have led to REM
sleep being described as "an awake brain in a paralysed body" (Coates
and Thoresen, 1980).
Clearly sleep is not simply an absence of wakefulness but is a period
of continual mental, physiological and behavioural activity, full of
complexity, yet following a relatively predictable pattern. It is also
worth noting that sleep should not be considered in isolation from
wakefulness, but rather as part of a 24—hour wake—sleep biological
cycle which varies uniquely from individual to individual.SLEEP AND THE AGEING PROCESS
Sleep patterns and sleep needs should be considered within a
developmental context. A strong daily cycle of sleeping and waking
develops with age. Babies gradually sleep by night and are awake during
the day, until as children a routine similar to that of adults is
established. The average time spent asleep becomes progressively
shorter with increasing age; with newborn infants requiring around 16
hours, compared with 8 hours in young adults (Kleitman and Engelman,
1953; Williams, Karacan and Hursch, 1974). The elderly obtain even less
sleep, largely because of more frequent and more prolonged wakenings
during the night (Webb and Campbell, 1980; Spiegel, 1981; Hayaschi and
Endo, 1982; Webb, 1982). McGhie and Russell (1962) found, in their
study of a large sample of subjects in central Scotland, that wakenings
were more concentrated during the second half of the night, and were
especially problematic for females of middle age or older. The major
change apparent in EEG records with  increased age is a dramatic
reduction in the "deepest" of sleep stages, ie. stages 3 and 4,
correlating highly with this propensity toward wakening in older
subjects (Coates and Thoresen, 1979). It would seem reasonable,
therefore, to regard these age-related changes in sleep as constituting
a type of "developmental insomnia".
Descriptive studies have been generally consistent in their findings
permitting some confidence that current descriptions of what sleep is
are fairly adequate. Understanding of the why of sleep, however, proves
more problematic. Since this issue is not of central importance to this
thesis it will be dealt with only briefly.
THE FUNCTIONS OF SLEEP
Several theories regarding the function of sleep have been proposed.
4The first of these is that sleep is needed for physical and
psychological restoration (Hartmann, 1973; Adam and Oswald, 1977).
Evidence for this restorative function comes from studies demonstrating
that sleep facilitates the synthesis of protein, and that the secretion
of growth hormone is sleep dependent (eg. Adam, 1982). Childrens growth
takes place largely during the night and they grow faster at times of
good sleep. Since proteins are the building blocks of development it is
also thought that tissue restoration progresses at a faster rate
during sleep. Horne (1983) has, however, pointed out that, although
there is strong evidence for this being so for brain tissue, there is
some doubt about the generality of the process.
As far as psychological functioning is concerned studies of sleep
deprivation have shown that disorders of thought and perception
resembling schizophrenia are provoked by total deprivation of several
days' sleep (eg. Johnson, 1969). Fatigue and decrements in performance
tasks	 (eg.	 reaction time) are also observed during prolonged
wakefulness, particularly during the early morning hours when subjects
would normally be asleep. Selective deprivation of REM sleep has been
said to produce a "hyper—response state" with increased irritability
and emotional lability (Agnew, Webb and Williams, 1967). It may be that
the recovery of REM sleep is most essential to adequate functioning
since REM sleep increases considerably beyond its usual proportion
during recovery nights (Dement, 1960). This may reflect the widely held
view that REM sleep plays a critical role in memory and learning (eg.
Dewan, 1970), and indeed a second theory concerning the function of
sleep is that it is central to the human capacity to learn, unlearn and
remember. Information may be programmed and memory consolidated during
sleep, and, in particular, REM sleep may be responsible for this
integration process (Greenberg and Leiderman, 1966).A further hypothesis, which has been termed the phylogenetic theory,
regards sleep as a mechanism for conserving energy. REM periods serve
to bring about brief wakenings during this period of defenceless
vulnerability, and prepare the organism for fight or flight without
disturbing sleep continuity (Snyder, 1966). The finding that humans
waken more readily from REM sleep than slow wave sleep is consistent
with this theory (Rechtschaffen, Hauri and Zeitlin, 1966), however,
other workers have reported contrary findings in that arousal from REM
sleep is more difficult in animals, and some defenceless animals have
considerably less REM sleep than do their predators (Drucker—Colin,
1979). In a similar vein, Webb (1979) has forwarded the ethological
theory which is another attempt to establish the "survival value" of
sleep. He suggests that ecological pressures exerted upon the organism
make non—responding important, and that sleep effectively removes the
individual from the environment at times when waking activities would
be dangerous or otherwise maladaptive.
In reviewing the literature on the "why" of sleep it is evident that no
single explanation enjoys general acceptance, although the theories are
not necessarily in competition and are not mutually exclusive. Having
considered thus far the pattern and role(s) of normal sleep, the
background is in place to examine the sleep disorders themselves.
DEFINITIONS OF INSOMNIA
For the purposes of this thesis, those sleep disorders which do not
have a direct bearing upon insomnia itself will be referred to only
briefly. The Association of Sleep Disorders Centres has published a
"Diagnostic Classification of Sleep and Arousal Disorders" (Sleep,
1979, 2(1)) which is also summarised in the American Psychiatric
Association's (1980) Diagnostic and Statistical Manual of Mental
Disorders (DSM III). This system separates the insomnias, defined as
6"disorders of initiating and maintaining sleep" (DIMS), from three
other major categories of sleep disturbance. These are a) disorders of
excessive somnolence (including narcolepsy and hypersomnolence), b)
disorders of the sleep-wake schedule (exemplified by jet-lag and the
effects of shift-work upon the circadian rhythm), and c) the
parasomnias (a heterogeneous group including sleep-walking, sleep
terrors and sleep-related enuresis). Under the DIMS classification nine
sub-types are identified as follows:-
1. Psychophysiological DIMS
2. DIMS associated with psychiatric disturbance
3. DIMS associated with drug and alcohol use
4. DIMS associated with sleep-induced respiratory impairment
5. DIMS associated with myoclonus and "restless legs" syndrome
6. DIMS associated with medical, toxic, environmental conditions
7. Childhood-onset DIMS
8. DIMS associated with other conditions
9. No DIMS abnormality (according to EEG criteria)
The reader's attention is directed towards the primary insomnias, that
is those which entail "a persistent inability to obtain adequate sleep"
(Williams et al, 1974; Ribordy and Denney, 1977;, Bootzin and Nicassio,
1978), and which are not secondary to medical or psychiatric illness.
In terms of the classification, therefore, sub-groups 1, 2 and 9
provide the focus of interest, with the remainder being of concern
solely for the purposes of exclusion. Psychophysiological insomnia can
be differentiated from subjective insomnia (sub-type 9) in that the
former is diagnosable upon examination of EEG records; that is
polygraphic evidence confirms self-report. Subjective insomnia,
however, refers to a sleep problem, not substantiated by EEG, which has
led some workers to doubt the validity of the complaint. Recent
evidence, however, has questioned the accuracy with which EEG can
identify sleep-onset within the insomniac group. (These issues will be
fully addressed in Chapter 4, when the relationship between subjective
and objective assessment will be considered. Criteria for the exclusion
of other DIMS categories will also be dealt with at that point). DIMSassociated with psychiatric disturbance (sub-type 2) are also of
considerable interest since this category covers sleep disorders where
neurotic profiles are elevated in simple association with poor sleep as
well as those which are an expression of underlying psychopathology.
The relationship between personality, anxiety, depression, and clinical
insomnia is discussed in Chapter 3 .
A number of studies have compared the sleep patterns of normal subjects
with insomniacs using patient samples rarging from 11 to 18 per group
(Monroe, 1967; Karacan, Williams, Salis and Hursch, 1971; Karacan,
Williams, Littell and Salis, 1973; Frankel, Coursey, Buchbinder and
Snyder, 1976; Gillin, Duncan, Pettigrew, Frankel and Snyder, 1979;
Gaillard, 1978). The most extensive study, however, has been that of
Kales, Bixler, Vela-Bueno, Cadieux, Soldatos and Kales (1984) who
evaluated the sleep of 150 insomniacs (age range 19-90 years) and
compared sleep characteristics with 100 normal control subjects.
Insomniacs were found to have significantly longer mean sleep-onset
latencies (SOL), within each of the age-bands studied, thus confirming
the results of the earlier, less extensive reports. This increased
sleep latency accounted for the greater "total wake time" also
experienced by the insomniac group. No significant differences were
found, .however, on the amount of wakefulness after sleep-onset, a
result which confirms the findings of Karacan et al (1971), but
contrasts with those of Monroe (1967) and Gaillard (1978). Kales et al
also considered the duration of nightly wakenings, however, and found
that more protracted wakenings were typical of the insomniac group. In
other words, insomniacs had greater difficulty returning to sleep. In
common with the research literature on age-related changes in sleep
patterns, these authors also found that wakenings after sleep-onset
increased with age in both experimental groups, suggesting that this
type of developmental, sleep-maintenance insomnia is, in fact, non-
8pathological, despite the distress which it causes to many. Kales et
al, therefore, concluded that "the insomniac's primary difficulty is
initiating sleep, whether at the beginning of the sleep period or
following awakenings during the night".
THE PREVALENCE OF INSOMNIA
It has been reported that more than 50% of adults complain of current
or past sleep disorder and 38% experience current difficulties with
sleep (Bixler, Kales, Soldatos, Kales and Healey, 1979). Insomnia was
by far the most prevalent problem in Bixler et al's study, accounting
for 32% of the present sleep disorders; a finding which is in broad
agreement with other reports where 10-15% of subjects experienced mild
insomnia, and a further 10-15% severe or frequent insomnia (Kales,
Bixler, Leo, Healey and Slye, 1974; Montgomery, Perkin and Wise, 1975)
In an American national prospective study of over 1 million men and
women, Hammond (1964) reported that 13% of men and 26.4% of women
complained of insomnia, and, in the United Kingdom, samples have
yielded prevalence rates of 18-25% (Shepherd, Cooper, Brown and Katton,
1966; Dunnell and Cartwright, 1972). In addition, McGhie and Russell
(1962) reported that more than 15% of their Scottish sample suffered
from chronic insomnia. Difficulties in sleeping are not, however,
confined to the adult population since Price, Coates, Thoresen and
Grinstead (1978) found that 13% of high school students were sleep,
disturbed on four or more nights per week, with a further 33%
complaining of occasional sleep difficulty.
Apart from these prevalence figures, evidence for the widespread
problems posed by poor sleep can be drawn from studies which have
reported on the prescribing of sleep medication. In spite of the now
total withdrawal of barbiturates, other non-barbiturate andbenzodiazepine hypnotics are commonly prescribed. These have remained
the medical treatment of choice, although there is increasing evidence
against the long—term effectiveness of chemotherapy (Kales, Bixler,
Tan, Scharf and Kales, 1974; Oswald, 1979; Kales, Soldatos, Bixler and
Kales, 1983). In the USA, studies have found that as many as 82% of
patients presenting at sleep clinics make regular use of night—time
medication (Roth, Kramer and Lutz, 1976), and Cooper (1977) reported on
the alarming 27 million prescriptions which were written for hypnotic
drugs during 1976 alone. In that same year, a UK survey indicated that
70% of all prescriptions for hypnotics had been written by the
receptionist, compared with only 22% for other types of drugs (Freed,
1976).
Having recognised the prevalence of sleep disorders and the
considerable management and financial issues involved in their
treatment, it is now important to consider some useful theoretical
models of the causation and maintenance of insomnia.CHAPTER 2
AETIOLOGICAL AND THEORETICAL FACTORS 
In this chapter a number of factors of proposed aetiological and
theoretical significance, for primary insomnia, will be discussed in
some detail. It will become clear that no definitive explanation can be
given regarding the causation and maintenance of insomnia, but recent
authors are agreed that models based upon the following theoretical
positions are meritorious and worthy of further investigation (Coates
and Thoresen, 1980; Turner and DiTomasso, 1980; Borkovec, 1982).
1. Physiological hyperarousal
2. Maladaptive operant learning
3. Heightened anxiety, especially performance anxiety
4. Pre—sleep cognitive intrusion
5. Sleep pattern variability and impoverished self efficacy
6. Dysfunction of the sleep—wake system
A review of the evidence supporting each of these theories will be
presented.
PHYSIOLOGICAL HYPERAROUSAL
In 1967 Monroe conducted an extremely influential study comparing good
and poor sleepers on a number of physiological and psychological
variables. His results gave rise to the view that poor sleepers exhibit
heightened autonomic arousal (higher rectal temperature,
vasoconstrictions per minute, perspiration rate and skin conductance,
body movements per hour) both prior to and during sleep. The intuitive
appeal of these findings along with the common use in clinical practice
of progressive relaxation techniques (based upon Jacobson, 1938) may,
however, have afforded this model a somewhat overvalued status since
adequate replication studies have not been forthcoming. Johns, Gay,
Masterton and Bruce (1971) did find higher levels of adrenocortical
activity in their insomniac group, but other workers have failed to
reproduce this effect (Frankel, Buchbinder, Coursey and Snyder, 1973).
11The relationship between EMG-defined muscle tension and insomnia was
investigated by Haynes, Follingstad and McGowan (1974) and Good (1975),
however, neither study found a significant association. Similarly,
Slama (see Borkovec, 1979) found no differences in skin conductance and
heart rate levels between insomniacs and good sleepers, although the
data from this study do refer to observations made during a day-time
nap session. Borkovec also quotes other unpublished studies on student
populations which yield inconsistent results, and he draws attention to
research from two related areas which pose serious problems for the
potential mediational role of physiological hyperactivity.
Firstly, length of latency to sleep-onset has not correlated with heart
rate or frontalis EMG levels (Haynes et al, 1974; Good, 1975; Browman
and Tepas, 1976) or even with physiological activity purposefully
elevated by physical excercise (Hauri, 1968); and secondly, numerous
outcome investigations of relaxation techniques have failed to yield
significant correlations between sleep improvement and within-therapy
assessments of change on various physiological measures, including
heart and respiration rate, and forearm and frontalis EMG (Borkovec and
Fowles, 1973; Haynes, Sides and Lockwood, 1977; Freedman and Papsdorf,
1976; Lick and Heffler, 1977; Borkovec, Grayson, O'Brien, and Weerts,
1979; Coursey, Frankel, Gaarder and Mott, 1980; Hauri, 1981). In
addition, Borkovec (1982) has suggested a further potentially
confounding variable. He observed that a number of his sleep disturbed
cases exhibited phase-shift desynchronies, which implies that
alterations in circadian rhythm may be a sufficient explanation for
observed arousal differences.
There are also a number of methodological difficulties with the
research reports in this area. Firstly, there are relatively few
reports and most have not differentiated adequately between good and
12problem sleepers in order to be convincing comparisons of two distinct
groups. Secondly, studies have approached insomnia as a unitary
phenomenon and have failed to consider specific sub-groups of
insomniacs, some of whom may be more typically "physiological
responders" than others. It may be that the Three Systems Model (Lang,
Rice and Sternbach, 1972), as employed elsewhere in the psychological
literature, could be fruitfully applied to the analysis of sleep
disorders by careful consideration of each individual's characteristic
behavioural, cognitive and physiological responses. Finally, the
clinical utility of relaxation techniques has afforded a validity to
the hyperarousal theory which has not been amply justified. The
reported success of this treatment may not be presumed to operate via
autonomic de-arousal. The role of a physiological mechanism in the
aetiology and maintenance of insomnia does, therefore, await further
innovative study.
MALADAPTIVE OPERANT LEARNING
Bootzin (1972) has proposed an operant learning concept of sleep
disturbance where the conditioning of sleep-incompatible behaviours to
bed-related stimuli may play a significant role in the creation and
maintenance of insomnia. Thus a treatment which eliminates such
associations and pairs rapid sleep-onset with bed cues should be
therapeutic. Within this stimulus control model, primary insomnia is
thought to result from bed-time behaviour which vitiates the bed's
"cueing potential" for sleep ; that is its potential to act as a
discriminatory stimulus for sleep. Stimulus control treatment,
therefore, aims to disassociate activities such as reading, watching
television, eating and smoking from the bedroom environment, since
these are most appropriately conducted elsewhere, and, thereby, to
establish a bedtime routine which is conducive to sleep. The emphasis
13is, therefore, upon altering habitual maladaptive patterns to
facilitate the development of a strong sleep rhythm. See Chapter 7
(Methodology) for details of the therapeutic instructions.
Zwart and Lisman (1979) conducted a component control analysis aimed at
isolating the critical mechanism involved, and reported that the active
ingredient of stimulus control may be that of doing "something else"
other than trying to sleep, if sleep has not rapidly occurred. This
seemed to be the case whether the chosen activity could be deemed
sleep—compatible or sleep—incompatible. Furthermore, their temporal
control strategy (do not nap during the day and rise at the same time
each morning) proved to be as effective as the complete set of stimulus
control instructions, which suggests that the stimulus control strategy
may function through an improved harmonisation of the individual's
circadian cycle rather than via the hypothesised reconditioning of
responses to the environment. In further contrast to the predictions of
the theory insomniacs have not been found to engage more frequently in
overt sleep—incompatible behaviours in bed than non—insomniacs (Haynes
et al, 1974).
Another, alternative explanation for the impact of stimulus control is
that it may preclude arousing cognitive events from the bedroom and the
immediate pre—sleep period, and achieve its therapeutic effect through
the reduction of worry and arousing efforts to initiate sleep. Turner
and Ascher (1979b), for example, have reported that all six subjects in
their study found that the therapy instructions served to "break up
lying in bed and thinking behaviour". Many adults appear to use the
first minutes after retiring to ponder the day's activities and to plan
strategies for the next day, and Turner and Ascher concluded that "this
reflection and problem—solving activity became habitual (for their
clients) and out of the individual's control 	 The stimulus control
14instructions seemed to provide them with a means of asserting self
control over their bedtime cognitions by simply getting out of bed".
It seems, therefore, that in spite of the encouraging results from
treatment studies of stimulus control procedures, the theoretical
rationale for its mode of action has yet to be satisfactorily
explained. The applicability of the concept of stimulus control as a
description of the therapeutic process is certainly in some doubt.
HEIGHTENED ANXIETY - ESPECIALLY PERFORMANCE ANXIETY
Research studies have consistently found that poor sleepers score more
highly on measures of anxiety and neurotic depression than do good
sleepers (see Chapter 3). In addition, it is a common clinical
observation that insomniacs experience considerable anticipatory
anxiety as bedtime approaches. Some researchers have focused,
therefore, upon the role of anxiety as a potential aetiological factor
in primary insomnia. Anxiety-based models can be readily sub-divided
into two categories; namely, that of performance anxiety mediation,
where the technique known as paradoxical intention has been employed as
a therapeutic strategy; and that of pre-sleep cognitive intrusion where
methods derived from cognitive-behavioural theory have recently gained
some popularity. It is the purpose of this section to consider the
former, and the latter will be dealt with in the section to follow.
The performance anxiety formulation proposes that anxiety responses may
be conditioned not only to external, situational cues but also to the
individual's own behaviour or performance. Fear of a performance
failure (and of the anticipated negative consequences of that failure)
is often described as performance anxiety. The victim of this anxiety
predictably attempts to immediately control and correct the deviant
performance through deliberate coping efforts, but these efforts in
15turn may only contribute to longer term exacerbation of the original
difficulty. The development of a vicious circle of performance fear and
failure is particularly evident when related to the maintenance of
control over physiological processes (Ascher, 1979). According to the
model sleep is, similar to other autonomic responses, considered to be
a member of a class of behaviours which cannot fully be placed under
voluntary control. The individual can arrange conditions which are
conducive to sleep (eg. darkened room, restful quiet) but there is a
point beyond which further, deliberate control cannot be exerted. At
this juncture attempts at sleep are usually relinquished, allowing
sleep to develop naturally, however, it is hypothesised that those who
suffer from insomnia exacerbate their problem by endeavouring to
maintain direct control over the sleep process itself, and the
resultant "effort to sleep" inhibits sleep-onset, either directly, or
through increased physiological and/or cognitive arousal. The
paradoxical instruction designed to obviate this performance anxiety is
to attempt to remain awake, yet relaxed, in an environment optimal for
sleep development. The preclusion of attempts to fall asleep,
therefore, is thought to enable the subject to sleep naturally.
To date, there have been no systematic investigations of this model,
although once again it can be seen to have some intuitive appeal.
Patients commonly report frustration and self-recrimination regarding
their inability to sleep, and are often very concerned about the
daytime sequelae of inadequate sleep (Espie and Lindsay, 1985). The
research literature is limited to clinical reports, although two recent
studies have highlighted some practical and theoretical problems with
the procedure. Firstly, Fogle and Dyal (1983) found that simply telling
subjects to "give up" trying to sleep and to stop worrying about the
negative consequences of sleep loss was as effective in improving sleep
estimates as the paradoxical directive to remain awake. Interestingly,
16however, only the "giving up" strategy produced a reduction in a self—
report measure of performance anxiety. This study, therefore, raises
the question of the critical ingredient in paradox. It also suggests
that paradoxical intention may function irrespective of reduction in
performance anxiety levels. It may be, for example, that patients
modify their expectations of sleep and redefine sleeplessness as less
aversive or problematic. For some, therefore, a reduction in anxiety
concerning sleep may be a sufficient therapeutic outcome, regardless of
changes in sleep pattern, whereas for others improved sleep efficiency
may be satisfactory irrespective of performance fear. Secondly, it has
been suggested that the instruction to remain awake may be followed
literally by some patients to the point where "effort to sleep" is
replaced by "effort to remain awake", in order to comply with
therapeutic instructions. In other words, performance anxiety may not
be obviated but refocused (Espie and Lindsay, 1985). These workers
reported on several cases where paradox exacerbated the initial sleep
problem, and they suggested that "effort to remain awake" could be
construed as an active, arousing process compared with the more passive
avoidance of effort to sleep.
There is need for research to investigate carefully the mechanism(s) by
which paradoxical procedures achieve their therapeutic effect. Strong
(1984), in a recent review article, has suggested that investigations
should work towards an understanding of "the relations of voluntary and
involuntary responses to psychological symptoms". The role of
performance anxiety in paradoxical treatment is unclear. It may be
that the performance—based model is a better explanation for the
maintenance (rather than causation) of insomnia since an extended
period of disturbed sleep could conceivably condition an apprehensive
expectation of insomnia rather than representing a primary aetiological
mechanism (Kales, Caldwell, Soldatos, Bixler and Kales, 1983).
17PRE-SLEEP COGNITIVE INTRUSION
Reference has been made to a number of reports which have suggested
that cognitive mediational variables may account for the effectiveness
of psychological treatments. In addition to the generally heightened
level of anxiety characteristic of the insomniac group, a number of
workers have described insomniacs as obsessive, repetitive worriers
(Coursey, Buchsbaum and Frankel, 1975; Roth et al, 1976) who have
difficulty in clearing their minds of anxious mentation, and more
specifically, suffer from persistent cognitive intrusion prior to
sleep-onset (Haynes et al, 1974; Borkovec et al, 1979; Mitche11,1979;
Lichstein and Rosenthal, 1980). This state of cognitive hyperarousal at
bedtime is, according to the model, responsible for inhibiting the de-
arousal and relaxation necessary for sleep induction, and may become an
habitual mechanism for problem-solving and goal planning. Other
reports,however, have obtained contrary results where pre-sleep mental
stress was not significantly associated with onset insomnia (Haynes,
Adams and Franzen, 1981; Freedman and Sattler, 1982) although the
latter study was conducted during a single night's recording in a sleep
laboratory where worrying would perhaps be less likely owing to the
novelty of the environment and its associated distraction potential.
Further investigation of the role of mental events has been undertaken
by Hauri (1975) and Borkovec (1979) who have developed what is known as
the "sleep system model", which hypothesises that the Reticular
Activating System (RAS) regulates wakefulness while the serotonergic
sleep system controls sleep. Low RAS activity can produce quiet
wakefulness (and possibly stage 1 non-REM sleep), however, the active
induction of the sleep system may be required to produce stage 2, 3 and
4 sleep. Hauri (1975) has proposed that insomnia may, therefore, result
from high RAS activity and/or a weak sleep system. Borkovec (1979) has
18suggested that the balance of the wakefulness/sleep systems differs
between two sub-groups of insomniacs, ie. objective (EEG-confirmed) and
subjective (experiential only) insomnia, in that the latter is a
function of a normal sleep system in combination with overly active
wakefulness, whereas objective insomnia is hypothesised to be the
result of a weak serotonergic system. Evidence for this analysis is
presented in Borkovec et al (1979) who found that their group of
experiential insomniacs retrospectively reported a significantly
greater amount of pre-sleep mentation than did their
psychophysiological insomniacs. On the basis of this finding, these
workers hypothesised that subjective insomnia may be the result of
affect-laden pre-sleep cognitions which are difficult for subjects to
differentiate from early sleep mentation, whereas mental correlates of
psychophysiological insomnia are less affect-laden. This theoretical
model goes some way towards explaining both the common reports of
cognitive intrusion in the insomniac population, and also the
recognised difficulty which many poor sleepers have in distinguishing
early sleep from wakefulness (see Chapter 4).
A more recent study has provided further, moderate support for a
relationship between cognitive factors and the subjective experience of
onset insomnia (Van Egeren, Haynes, Franzen and Hamilton, 1983),
although Borkovec's theory regarding a differential causal mechanism,
incorporating the role of affect, was not substantiated. Van Egeren et
al employed a multiple regression paradigm, the results of which
suggested that the anxious content of pre-sleep cognitions and the
attributions of sleep difficulties were significantly associated with
sleep-onset latency. They concluded that "although at an early stage of
conceptual and methodological development, research designs to identify
specific pre-sleep cognitive activities and beliefs can provide the
basis for the development of effective cognitive interventions for the
19treatment of sleep-onset insomnia". However, their findings are also
limited, by their own admission, that "a significant proportion of the
variance of the sleep quality variables (eg.restedness) remains
unaccounted for and requires additional investigation". The
relationship between sleep satisfaction and mental stress at bedtime
has yet to be investigated.
SLEEP PATTERN VARIABILITY AND IMPOVERISHED SELF EFFICACY
There is some evidence to suggest that insomniacs exhibit greater night
to night variability on most sleep parameters compared with good
sleepers (study by Coates, Strossen, Rosekind and Thoresen referred to
in Killen and Coates, 1979). It would seem possible, therefore, that
due to this inherent unpredictability of what sleep will be like on any
given night, the insomniac might consider his sleep pattern (and his
sleep problem) to be uncontrollable. Killen and Coates (1979) proposed
that the uncertainty which results from a variable sleep pattern might
interact with other worries and concerns to inhibit sleep, or foster
the perception that sleep is much worse than it really is. According to
this model, therefore, insomnia develops as an anxiety response to
uncertainty regarding sleep and is associated with a reduction in self
efficacy; that is the perception of one's own ability to manage and
modify a problem. A study by Evans (1977) attempted to identify the
characteristics of sleep efficiency which are of principal concern to
poor sleepers. Interestingly, the factor of "voluntary control of
sleep" emerged to account for the greatest proportion of variance,
indicating the perceived importance of the "decision process" in sleep
onset (cf. paradoxical intention). If this process is disturbed, or
rendered ambiguous, because of a highly variable sleep pattern, it
would seem probable that anticipatory anxiety would increase and
positive perceptions of self efficacy would reduce. As Bandura (1977)
20has observed, however, the cognitive processing of efficacy information
is likely to differ from individual to individual with differing
expectations and anticipations arising from similar experiences of
mastery and failure.
One difficulty emerging from the available literature has been the
persistent use, in both descriptive and statistical analyses, of weekly
mean values to quantify sleep pattern [eg. mean score (over 7 nights)
for sleep latency (minutes)]. Average values, however, convey little
impression of the night to night variability of sleep which may be
typical of insomnia. A concomitant measure of variance would appear,
therefore, to be necessary.
DYSFUNCTION OF THE SLEEP-WAKE SYSTEM
It is a common experience for shift workers and airline personnel to
develop sleep problems when they are forced to obtain sleep at times
when circadian cycles favour wakefulness (Rutenftanz, Colquhoun, Knauth
and Ghata, 1977). Irregular non-24 hour schedules, in which sleep and
wake times are shifted frequently, have been found to decrease sleep
efficiency and total sleep time and to increase time awake during the
night and daytime sleepiness (Webb and Cartwright, 1978; Webb and
Agnew, 1978). A number of studies have demonstrated that advancing,
delaying, extending or reducing established sleep periods produces
measurable deficits during waking behaviour (Taub and Berger, 1973;
Taub and Hawkins, 1977), and chronically irregular sleepers have been
found to have demonstrably lower physiological arousal, poorer
psychomotor performance and a greater frequency of negative mood states
than sleepers who maintain regular sleep—wake cycles (Johnson, 1973;
Webb and Agnew, 1974, 1978). Reference has already been made to data
from Monroe's (1967) study, suggesting that poor sleepers are
autonomically overaroused, but Killen and Coates (1979) have proposed
21that such physiological disturbances in sleep could represent abnormal
fluctuations in rhythmic processes which then lead to disturbed sleep.
Miles, Raynal and Wilson (1977) have also suggested that poor sleep may
result from anomalies within the circadian cycle although they were
unsuccessful in their attempt to modify the abnormal circadian rhythm
(24.9 hours) in their single case study.
In spite of some evidence indicating the potentially disruptive
influence of unsettled sleep—wake cycles, it seems unlikely that this
model can explain adequately the aetiology of typical cases of
insomnia. However, it may be particularly appropriate for the type of
sleep problem often experienced by shift workers. Interestingly, the
notion that there may be an optimal period for sleep is also
incorporated in other theoretical approaches such as the stimulus
control paradigm and the sleep variability model, where the principal
aim of therapy is to establish a predictable nightly sleep routine.
Investigation of an individual's functioning from a 24—hour perspective
would appear, therefore, to be useful especially if psychological
correlates are considered.CHAPTER 3
OTHER COVARIATES OF INSOMNIA
This chapter will consider a number of factors which bear some
important, but not necessarily causal, relationship to insomnia. The
areas under consideration will be presented in the following order:—
1. Personality variables in insomnia
2. The role of life events
3. The effects of monotonous stimulation
4. The effects of physical exercise
5. The effects of diet
6. The effects of insomnia upon daytime functioning
PERSONALITY VARIABLES IN INSOMNIA
Numerous studies have documented differences between good and poor
sleepers on measures of psychopathology and personality. Free—floating
anxiety, phobic anxiety, somatic concomitants of anxiety and neurotic
depression have all been elevated within the poor sleep group (Kumar
and Vaidya, 1984), and several studies have found that the Taylor
Manifest Anxiety Scale is a useful discriminator of insomniacs and non—
insomniacs (Haynes et al, 1974; Hicks and Pellegrini, 1977; Kumar and
Vaidya, 1984). Only one study has suggested the opposite relationship,
conceptualising short sleepers as "non—worriers" (Hartmann, 1973). The
most commonly adopted measure, however, has been the MMPI (Minnesota
Multiphasic Personality Inventory) where research results have been
consistent over a wide range of insomniacs in terms of age, chronicity,
presence or absence of medication and source of sample. There is some
evidence, however, that psychopathology is more prominent in younger
insomniac subjects (Roehrs, Lineback, Zorick and Roth, 1982) with the
older agegroups being more likely to suffer sleep loss as part of the
natural ageing process. In general, insomniacs have exhibited neurotic
profiles on the MMPI, with elevations on the depression,
hypochondriasis, psychopathic deviance, psychasthenia, and hysteria
23scales (Monroe, 1967; Johns et al, 1971; Coursey et al, 1975;
Carskadon, Dement, Mitler, Guilleminault, Zarcone and Spiegel, 1976;
Freedman, 1976; Kales, Caldwell, Preston, Healey and Kales, 1976;
Monroe and Marks, 1977; Shealy ,Lowe and Ritzier, 1980; Kales et al,
1983a; Levin, Bertelson and Lacks, 1984). MMPI reports have been
further corroborated by studies reporting higher rates of dysphoric
mood (Beutler, Thornby and Karacan, 1978; Johnson, Church, Seales and
Rossiter, 1979), depression (Coursey et al, 1975) and general medical
complaint (Monroe, 1967; Roth et al, 1976). Thus, the insomniac can be
characterised as a person who is mildly depressed, anxious,
hypochondriacal and overly worrisome.
Borkovec (1982) has pointed out that there are interpretative problems
with personality study data since these psychological features may not
be causatively related to disturbed sleep, and few significant
correlations have been found between personality variables and
objective sleep parameters. He also refers to studies which failed to
establish personality differences between insomniacs and good sleepers
(Rechtschaffen, 1968; Gering and Mahrer, 1972). Kales et al (1983a),
however, suggest that the homogeneity of the MMPI profiles amongst
their (and other) chronic insomniacs should be interpretated as strong
evidence of their psychopathology being primary to their sleep
disorder. They propose that, during the day, the insomniac typically
inhibits, denies and represses conflicts which at night, in the
relative absence of external stimulation, re-emerge, resulting in an
internalised focusing of attention (Kales, Soldatos and Kales, 1982).
This process of internalisation is hypothesised to lead to chronic
emotional arousal, in turn also provoking physiological arousal, and
rendering the subject unable to sleep.
Whether or not these psychological characteristics prove to be a cause
24of insomnia, or simply correlates of disturbed sleep, the available
evidence does point towards the appropriateness of considering insomnia
from a cognitive—behavioural perspective, since, whether before or
after the development of poor sleep, there develops a consistent
clinical picture of neurosis.
THE ROLE OF LIFE EVENTS
There is now considerable evidence that physical illness and
psychological problems are more likely to develop when there is an
increase in life events which effect change in the relatively stable
pattern of an individual's life (eg. Holmes and Masuda, 1974; Paykel,
1974). The person's ability to cope appears also to be related to the
magnitude and nature of these stressful events, and to the manner in
which they are perceived and interpreted. Personal vulnerability is
thought to be mediated by a combination of biological predisposition,
learning history, current life situation and personality
characteristics and attitudes (eg. Rahe, 1974; Hinkle and Wolff, 1958).
A study by Healey, Kales, Monroe, Bixler, Chamberlain and Soldatos
(1981) compared groups of good and poor sleepers on various life
experience questionnaires within the context of a structured interview.
Although the onset of insomnia was regarded as gradual by the majority
of poor sleepers, major life events during the year in which insomnia
started were evident in 70% of cases. In addition, insomniacs exhibited
a greater degree of personal vulnerability (more emotional upset)
during childhood and were less content with their parents and their
family lives than were the good sleepers. Consistent with previous MMPI
studies, poor self—concept and frequent health complaints were noted,
and the authors proposed that their poor sleepers seemed prone to
internalise stress reactions. Healey et al concluded by stating that
"one of the early goals of treatment should be to help insomniacs
25acknowledge their sleep disturbance as inextricably related to their
waking lives, and not a disease entity for which a magical cure can be
found".
This study is the only one available which has investigated the
association between life events and insomnia. The findings, however,
may run in parallel with the research on psychopathology since
obsessively worrying people might be prone to react adversely to major
life change. Further investigation is required to replicate these
results, particularly within the context of a prospective study. As
with all retrospective analyses there is the problem of attribution
where subjects may make false causal connections between current
problems and previous circumstances.
THE EFFECTS OF MONOTONOUS STIMULATION
A series of investigations by Bohlin (1971, 1972, 1973) has indicated a
relationship between orienting response habituation and the development
of sleep-onset. In each of these experiments subjects achieved more
rapid sleep-onset after monotonous stimulation (repetition of an
audible tone every 20-40 seconds) compared with the no stimulation
control procedures, suggesting that orienting response habituation is
an actively de-arousing process. Bohlin (1973) proposed that the rate
of this habituation and subsequent sleep development interact with
initial arousal level such that rapid habituation occurs when the
subject is in a low state of arousal and slower habituation accompanies
high arousal.
Borkovec (1979) has raised the possibility that these findings may have
some implications for the traditional psychological approaches to the
management of insomnia and their underlying theoretical models. It is
possible, for example, that repeated tension-release cycles in
26relaxation, and the repetition of a "mantra" in meditation function as
soporific stimuli within this habituation model. Similarly, techniques
aimed at blocking out external stimulation and the preclusion of
intrusive thinking might significantly reduce initial arousal levels to
facilitate habituation. Since attentional processes are of paramount
importance in this theoretical analysis, any therapeutic procedure
which overcomes the problem of dishabituating stimuli (overt or covert)
might be of considerable value, and worthy of further investigation.
THE EFFECTS OF PHYSICAL EXERCISE
The possibility of there being a significant relationship between
physical exercise, subsequent fatigue, and night-time sleep has
considerable intuitive appeal. Insomniacs frequently report that they
try to "tire themselves out", and the restorative hypothesis of sleep
would predict that such physical activity would increase the total time
slept, particularly in "deep sleep". The earliest evidence for this
view was provided by Baekeland and Lasky (1966) who obtained
significant increases in SWS sleep especially following afternoon
exercise in their sample of 10 athletes. By comparison, evening
exercise was associated with more disturbed sleep characterised by more
frequent, brief wakenings and increased stage 1 sleep. These authors,
therefore, identified the importance of the timing of exercise, and
suggested that the later the exercise the greater its potential as a
"stressor producing CNS activation". Horne and Porter (1976) have also
provided tentative evidence that late daytime exercise intrudes upon
sleep. A comprehensive review by Torsvall (1983) considered 20
investigations of the association between sleep and exercise. Half of
these studies were found to support the hypothesis that activity
facilitates deeper and longer sleep, and three of these also found
reductions in sleep-onset latency. However, the remaining studies were
27categorised as either inconclusive or unsupportive of the theory.
Torsvall concluded that the strongest weight of evidence for the
positive impact of exercise upon sleep is in physically fit subjects.
The optimal level of this activity has yet to be investigated. He also
stressed the need for longitudinal studies, incorporating sufficient
numbers to compare trained and untrained cases during an exercise
programme.
The impact of exercise within the insomniac population has not been
systematically examined. Marchini, Coates, Magistad and Waldum (1983)
did find that the daytime behaviour of insomniacs and good sleepers
differed in that the good sleepers had busier and more active daytime
lives than their insomniac counterparts, and these workers proposed
that "increased activity, especially in the mornings and early evenings
may be helpful in treating insomniacs". Although such an instruction is
frequently included in "self—help" programmes, controlled research i s
clearly required to establish firstly, whether significant changes in
insomniac sleep pattern can be obtained by this method alone; and
secondly, whether or not such improvements are of clinical importance.
The most recent review of psychological management issues in insomnia
(Lichstein and Fischer, 1985) strongly supports Paxton, Trinder and
Montgomery's (1983) conclusion that "the relationship (between sleep
and exercise) is unreliable and subject to alternative explanations.
Clinical prudence demands that the sleep effects of exercise be judged
on an individual basis".
THE EFFECTS OF DIET
Bootzin and Engle—Friedman (1981) have stressed the importance of
considering all aspects of drug use and diet in the assessment of
insomnia (see Chapter 5 for information on the effects upon sleep of
hypnotic drugs, including alcohol). Probably the most commonly taken
28drug in daily use is caffeine, which is contained in coffee, tea,
"cola" drinks and certain analgesics and weight—control agents.
Research has suggested that this stimulant drug can disrupt sleep and
be associated with racing, worrisome thoughts (Goodman and Gilman,
1969). Such sleep disturbance has been found to be dose—related since,
in one study, the equivalent of four cups of coffee induced a reduction
in total sleep time of 0.4 hours and increased sleep latency by 13
minutes, whereas one cup of coffee taken 30 minutes prior to bedtime
had no significant effects. A report by Brezinova, Oswald and Loudon
(1975), however, found that caffeine 15 minutes prior to bedtime
produced more frequent and longer awakenings in their subjects. In
addition, Bolton and Null (1981) have suggested that heavy, regular
consumers are more likely to develop a tolerance to caffeine and,
therefore, suffer less ill—effects on their sleep than sporadic
consumers. Despite the fact that patients are often advised to avoid
drinking coffee in the late evening (eg. Hauri, 1979) there is no
direct evidence to suggest that such dietary control is an effective
remedy for even mild insomnia. Similarly, the ingestion of Ovaltine,
Horlicks or warm milk has been found, in laboratory studies, to improve
sleep, especially during the last third of the night (Brezinova and
Oswald, 1972) but it seems unlikely that this would offer much
potential as a treatment for clinical insomnia. Although sleep
parameter changes have been found to be statistically significant,
providing some evidence for the value of emphasising dietary change as
a piece of useful advice, such procedures have not been evaluated in
comparison with other, medical or psychological treatments.
THE EFFECTS OF INSOMNIA UPON DAYTIME FUNCTIONING
The definition of insomnia as "a persistent inability to obtain
adequate sleep", highlights the importance of establishing the point at
29which sleep becomes inadequate for the purposes of daytime functioning.
Research has generally considered this issue by examining three main
categories of "next day effects" which are consequent upon an
impoverished sleep.
Firstly, Bootzin and Engle—Friedman (1981) have provided a helpful
review of "performance measures" which appear to be sensitive to the
effects of sleep loss. Sleep deprivation studies on normal samples
have shown that subjects perform poorly on vigilance, reaction time,
and arithmetic tasks making greater numbers of detection errors due to
poorer attentional functioning, being slower to respond to both visual
and auditory stimuli, and getting fewer problems correct in mental
arithmetic exercises (Glenville, Broughton, Wing and Wilkinson, 1978;
Poulton, Edwards and Colquhoun, 1974; Williams and Lubin, 1967). More
recent work on insomniac patients has also revealed similar deficits on
a variety of psychomotor and cognitive tasks, along with specific
difficulties in semantic memory (Mendelson, Garnett and Linnoila, 1984;
Mendelson, Garnett, Gillin and Weingartner, 1984). Inadequate sleep has
been associated, therefore, with impairment of certain aspects of
cognitive function.
A second area of concern is that of daytime fatigue. Dement, Seidel and
Carskadon (1984) have reviewed the available evidence on the
association between such fatigue and night—time wakefulness. They
reported the results of some of their own work (Carskadon and Dement,
1982) which demonstrated a linear relationship between daytime
sleepiness and sleep, in that fatigue increased as sleep was
systematically reduced in experimental subjects. They recommend the use
of the Multiple Sleep Latency Test (MSLT) (Richardson, Carskadon,
Flagg, Van den Hoed, Dement and Mittler, 1978) as an objective measure
of daytime tiredness since it is sensitive to the effects of even the
30relatively small reductions in sleep which have been found to produce
substantial, and highly significant increases in daytime sleepiness
(Carskadon and Dement, 1981; Roehrs, Zorick, Sicklesteel, Wittig and
Roth, 1983). Dement et al (1984) have proposed that, where there are no
symptoms of fatigue, but there is substantial evidence of sleep
disruption, the most obvious explanation is that too much time is being
spent in bed. In such cases, a didactic approach may be indicated, and
indeed, Lichstein (1980) has reported the successful "treatment" of
such an individual by simply advancing bedtime and backing up the time
of morning rising.
A third group of studies have reported disturbances in daytime mood in
poor sleepers. Nicassio and Bootzin (1974) found that psychological
therapy was associated with a reduction in ratings of irritability, and
Marchini et al (1983) reported that their insomniacs differed from
normal controls in that the former rated themselves as significantly
more worried, upset, self—critical, hostile; and depressed, and
significantly less energetic and physically active, and also considered
that they "enjoyed themselves" less. It is of course possible that such
features of insomniac mood state are a reflection of neurotic
disposition, as previously described. The study by Mendelson et al
(1984a), however, did not find any difference between insomniacs and
controls on a mood rating scale which comprised a series of analogue
measures.
In conclusion, the research literature provides conflicting evidence on
the effects of insomnia upon daytime behaviour, mood and performance.
Certainly, it would seem that when subjects are deprived of their usual
sleep requirement, deficits become evident. However, few studies have
been completed upon severe insomniacs, and it seems possible that these
patients fall into a number of sub—groups; some having marked
31impairment of daytime activities, others mild to moderate impairment,
and yet others who exhibit no ill—effects whatsoever. For a proportion
of poor sleepers, therefore, a didactic approach, highlighting the
normality of their own sleep patterns, and the identification of actual
sleep needs might enable them to re—define their complaints. A
rescheduling of night—time routine would seem appropriate in such
cases. Clearly, considerable research is still required to establish
the association between subjective and objective parameters of
sleepiness, and the question of whether or not the absence of daytime
disturbance invalidates treatment for primary insomnia remains to be
adequately addressed.CHAPTER 4
THE ASSESSMENT OF SLEEP PATTERNS 
Recent reviews (Coates and Thoresen, 1980; Bootzin and Engle—Friedman,
1981; Kales and Kales, 1984) have indicated that a thorough evaluation
of sleep pattern should incorporate measures from each of the following
areas:—
1. The taking of a sleep history
2. A medical examination
3. Electroencephalographic assessment
4. A comprehensive behavioural analysis
This chapter will describe each of these aspects of sleep measurement
with reference to the assessment of insomnia. Particular attention will
be paid to the practical usefulness of the information obtained. The
chapter will conclude with a comparison of self—report and EEG measures
and an overview of sleep assessment within the natural environment.
THE SLEEP HISTORY
In clinical practice the sleep history and medical examination are
usually completed during a brief consultation, the outcome of which is
often the prescription of sedative—hypnotic medication. The main
emphases of this interview are upon the confirmation of a clinically
significant sleep problem and the exclusion of aetiological medical
problems and transient personal/situational upsets. As with any intake
interview, personal details and other demographic information are
recorded followed by the eliciting of a verbal description of the
nature and development of the sleep disturbance itself. The importance
of considering insomnia within a developmental context, especially with
elderly patients, and of distinguishing between "natural" sleep pattern
changes and clinically important sleep difficulties has been stressed
(eg. Bootzin and Engle—Friedman, 1981). Since individual sleep needs
are known to vary considerably even within age—groups, the interviewer
33must also consider the patient's perception of his/her sleep needs, and
the associated expectations and attributions which result therefrom.
The evaluation of the degree of "intrusiveness" experienced, in terms
of next day effects such as fatigue and irritability, is also central
to the diagnostic process (Dement et al, 1984). In addition, the
numerous studies which characterise the insomniac as an overly anxious,
mildly depressed individual point to the importance of including a
careful history of such factors. Cases of clinical depression are
likely to present with secondary sleep disorder. An evaluation of
individual coping styles may also reveal psychological factors of
aetiological significance, and although no standard measures have as
yet been developed, prudent questioning can often yield a preliminary
formulation in terms of the models of causation and maintenance already
outlined.
MEDICAL EXAMINATION
There are three principal reasons for including a medical examination
in the assessment of insomnia. Firstly, insomnia can result from
physical pathology, either directly (ie. through central nervous system
pathology), or indirectly as a result of pain/discomfort caused by
physical illness. Secondly, the clinical implications of
pharmacological intervention require consideration since the use of
both stimulant and hypnotic drugs can lead to tolerance, dependance and
poor sleep (Kales et al, 1983b); Kales and Kales, 1984). Patients may
have to be stabilised on medication, have it withdrawn, or be
safeguarded from the potentially deleterious effects of certain drug
interactions. Thirdly, there is now strong evidence that a normal
physical examination is adequate for differential diagnosis amongst
various sub-types of insomnia. Guilleminault and Dement (1977) reported
that 85% of cases of narcolepsy, sleep apnea, nocturnal myoclonus and
34restless legs syndrome were diagnosable via a physician's normal
physical examination. Given the relative rarity of these disorders
compared with insomnia (Borkovec, 1982) it is estimated that this would
result in less than two sleep-disordered patients per 100 being wrongly
classified. Other workers have also supported this view (Coates and
Thoresen, 1980). Furthermore, there has developed recently a reaction
to what some believe to have been an over-emphasis upon physiological
factors in sleep laboratory studies of insomnia. For example, Kales and
Kales (1984), two of the most respected research scientists working in
this field, quoted from a pertinent editorial that "it is time to re-
assess the value of clinical judgement. It is time for the pendulum to
swing the other way, not only because of economic pressure but because
of another lost art - common sense" (Scott, 1979). Kales and Kales go
on to say that the general practitioner in the context of the office
setting is best able to assess all aspects of the patient's functioning
in order to balance all of the contributory factors towards an
understanding of the patient's problems. Similarly, Oswald (1981)
concluded that the GP is the best person to diagnose and manage most
sleep disorders.
ELECTROENCEPHALOGRAPHIC METHODS
Interest in all-night polygraphic recording of sleep was initially
aroused by the discovery of changes in the EEG during sleep (Loomis,
Harvey and Hobart, 1937), and the subsequent definition of sleep stages
(Dement and Kleitman, 1957). Over the past 30 years, a vast research
literature has developed describing "objectively-defined" sleep
patterns, stages and disorders. Much of this work has been the product
of numerous "Sleep Disorders Centres" set up during the 1960's in
various parts of the USA. Researchers have (rightly) made a science of
the study of sleep physiology, but there have been problems inherent in
35the evaluation of insomnia for two, related reasons. Firstly, insomnia
is primarily a subjectively experienced and reported phenomenon
(dissatisfaction with sleep); and secondly, objective indices of
insomnia have frequently correlated poorly with self-report. The
relationship between subjective and objective measures will be dealt
with in some detail later in this chapter.
Although the term EEG refers only to electrophysiological recording of
brain activity, via the standard positioning of electrodes, in
practice, EEG is generally recorded through a polygraph with an
attached printer, other channels of which are used to measure eye
movement and muscle activity. These two latter measures are known as
the elecro-oculogram (EOG) and the electromyogram (EMG). EEG, EOG and
EMG are recorded concurrently throughout the night and the resulting
polygraphic trace is usually scored visually in segments of 20 or 30
seconds, which can be assigned to stages of sleep according to
recognised criteria (Rechtschaffen and Kales, 1968). Objective data are
generated, therefore, on the various stages within sleep, and the EEG
is uniquely appropriate for detailed descriptive analysis, and for the
definitive descriptive diagnosis of difficult cases.  EEG recording is
not only a highly technical procedure but it is also very expensive,
not least in terms of the sheer volume of recorder paper (300 to 700
metres per subject night). There are, however, two rather more serious
methodological difficulties in the measurment of insomniac sleep.
Firstly, during the first night in the sleep laboratory, subjects take
longer to fall asleep, awaken more often and have more total wake time
than on subsequent nights when they have adjusted to their new
environment (Rechtschaffen and Verdone, 1964; Agnew, Webb and Williams,
1966). For this reason, an adaptation night is now routinely included
in sleep studies in order to obviate such "first night effects".
36Although subsequent nights may be less reactive, it should be
remembered that the stimulus control hypothesis would predict rather
less transitory alterations in the sleep pattern of chronic insomniacs,
and the directionality of any change might also vary (sleep pattern
might improve rather than deteriorate). The removal of the subject from
the home environment is, therefore, a confounding variable in
psychological research. Potential changes in physical and mental
relaxation may also modify the problem under observation eg. the
attachment of 12 electrodes and the novel environment may occupy
thinking and preclude intrusive worry.
A second methodological problem concerns the fact that researchers
frequently require subjects to sleep only within the limits of
predetermined recording periods, in order to cater for between group
comparison. This experimental manipulation is certainly invasive of the
sleep process itself on the recording nights, but might also modify the
sleep pattern on subsequent nights by rescheduling wakening time. The
rather more flexible "ad lib" design, however, has the advantage of
permitting subjects to remain in bed for as long as they wish, but
proves problematic in data comparison.
The use of home polysomnography (Coates, Killen, George, Marchini,
Silverman, Hamilton and Thoresen, 1982), where polygraphic data are
transmitted over a single telephone line, may be one solution to some
of these problems. It is still at a relatively experimental stage, and
although it allows for recording within the natural environment, it
does remain considerably intrusive. In addition, in spite of the
technological advances involved, one study reported the loss of 37% of
EEG recordings through technical failure (Ancoli—Israel, Kripke, Mason
and Messin, 1981).THE BEHAVIOURAL ASSESSMENT
Within the psychological literature, sleep has been construed as an
observable behaviour, or set of behaviours, which conforms to the
principles of learning theory. The insomniac is seen as having acquired
a maladaptive sleep pattern, which may be initiated by certain
antecedent conditions (for example tension or sleep—incompatible
stimuli), and maintained by reinforcing consequences (eg. perception of
self as a "poor sleeper", performance failure). Behavioural analysis is
able, therefore, to provide information on the situational correlates
of sleep and their interactions with actual sleep pattern parameters.
Importantly, however, the experiential and qualitative data which form
the basis of routine clinical presentation may also be usefully
addressed. In common with most psychological research, behavioural
assessment has become a logical extension of the initial interview,
thus providing baseline data against which treatment process and
treatment outcome may be measured. The methods employed in behavioural
analysis of sleep problems will be reviewed under three headings. These
are a) self—report, b) observer report and c) recording devices.
Self Report
The two most commonly used self—report measures are sleep
questionnaires and sleep diaries. The questionnaire is particularly
useful where a large number of subjects are to be surveyed or screened
(eg. McGhie and Russell, 1962) and has the advantages of being quick,
easy and inexpensive to administer. Johns (1975) and Evans (1977) have
reported factor analyses and normative data on sleep questionnaires,
and Bootzin and Engle—Friedman (1981) have suggested that such measures
may be usefully supplemented by the use of rating scales, which provide
process data (eg. Parrot and Hindmarch, 1978). Most of the influential
treatment studies, however, have preferred the diary to the
38questionnaire because the latter is particularly vulnerable to
criticism based upon the problem of reporting bias. When patients are
requested retrospectively to summarise their sleep, they may be unduly
influenced by recent experiences of sleep and may be prone to
inaccurate attributions and generalisations. In those situations where
the possibility of treatment is envisaged by the patient, there may be
bias towards exaggerated reporting. Global reports, nevertheless, may
serve as useful adjuncts to continuous sleep records.
The general use of daily sleep logs, based upon the revised daily sleep
questionnaire (DSQ) (Monroe, 1967), has led Bootzin and Nicassio (1978)
to describe these as the "staple of assessment procedures in insomnia
treatment outcome research". This questionnaire is completed each
morning upon wakening and includes variables such as : number of
minutes to sleep-onset, total time slept (hours and minutes), frequency
of intermittent wakenings, and several qualitative ratings of, for
example, sleep satisfaction and restedness. The DSO makes the subject's
task more specific and less ambiguous than the sleep questionnaire and,
therefore, diminishes the problem of response bias, although it does so
incompletely. Some researchers have required subjects to return
questionnaires each day by mail to counteract the tendency of some
retrospectively to complete the logs on the day prior to their next
appointment (Lick and Heffler, 1977; Lacks, Bertelson, Gans and Kunkel,
1983). Steinmark and Borkovec (1974) have also developed an
experimental design which controls for therapy-induced expectancy
effects and demand characteristics, thus improving reliability of self-
report (A description of this procedure is contained in the methods
section of this study - Chapter 7).
An investigation by Coates et al is quoted in Bootzin and Engle-
Friedman (1981) as evidence for the reliability of sleep diary
39measures. These workers obtained an average test-retest correlation,
for daily sleep-onset latency, of 0.93 for poor sleepers and 0.58 for
good sleepers. The comparable test-retest figures for EEG assessment
were only 0.70 and 0.58 respectively. Overall sleep diary reliabilities
were 0.69 and 0.35, while EEG reliabilities were 0.66 and 0.60 for poor
and good sleepers. Bootzin and Engle-Friedman concluded, therefore,
that "sleep diary reliabilities are equivalent to EEG reliabilities,
especially for insomniacs". Measures of validity are equally
encouraging. Sleep log estimates have been found to correlate highly
with observer estimates of the same night's sleep (r = 0.84, Turner and
Ascher, 1979a). Of equal importance, however, is the self-evident fact
that, since it is verbal complaint of insomnia which initiates
treatment, verbal statements of sleep pattern must, likewise, be of
primary evaluative importance. Notwithstanding these results on
reliability and validity there has been considerable debate concerning
the accuracy and usefulness of self-reporting of insomnia. These
matters will be addressed again shortly.
Observer Report
A number of workers have made use of nurses' (Kupfer, Wyatt and Snyder,
1970; Erwin and Zung, 1970) and spouse's or room-mate's (Nicassio and
Bootzin, 1974; Turner and Ascher, 1979ab) observations to provide a
more objective measure of sleep. The observer has been asked to attend
to criteria such as : subject's eyes closed, absence of voluntary
movement, deep respiration, and failure to respond to the question "are
you asleep"?, and to make a decision as to whether he/she is awake or
asleep. In the ward setting, time sampling procedures have been used
from which estimates of sleep latency, sleep time and frequency of
wakenings have been derived, although the results from the two
available studies have produced very different results for the
40reliability of these observations. Erwin and Zung consistently obtained
reliability coefficients greater than 0.90, whereas Kupfer et al
reported that less than 25% of estimates were "accurately determined"
compared with EEG criteria. It should be noted, however, that the
subjects sampled in the latter study were psychiatric in-patients, many
of whom had depressive illnesses, and could not be considered as
similar to primary insomniacs. In addition, Kupfer et al reported that
almost one third of the observations themselves precipitated sleep
stage changes suggesting that the monitoring process may have been
unacceptably intrusive. A further serious limitation to nurse
observation is that subjects need to be hospitalised. Similar to the
sleep laboratory studies, therefore, the question is also raised of
whether data gathered in a controlled environment can be taken as a
reasonable sample of typical sleep at home.
The possibility of engaging spouses or room-mates as home-based
observers certainly solves some of these difficulties, but has the
disadvantage that these observers are often unable to provide
consistent data, unless they too are poor sleepers, or are willing and
able deliberately to remain awake and vigilant. For the assessment of
moderate to severe insomnia this solution appears to be impractical.
Indeed the available literature is confined to recruited populations
(Nicassio and Bootzin, 1974; Turner and Ascher, 1979a,b).
Recording Devices
The importance of obtaining accurate information to corroborate the
self-report of insomniac patients has led to the development of a
number of recording devices. Most of these are based upon the premise
that the subject's response to external stimuli reduces as sleep
commences and deepens, ie. awakening threshold increases and greater
intensity stimulation is required to produce arousal. The detection (or
41not) of a cue stimulus, therefore, should reveal the presence or
absence of sleep. For the purposes of assessment, of course, it is
important that the cue is perceptible, but not intrusive.
The most useful device currently available, and for which there is most
support in the research literature, is the "Somtrak" Sleep Assessment
Device (SAD) (Kelley and Lichstein, 1980). The SAD generates a brief,
soft tone at pre-set intervals throughout the night and tape records
verbal responses to these cues. The tone generator is linked to a
cassette recorder for this purpose. Clearly, if the subject is awake,
the tone will be heard and the criterion response of "I am awake" will
be recorded. Conversely, if no response is recorded the interpretation
is made that the subject was sleeping. The volume and pitch of the tone
are adjusted for the individual to ensure that it is perceptible while
awake but not intrusive upon sleep. The usual inter-tone interval of 10
minutes is not sufficiently frequent to render it soporific or to cause
habituation (Lichstein, Hoelscher, Eakin and Nickel, 1983). Comparisons
with EEG recordings have demonstrated levels of agreement greater than
90% with no significant differences on measures of sleep latency, total
sleep time and sleep efficiency (Lichstein, Nickel, Hoelscher and
Kelley, 1981). The number of awakenings measure, however, has proven
less valid due to the time-sampling procedure utilised by the SAD
wherein some data are inevitably forfeited. The SAD would appear to be
the best available objective measure of sleep for use within the
natural environment. It fulfils all the criteria, proposed by Lichstein
and Kelley (1979), to be important for accurate, valid and practical
measurement. These criteria are as follows:- a) portable to the natural
environment, b) self-administered, c) non-intrusive, d) relatively
inexpensive, and e) very accurate.EEG AND SELF REPORT
It is important now to return to the key issue raised earlier,
regarding the association between objective and subjective measures of
insomnia. Over the past 15 years researchers have attempted to validate
self-report by comparison with EEG criteria. The inherent assumption,
therefore, has been that EEG identifies "true insomnia" and that the
substantial sub-group of patients who complain of significant sleep
disturbance, not ratified by polysomnography, suffer from "pseudo-
insomnia". More recently, however, there has been some recognition of
the possibility that EEG may not be sensitive to all the crucial
variables which predict clinical reports of insomnia, and the two
groups have been re-labelled "objective" and "experiential" insomnia
respectively. Studies have also begun to reconsider the appropriateness
of the EEG criteria used to establish the point of sleep-onset. In
order to understand the development and complexity of current opinion,
the relevant literature will be reviewed in some detail.
A number of studies have examined the subjectively and objectively
defined sleep patterns of normal subjects. Johns (1971) provided the
earliest review paper and quoted evidence for the satisfactory test-
retest reliability of sleep questionnaires. He suggested that, although
subjects were not accurate in their estimates, their reports did shift
in the same direction as objective measures (eg. Lewis, 1969).
Baekeland and Hoy (1971) reported greater accuracy than Lewis in sleep
diary measures of sleep latency and frequency of wakenings in normal
adult men. In his own work, Johns found that normal subjects estimated
the time of falling asleep to within two minutes, and the total
duration of sleep to within eight minutes. He concluded that no single
method of assessment could give sufficient information to permit
neglect of the others, and that greater attention should be paid to
43information concerning sleep quality which cannot be inferred from EEG
records.
A study by Frankel et al (1976) compared the recorded and reported
sleep of chronic primary insomniacs with matched controls. Eighteen
insomniacs, with an average age of 44.5 years, and a mean duration of
insomnia of 19 years, were included in the study. Frankel et al found
significant discrepancies between the insomniacs' and controls'
subjective assessment of their sleep and the sleep polygraph data, with
insomniacs over-estimating sleep latency and under-estimating total
sleep time and sleep efficiency. Insomniacs took an average of 54
minutes to fall asleep (estimated at 81 minutes), slept a total of 340
minutes (estimated at 306) and woke up 1.9 times (estimated at 2.7).
Polygraph data showed sleep efficiency to be 76.5% while questionnaire
data yielded a figure of 67.1%. Control subjects' reports were not
significantly different from EEG measures but they tended to rate in
the opposite direction to the above errors. Frénkel et al recommended
that the focus of interest should be upon how much insomniacs are not
sleeping, ie. their sleep efficiency, since its calculation takes into
account both sleep latency and wake-time after sleep-onset in relation
to total time in bed. They suggested the figure of 85% sleep efficiency
as a useful diagnostic criterion to differentiate between insomniacs
and non-insomniacs.
Carskadon et al (1976) compared the EEG records and subjective
estimates of 122 drug-free patients who complained of chronic insomnia.
Unfortunately, however, the length of the drug-free period, preceding
the laboratory sleep nights, was described as "typically more than 2
weeks" which falls short of the generally accepted 5-6 weeks required
for drug withdrawal effects to have ceased (Oswald and Priest, 1965).
Subjective reports of sleep time averaged well below objective
44measurement, and were consistently underestimated by a margin of more
than one hour in one third of the cases. Similarly, there was a
significant difference between the average recorded sleep latency of 26
minutes and the estimated latency of 62 minutes. Significant
correlations were, however, obtained between self-report and EEG for
both women (r = 0.64, p < .001) and men (r = 0.60, p < .001). Frequency
of arousal demonstrated a significant difference across age-groups
with, as expected, older subjects wakening more often. Importantly,
Carskadon et al also found that only around one half of the
insomniacs could be distinguished from normal subjects by EEG measures
of total sleep time. This is a finding which has been replicated by
Borkovec and his colleagues (Borkovec, Grayson, O'Brien and Weerts,
1979; Borkovec, 1979) who have emphasised the importance of
differentiating between the two sub-types of primary insomniacs
(objective and experiential), as previously defined.
It would seem , therefore, that both electro-physiological and self-
report data are useful in a detailed descriptive analysis of insomnia.
The substantial and consistently reported concordance rates indicate
that verbal report may be a useful predictor of objective indices.
The discussion of EEG and self-report in terms of "agreement" does, of
course, presuppose that the same question is being asked of both
measures. In other words if, according to EEG criteria, the subject is
objectively (factually) awake, then he should if asked at that time
report the self-perception of wakefulness. Conversely, if objectively
asleep he should corroborate this upon being awakened. It is only if
these things are found to apply that verbal report can be considered
unreliable compared with this EEG ustandard".
The study by Campbell and Webb (1981) was the first to investigate the
relationship between EEG-defined awakenings and subjects' awareness of
45them. As a prologue, these authors commented on research examining
"mental activity at sleep-onset" which showed that people often report
that they are "drifting off to sleep" or "awake but drowsy" during the
early stages of EEG-defined sleep. They quoted one study where 44% of
subjects who reached EEG stage 1 or stage 2 stated that they had not
gone to sleep, and 2 of the 13 subjects, even within SWS (stages 3 and
4), also replied in the negative (Agnew and Webb, 1972). In their own
study, subjects were asked to signal periods of wakefulness by pressing
a button while being recorded during a night of laboratory sleep.
Campbell and Webb found that a significant proportion of the failures
to signal wakefulness occurred during EEG wakefulness, and also that
wakefulness was commonly perceived in the absence of EEG evidence.
In a replication study, Borkovec, Lane and Van Oot (1981) awakened 25
insomniacs out of stage 2 sleep and asked them to report on their
experience of sleep/wakefulness. They found that sleep was reported by
only 4-12% of the insomniac group, and that even in a "good sleep"
control group only 30% stated that they had been asleep. Ratings of
"certainty" of being awake were much higher in the insomniac group. The
results of a study by Slama (1979), quoted in Bootzin and Engle-
Friedman (1981), are also suggestive of perceptual differences between
good and poor sleepers. Slama found that 8 out of 10 insomniacs who
were aroused after 4.5 minutes of stage 2 sleep reported that they had
been awake when roused, compared with good sleepers who all reported
having been asleep. These studies raise the question of what cues the
insomniac uses to determine whether or not he is asleep, and how these
cues differ from those used by normal sleepers. The possibility that
the sleep mentation of insomniacs is similar to waking mentation,
making it difficult for them to distinguish sleep from wakefulness, is
at present the most promising explanation for these research
observations (Rechtschaffen and Monroe, 1969; Borkovec, 1979).
46A study by Coates, Killen, George, Marchini, Silverman and Thoresen
(1983) provided a powerful psychometric test of the validity and
reliability of self-report compared with  EEG measures. These workers
pointed out that the correspondence between the two measures had
largely been investigated via simple correlational methods and that
more robust and sophisticated analysis was required. In their study,
therefore, they applied the multi-trait multi-method matrix approach
(Campbell and Fiske, 1959); a technique which permits the simultaneous
exploration of reliability and convergent validity of variables (in
this case physiological and self-report measures of the main parameters
of sleep). Their findings indicated that although insomniacs reported
significantly more minutes to sleep-onset when compared with EEG-
defined non-REM stage 1 sleep, there were no significant discrepancies
when the comparison was made at the onset of EEG-defined stage 2 sleep.
Significant differences were found between the recorded and reported
awakenings for both good and poor sleepers, and disagreements between
measures of time awake after sleep-onset appeared to be related to the
degree of sleep difficulty. Coates et al concluded that "if the EEG is
to be regarded as the criterion of sleep, then self-reports of minutes
to sleep-onset are reliable and valid measures for good sleepers. Self-
reports of minutes to sleep-onset and minutes awake after sleep-onset
provide a reliable and valid relative index for insomniacs".
Some work by Hauri and Olmstead (1983) has provided further support for
the use of stage 2 onset as the EEG equivalent of perceived sleep in
insomniacs, since "these insomniacs were about as accurate in their
sleep latency estimates using this criterion, as the good sleepers were
using the traditional one". They also pointed out that consideration
should be given to the fact that the insomniac's task is a harder one.
Insomniacs often have to estimate sleep latency lasting anywhere from
30 minutes to several hours. In Hauri and Olmstead's study they did so
47to within a few minutes. The good sleepers on average had to estimate
latencies of only several minutes; a much simpler task. These workers
went on to say that they could see no advantage in accepting, as fact,
the statement that insomniacs habitually overestimate sleep latency,
but rather the issue of importance is the establishment of appropriate
criteria, suitable for them. They suggested, therefore, that the
beginning of the first 15 minutes of uninterrupted sleep, of stage 2 or
better, may be such a criterion. Another recent study by Birrell
(1983), using a student population, has reached the same principal
conclusion.
Finally, further evidence from Sewitch (1984) extends the controversy
by suggesting that EEG may not accurately represent the sleep reports
of normal sleepers. She employed a signal detection theory (Stir)
framework systematically to examine the verbal report/polygraph
discrepancy in 11 volunteer subjects. She found that all of the
decisions made by these normal sleepers demonstrated a strong bias
towards signalling "awake" regardless of polygraphic criteria. She
concluded that "what the subject attends to in making a sleep/awake
decision is to a significant extent independent of what is presently
defined polygraphically as sleep. In terms of SDT, the polygraphic data
in current use are only a weak index of the underlying internal
signals, detected and used by normal sleepers in making an awake or
asleep decision."
Clearly, further research is required before definitive statements can
be made regarding the precise relationship between the experience of
sleep and wakening and its objectively measurable concomitants.
Certainly, it is possible that a number of the early studies which
doubted the accuracy of self—report may have provided less critical
results had alternative criteria been used for scoring the EEG traces.
48At the very least, there is the consistent finding of a significant
correlation between EEG and verbal report, and the strong possibility
that concordance may be further strengthened when appropriate  EEG
indices are finally established.
AN OVERVIEW OF SLEEP ASSESSMENT IN THE NATURAL ENVIRONMENT
A thorough assessment of insomnia should include firstly, the taking of
a comprehensive sleep history, complemented by an examination of
physical and psychological status. Cases of physical illness or
functional disturbances such as depression which would render insomnia
a secondary symptom, can be identified through prudent clinical
interviewing and a routine medical examination.
Secondly,	 a comprehensive behavioural analysis permits the
investigation of situational factors and/or stressors which may have an
aetiological role. Some of these may be transient or readily remedied.
Close attention to the behavioural, cognitive and physiological
correlates of the presenting insomnia will often yield information
which is of both theoretical and practical importance, and details of
sleep covariates such as drug use (for reasons which will become
evident in the next chapter), exercise, diet, and daytime coping
should be gathered routinely. It may be useful also to interview the
patient's spouse to obtain adjunctive information, especially upon
daytime effects, although he/she is unlikely to be able to provide
reliable data on the actual parameters of sleep.
The third and most adaptable source of data comes from daily sleep
charts, kept by the subject and completed each morning upon rising.
Every effort should be made to ensure that recordings are not made in
retrospect since reliability decreases, and experimental demand
increases in such circumstances. Diaries permit the monitoring of day-
49to-day sleep variations, and can be used to evaluate the process of
sleep pattern change, both in terms of the sleep variables themselves,
but also in tems of perceived sleep quality. Since it is often this
latter element which precipitates and maintains help-seeking behaviour,
adequate assessment is fundamental to treatment outcome evaluation.
Fourthly, there are now available a number of simple time-sampling
devices which can provide an inexpensive, reliable and non-intrusive
approach to the objective assessment of insomnia. These may be
particularly appropriate for the within-therapy assessment of sleep,
where corroborative evidence of the validity of verbal report is
required, but without unduly disturbing the sleep pattern itself.
Although EEG assessment is pre-eminent within the general sleep
research literature, it is, apart from the considerable technical and
financial Considerations, likely to prove unacceptably intrusive in the
investigation of psychological processes in insomnia. Some recent
developments in the use of home-based polysomnography do, however,
suggest that this problem may be at least partially surmounted in time
to come. The recent evidence which has reinstated the credibility of
self-report as a relative index of sleep parameters has redressed the
hitherto and perhaps unequal balance, which was in favour of EEG
assessment. Nevertheless, the polygraph remains the only completely
reliable method of establishing diagnosis in the case of some of the
rare sleep disorders. Kales, Kales, Bixler and Soldatos (1979) have
best expressed these sentiments in stating that "the use of highly
sophisticated and highly expensive procedures, and the close attention
to polygraphic sleep patterns, often render little information of
clinical importance."CHAPTER 5
THE MANAGEMENT 0F INSOMNIA
Reference was made in Chapter 1 to the prevalence of sleep disorders
within the general population and to the clinical and financial burden
which they place upon the Health Services. This chapter will provide a
detailed analysis of these issues, with particular respect to
establishing a case for psychological intervention in chronic insomnia.
The merits and drawbacks of pharmacological treatment will be
considered firstly, followed by a review of the literature on each of
the major psychological approaches to therapy. The chapter will
conclude with a synthesis of this literature based upon available
comparative treatment studies. Methodological issues will be referred
to throughout, but will be dealt with in more detail in Chapter 6 since
they are salient to the development of the present study.
PHARMACOLOGICAL TREATMENTS
Sedative—hypnotics, at first barbiturates and more recently the
benzodiazepine drugs have been the medical treatment of choice for
insomnia. It is beyond the scope of this thesis to explain in detail
the effects of sleeping pills upon sleep, but the following information
has been drawn from review papers.
Hartmann (1978) reported on more than 150 pharmacological studies
covering 10 barbiturate and 25 non—barbiturate sleep medications and
concluded that, when used with insomniacs at the usual clinical doses,
the barbiturates and benzodiazepines "do generally reduce sleep latency
and increase sleep time. However, they also clearly produce
distortions in normal sleep patterns." The most striking distortion
effect, consistently found, was that of REM sleep suppression, although
several drugs appear to be free from this phenomenon at low doses
51(chloral hydrate, flurazepam, methaqualone : Kales, Allen, Scharf and
Kales, 1970). Hartmann also referred to the common finding that
sleeping pills suppress stage 4 sleep, ie. the "deepest" portion of
non-REM sleep. Over the past 15 years, the restrictions placed upon the
prescription of barbiturate drugs have led to a focusing of attention
upon the benzodiazepine group. These drugs are usually, but somewhat
arbitrarily, divided into two sub-groups on the basis of their
anxiolytic versus sedative effects. Greenblatt, Divoll, Abernethy and
Shader (1982) have highlighted the incorrect assumption that hypnotics
and anxiolytics have important neuropharmacological differences, and
stated that drug effects are entirely dose-related. That is, at low
doses they act as anti-anxiety agents and at high doses as sleeping
pills. These workers also reviewed the available range of medications
and came to the conclusion that "although benzodiazepines are clearly
superior to other classes of hypnotic agents in safety, and possibly
also in efficacy, clinically meaningful differences among the various
benzodiazepines are often subtle." (For a detailed analysis of the
neurochemical action of these drugs, the reader is referred to Van Oot,
Lane and Borkovec, 1982).
Although EEG studies have demonstrated that hypnotic drugs reduce sleep
latency and increase total sleep time, and there is evidence that they
may also have anxiety-reducing effects (Dement, Seidel and Carskadon,
1984), the key question remains - do hypnotics make insomniacs good
sleepers? This most important issue was addressed by Adam (1984) who
reported on some of the work undertaken by a research group in
Edinburgh which found that poor sleepers reported qualitative
improvement in their sleep, which was maintained for a few months of
continued use (Adam and Oswald, 1982; Oswald, French, Adam and Gilham,
1982). Unfortunately, however, it has been known for some time that
hypnotic drugs become very ineffective in longer-term administration,
52and often render their users not only persistingly poor sleepers, but
also drug-dependent (Kales et al, 1974). The prevailing opinion and
advice offered to medical practitioners is, therefore, to administer
sleep medication only as a short-term course of therapy, to carefully
evaluate factors of aetiological significance, and to exercise care in
the withdrawal of the sleeping pills, paying due attention to likely
withdrawal effects (Institute of Medicine, 1979, Council on Scientific
Affairs, 1981; Kales et al, 1983b). The drawbacks of using sleep
medication for any extended period require further consideration since
chronic insomnia is frequently associated with a history of drug use.
There appear to be five main areas of concern.
Firstly, Hartmann (1978) has made the simple but important observation
that pressure of work upon the GP often facilitates prescription as a
fortuitous expedient, thereby undermining the exploration of potential
aetiological factors. He states that "patients with sleep problems are
far more likely to have a sleeping pill prescribed if their physician
has only 10 minutes to spend with them than if he has 30 or 40
minutes". It is often within the context of restricted consultation
time, or alternatively, through the ready availability of sleeping
tablets to medical and surgical patients in hospital that patients are
first introduced to benzodiazepines. There would appear, therefore, to
be some dysharmony between the attested applicability of medications
for sleep and routine medical practice.
A second reason for caution stems from evidence that tolerance develops
to hypnotic drugs, and it often does so rapidly. Tolerance has been
found to occur with most hypnotics with a diminution of effect over a
period of 2 to 6 weeks of nightly administration (Kales et al, 1974;
Kales, Kales, Bixler and Scharf, 1975). Such habituation proves less
problematic when medication is used only occasionally, but after
53regular use the drugs tend not to have a substantial potentiating
effect upon sleep. They do, however, continue to suppress REM sleep and
stage 4 sleep, and percentage REM is reduced relative to total sleep
time (Kales et al, 1975). Thus, within just a few weeks, the drug has a
consistent but largely unbeneficial effect and the patient continues to
complain of insomnia. It is because of these relatively short periods
of effectiveness that many chronic insomniacs have been on a wide
variety of hypnotic preparations. For persistent cases of sleep
disorder, therefore, there is evident danger of the development of a
vicious circle involving prescription and regular nightly use, followed
by an increased dosage requirement, followed in turn by the substitute
prescription of an alternative sleeping tablet.
Thirdly, it has been known for some time that certain hypnotics produce
"carry-over" effects including morning drowsiness, nausea and headache
(Oswald, 1968). These are caused by drug accumulation during chronic
use, determined primarily by the elimination hâlf-life and metabolic
clearance rate of the drug (Greenblatt and Koch-Weser, 1975). If a
drug's half-life is short there will be minimal accumulation, and
conversely if the half-life is long, some portion of the prior dose
will remain in the body when the next is given. Long half-life implies,
therefore, that the medication will continue to promote drowsiness and
fatigue during the daytime.Clearly, in as far as an hypnotic is given
to improve sleep, and thereby improve subsequent daytime functioning,
the impairment of such functioning proves to be a serious shortcoming.
A recent study by Dement et al (1984) has replicated a considerable
volume of previous work in finding changes in daytime alertness after
bedtime administration of long-acting hypnotics in normal subjects,
chronic insomniacs and in the elderly. These workers stated that
"patients and subjects generally show microsleeps and fall asleep
involuntarily, with a corresponding interruption of ongoing behaviour
54and performance. 	  (This) simply means that individuals are more
likely to fall asleep while driving a car, while listening to a
lecture, and so forth". Other reports by Hindmarch (1984) and Hindmarch
and Ott (1984) have also identified specific impairments in psychomotor
performance, reaction time and arousal levels after regular drug use.
Fourthly, Kales et al (1983b) have extensively reviewed the literature
on withdrawal from hypnotic drugs. They have pointed out that
physicians are generally concerned with issues of efficacy and side-
effect during administration, but neglect to give due attention to
possible changes which follow drug withdrawal. Since sedative-hypnotics
are basically CNS depressants, they are capable of producing dependence
and a withdrawal syndrome. Alcohol should also be included in
discussion of these matters since it too is a CNS depressant, and a
commonly self-prescribed hypnotic agent. Evidence from Pokorny (1978)
substantiates the similarities in effects of alcohol and prescribed
medications. The withdrawal syndrome typically includes nausea,
excitation, agitation, insomnia and nightmares and, of course, with
more severe reactions (especially from barbiturates and alcohol), gross
behavioural and perceptual disturbances may be found. In addition to
this general abstinence syndrome, drug withdrawal insomnia may present,
consisting of severe difficulty in initiating sleep, and thereafter
within sleep, a fragmentation and disruption of sleep pattern
associated with marked increase in REM sleep above baseline levels. The
term "rebound insomnia" is a specific type of withdrawal sleep
disturbance identified with benzodiazepine drugs (Kales, Scharf and
Kales, 1978). Rebound effects occur particularly with the short
elimination half-life drugs and in some instances are observable after
a single night-time dose (Kales et al, 1983b). Increased frequency of
REM periods is also related to a number of other sleep disturbances
55including intense dreams and nightmares, frequent arousals, and with
the very short—acting drugs, earlier morning waking. The clinical
problem posed by these phenomena is even more apparent when two other
factors are taken into consideration. Firstly, withdrawal effects have
been observed to endure for up to 5 weeks after total drug withdrawal
(Oswald and Priest, 1965; Nicholson, 1980). This perhaps explains why
many insomniacs fail to persevere with abstinence programmes. Secondly,
rebound effects have been associated with increased anxiety levels
(Kales et, al 1978; 1983b) and even with anti—social behaviour
(Salzman, 1974; Oswald, 1982).
Finally, there are also psychological factors implicated in the
protracted use of sleeping pills. Ribordy and Denney (1978), in their
consideration of behavioural treatments as an alternative to
chemotherapy, stressed the importance of attributional effects during
drug use. They suggested that the insomniac taking sleep medication is
likely to attribute the sleep which he does get to the drug and to
attribute to himself little capacity for falling asleep.
Correspondingly, the removal of the drug not only introduces physical
rebound effects, but also gives rise to apprehensions concerning
ability to fall asleep on one's own. These apprehensions are then
largely confirmed by the withdrawal syndrome itself. An experimental
study by Davison, Tsujimoto and Glaros (1973) investigated the causal
attributions of insomniacs who had responded to a treatment package
consisting of a hypnotic drug, a relaxation procedure and the
scheduling of bedtime behaviours. Treatment responders were divided
into two groups, half being told that they had received an optimal
dosage of the drug, and half being told that they had received a
minimal dosage which research had proven to be ineffective. The drug
was then discontinued while subjects practised the other elements of
the programme. Those subjects who had been in the minimal dosage group
56and been led to attribute improvement to their own resources were found
to maintain improved sleep compared with the other group who returned
to their pre-treatment sleep latencies. Clearly, therefore, the
attributional effects of drug-taking (psychological dependence) may
interact with the physical withdrawal effects to produce an even
stronger dependency syndrome.
In conclusion, there are a number of serious shortcomings associated
with the prescription of sedative-hypnotics. What then are the general
recommendations which can be drawn from the research literature?
Flurazepam is usually listed as the drug of choice since it appears to
promote maximum improvement for most people and does not appear to lead
to tolerance and dependence (Kales et al, 1974). Coates and Thoresen
(1980) and Dement et al (1984), however, urge caution even in the
administration of flurazepam, since long-term evaluation has included
only two studies which have monitored progress for more than 28 days
(Kales et al, 1975; Dement, Zarcone, Hoddes, Smythe and Carskadon,
1973). Researchers concur in advising of the potential benefits of
selective use of hypnotics in cases of transient insomnia, but
recommend that any such "coping strategy" should occur in the context
of strengthening other adaptive coping mechanisms (Dement et al, 1984;
Kales and Kales, 1984). Oswald (1979) has reiterated an earlier view
(Clift, 1972) that patients should be educated into regarding any
hypnotic drug as a temporary expedient, in order to minimise long-term
usage. Dement et al have stated, in this connection, that "the major
issue is whether or not a course of hypnotic therapy could induce a
remission". Similarly, Kales and Kales have proposed that "the primary
goal of using hypnotic medication in the treatment of chronic insomnia
should be to alleviate the symptom of sleeplessness so that
psychotherapy can proceed effectively". For cases of severe and long-
57standing sleep disturbance, the regular use of medication offers,
therefore, an incomplete therapeutic approach and represents poor
clinical practice because of the liklihood of ultimate ineffectiveness
and the possible deleterious consequences of both prolonged use and
withdrawal.
PSYCHOLOGICAL TREATMENTS
The emphasis in this review is necessarily upon sleep-onset insomnia,
for two reasons. Firstly, there are only six published reports on the
management of sleep-maintenance difficulties (Coates and Thoresen,
1979; 1984; Thoresen, Coates, Kirmil-Gray and Rosekind, 1981; Lacks,
Bertelson, Sugerman and Kunkel, 1983; Hohenberger-Sieber, Mueller and
Schindler, 1986; Espie and Lindsay, 1987). Secondly, the present study
is primarily concerned with chronic sleep-onset insomnia (with or
without maintenance difficulty). The order of presentation of the
literature reflects the historical development and application of the
various treatment strategies. The reader is referred to Chapter 2 for
theoretical background. The structure of the chapter is as follows:-
1. Progressive relaxation and other anxiety-reduction techniques
2. Treatments based upon stimulus control principles
3. Treatments based upon paradoxical intention
4. Comparative studies of treatment outcome
Progressive Relaxation and other Anxiety-Reduction Techniques
The bulk of this section concerns the application of progressive
relaxation therapy (Jacobsen, 1929; Bernstein and Borkovec, 1973),
however, other methods of anxiety management such as desensitisation,
and variants of relaxation such as autogenic training and meditation,
will be addressed as they become relevant to the review. Biofeedback
techniques will be included also since these have generally appeared
either in conjunction with or in comparison with relaxation training.The early development of progressive relaxation is credited to Jacobsen
(1929) who found that the sequential tensing and relaxing of the main
muscle groups was associated with considerable decreases in muscle
activity, blood pressure and heart rate. The advent of behaviour
therapy, and particularly the proposition that relaxation could provide
an effective competing response with phobic anxiety (Wolpe, 1958),
however, was largely responsible for continued interest in the
technique, after many years of relative obscurity. Over the past 30
years relaxation has become one of the mainstays of clinical behaviour
therapy and various workers have produced abbreviated forms of
Jacobsen's procedures; the best known of which being the manual by
Bernstein and Borkovec (1973). Researchers have investigated the
individual components of the relaxation procedure, in some detail (eg.
Benson, Beary and Carrol, 1974; Davidson and Schwartz, 1976; Borkovec
and Hennings, 1978; Borkovec and Sides, 1979), but, in spite of the
wide applicability of the technique, and the fact that it is positively
perceived by most subjects, King (1980) has recently concluded that
"the critical procedural variables are not well understood,
although certain antecedent conditions and the muscle—tension release
exercises and physiological attention—focusing appear to be necessary,
depending upon the processes maintaining the presenting problem". It is
beyond the scope of the present report further to discuss the very
extensive literature on relaxation training, but the reader is referred
to King's review, which is an excellent resource.
Table 1 provides a summary of the experimental designs and principal
findings of 33 treatment studies which have appeared in the major
journals over the past 20 years. The table does not include studies
comparing outcomes across diverse therapeutic strategies since these
will be dealt with at a later point. Not every report will be referred
to in the text, but an overview of the main results will be provided.
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64Only 8 studies have controlled adequately for both placebo and passage
of time effects (Borkovec and Fowles, 1973; Nicassio and Bootzin, 1974;
Steinmark and Borkovec, 1974; Borkovec et al, 1975; Borkovec and
Weerts, 1976; Lick and Heffler, 1977; Shealy, 1979; Nicassio et al,
1982), with a further 10 studies (Haynes et al, 1974; Freedman and
Papsdorf, 1976; Pendleton and Tasto, 1976; Woolfolk et al, 1976; Haynes
et al, 1977; Mitchell and White, 1977; Borkovec and Hennings, 1978;
Toler, 1978; Borkovec et al, 1979; Carr—Kaffashan and Woolfolk, 1979;
Hauri, 1981; Woolfolk and McNulty, 1983) incorporating controls for one
or other of these factors. Unfortunately, not one of these 18 at least
partially controlled investigations was conducted on a clinically—
presenting patient sample, and only one (Hauri, 1981) included referred
cases of insomnia. Nevertheless, a number of consistent findings can be
highlighted.
Studies are in general agreement that relaxation procedures are
superior to no treatment in reducing self—repOrted sleep—onset time.
Untreated subjects have exhibited little therapeutic improvement
whereas SOL has reduced from an average (across studies) of 69 minutes
at baseline to 40 minutes at post—treatment; a mean reduction of
approximately 42% with relaxation training. Those studies which
incorporated EEG measures have confirmed the usefulness of relaxation,
though the magnitude of treatment effect has been less than that
indicated by the subjective data alone (Borkovec and Weerts, 1976;
Freedman and Papsdorf, 1976; Borkovec et al, 1979). Placebo treatments
have produced variable results, with some proving very ineffective (eg.
Nicassio and Bootzin, 1974; Haynes et al, 1977). The majority, however,
have produced at least some improvement. At times, post—treatment
improvement with placebo has been equivalent to active therapy
(Steinmark and Borkovec, 1974, Borkovec et al , 1975; Carr—Kaffashan
and Woolfolk, 1979; Shealy, 1979). The studies by Borkovec and his
65associates introduced an imaginative, experimental procedure to control
for experimenter demand and expectancy effects (Steinmark and Borkovec,
1974), and their work has generally found that active treatments
operate effectively, even under conditions of negative expectation
(counterdemand) whereas placebo instructions are effective only in
combination with induced positive demand (Borkovec et al, 1975;
Borkovec and Weerts, 1976). For the purposes of comparison, the average
reduction in SOL, after placebo intervention, has been around 25%.
A number of authors have questioned the clinical significance of
improvements via relaxation. Given that training involves at least 20
minutes practice per evening, a mean reduction of only 30 minutes in
sleep latency renders these results clinically unimpressive (Freedman
and Papsdorf, 1976). In addition, the concentration upon SOL as the
major, and frequently the only, outcome measure makes it impossible to
ascertain whether or not there is overall sleep pattern change. Also
the relationship of SOL change to perception of sleep quality and
sleep-complaints is unknown. Steinmark and Borkovec (1974) did report
improvements on subjective ratings of difficulty in falling asleep and
morning restedness, although only the former correlated significantly
with SOL, and Borkovec et al (1975) were unable to replicate this
improvement on the restedness rating. Borkovec et al (1979) have also
produced some tentative evidence for increases in SWS after successful
treatment.
Borkovec has conducted a number of investigations into the various
components of the progressive relaxation programme (Borkovec et al,
1975; Borkovec and Hennings, 1978; Borkovec et al, 1979) which
tentatively suggest the superiority of the total relaxation programme
over the effects of its individual parts. The results of Borkovec et al
(1979) were supportive of the hypothesis that tension-release is a
66critical ingredient, however, the study by Woolfolk and McNulty (1983)
reported a superior response with "imagery training" (a visualisation
training procedure where subjects learned to call to imagination a
number of common objects). Of interest in this last study was the
achievement of a reduction in sleep—latency variance over time, as well
as mean SOL (ie. sleep latency reduced and became less variable from
night to night). In addition, it is also noteworthy that training
procedures in relaxation therapy have been administered in a variety of
formats. Relaxation training has been conducted "in vivo" in most
cases, although a case study by Weil and Goldfried (1973) achieved
significant improvement using tape—recorded instructions, and Gershman
and Clouser (1974) made quite effective use of group relaxation.
Table 1 also permits the analysis of comparative effectiveness amongst
the various types of relaxation procedure. Briefly, it seems that there
is little to choose between them. Borkovec and Fowles (1973) found that
hypnotic relaxation and a self—administered relaxation programme were
as effective as progressive relaxation, and a number of reports have
indicated the utility of autogenic training, originally developed by
Schultz and Luthe (1959) (Kahn et al, 1968; Traub et al, 1973; Nicassio
and Bootzin, 1974; Coursey et al, 1980). Other workers have made
effective use of similar, passive relaxation and meditation techniques
(Shealy, 1979; Haynes et al, 1977). These procedures generally involved
sequentially focusing attention on pleasant bodily feelings without
muscle tension—release cycles.
Before leaving the consideration of treatment comparisons, it would be
useful to deal, briefly, with biofeedback techniques. There are two
current explanations forwarded to account for the mechanism of effect
in biofeedback. The first stems from the common use of EMG biofeedback
where muscular relaxation is presumed to help prepare the individual
67for sleep; and the second hypothesis, associated with EEG biofeedback,
is that specific alterations in brain activity can be made in order to
closely resemble EEG sleep and, thereby, to enhance relaxation more
"centrally". Table 1 contains a number of studies which have used
feedback techniques, with varying degrees of success. EMG feedback has
been found to be as effective as relaxation (Freedman and Papsdorf,
1976; Haynes et al, 1977; Nicassio et al, 1982). There may be, however,
a particularly strong placebo element in biofeedback, since the use of
elaborate equipment may magnify non-specific effects (Nicassio et al,
1982). A recent series of studies by Hauri and his colleagues (Hauri,
1981; Hauri et al, 1982) trained insomniacs firstly in EMG and then in
EEG feedback and found that brain activity feedback added little to the
effects of EMG, except in the case of subjects who could be regarded as
"non-tense". This is a developing area of research, but for the
present the techniques are of unproven efficacy.
In concluding this section on the relaxation therapies, it is worthy of
note that the approximate 50% of reports which have included follow
up, have revealed maintenance of treatment gains after active therapy
and, in a number of cases, these have been extended beyond the post-
treatment level.
Treatments Based upon Stimulus Control Principles
Bootzin (1972) was the first to present an operant analysis of insomnia
when he reported the case study of a 25 year old male with initial
insomnia. He found that his stimulus control approach successfully
reduced SOL, increased total sleep by more than two hours, and
dramatically reduced the frequency of nightly risings from bed. It was
this last variable which he presented as his main outcome measure and
improvements were maintained at 2 month follow-up. Data from this and
other studies employing stimulus control are contained in Table 2.
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69Since Bootzin's pioneering work a number of researchers have published
case report papers. Haynes et al (1975) reported four single case
experimental designs of subjects who had longstanding sleep
difficulties, but had not benefitted from hypnotic medication. After a
two week baseline, stimulus control therapy was initiated and
maintained until sleep pattern stability was evident. The subsequent
return to baseline conditions revealed the expected reversal effect,
but in only two of the four cases. For all subjects, however, treatment
was effective in reducing SOL by approximately 40 minutes and
improvement was maintained at follow-up 9 months later. Although the
absence of a reversal could be viewed as evidence against the specific
impact of stimulus control, the fact that treatment gains persisted, at
lengthy follow-up, at least suggests that therapy produced some form of
habit change.
Turner and Ascher (1979b) criticised the Haynes et al study on the
grounds that ABAB designs are ill-advised with behavioural procedures,
because of the "carry-over" effect upon cessation of treatment (Hersen
and Barlow, 1976). Instead they proposed the use of a multiple baseline
approach more adequately to test cause-effect relationships. They
presented a series of six self-referred out-patients with initial
insomnia. All subjects completed a baseline phase after which half were
allocated to stimulus control and half to a quasi-desensitisation
placebo, which has commonly been used in psychological research
(Steinmark and Borkovec, 1974). After 4 weeks, clients in the second
group were also given active therapy which the first group received
throughout. Stimulus control was found to have a specific impact upon
sleep latency, in each case reducing SOL by two-thirds or more. Placebo
treatment did not produce this effect but when these patients were
introduced to stimulus control significant change was observed.
Reductions in medication also followed the introduction of stimulus
70control. The slight increment in SOL in one case could have been caused
by rebound insomnia. The major advantage of this study was that it
reported cases of severe and long-term sleep disturbance. The rapid
elimination of these difficulties provides strong evidence for the
potency of stimulus control. A more recent case study by Norton and
De Luca (1979) found a combination of relaxation and stimulus control
procedures effective in reducing sleep latency and intermittent
wakenings in a mild case.
A number of workers have attempted to investigate the effectiveness of
component parts of the stimulus control "package", and some of this
work was introduced in Chapter 2. Bootzin and Nicassio (1978) referred
to an unpublished study by Tokarz and Lawrence (1974) which compared
the efficacy of the complete stimulus control procedure with two
different constituent parts. These were, a temporal control strategy,
including only instructions aimed at regularising the sleeping pattern
according to the constraints of time, and an alternative approach based
solely upon improvement of the bed and bedroom environment's function
as discriminative stimuli for falling asleep. Relaxation placebo and no
treatment control groups were also included. These workers found that
all three active interventions resulted in highly significant
reductions in SQL, and that there were no differences between them.
Zwart and Lisman (1979), however, have criticised this study suggesting
that the temporal control procedure did not closely approximate to that
element in Bootzin's conception of stimulus control. They conducted
their own analysis comparing stimulus control with temporal control,
counter-control (subjects were to sit up in bed, read, watch TV etc. at
bedtime, and to deliberately engage in sleep-incompatible behaviours in
the bedroom during the daytime), non-contingent control (the
theoretically critical contingency of rising after 20 minutes was
removed by instructing subjects to rise a fixed number of times within
7120 minutes of retiring), and a waiting-list control group. All patients
were given the counterdemand instruction that improvement would not
occur until the fourth week of therapy. Results indicated that those
receiving stimulus control and counter-control improved significantly
compared with non-contingent control and waiting-list cases, during the
counterdemand period, although, after positive demand the temporal
control group became as effective as either of these procedures. At
follow-up one month later treatment gains were maintained and there
were no significant differences amongst any of the treatment groups on
any measure.
Zwart and Lisman provided some useful indications as to the effective
elements of stimulus control. Firstly, the study by Tokarz and Lawrence
was corroborated in the finding that the complete "package" was not
superior in effectiveness to some of its elements. Secondly, the
efficacy of the counter-control procedures implied that supposedly
sleep-incompatible behaviors may not be particularly relevant cues for
arousal in insomniacs. It may be that any disruption of usual sleep
pattern might produce improvement. Turner and Ascher (1979b) have
reported that subjects regarded stimulus control as helpful in breaking
up the usual chain of worrying and anxiety. Thirdly, there is the
unexplored possibility that rising from bed may act as an aversive
consequence of continued wakefulness, and this is an area which could
be usefully examined in further research. Finally, the fact that Zwart
and Lisman's student subjects did not improve during counterdemand,
when treated with temporal control alone, may simply reflect their
relatively mild insomnia difficulties. It has already been suggested
that a didactic approach, involving the rescheduling of bedtime and
rising time, may be particularly appropriate for older patients who
have "developmental" insomnia in the absence of daytime impairment.
72Alperson and Biglan (1979) have reported a comparison study where
stimulus control plus passive relaxation was given to groups of young
and old subjects. Interestingly, they found that therapy was
statistically and clinically more beneficial for their younger group.
The older subjects showed little change. Puder et al (1983) have also
provided a report of stimulus control treatment with older adults.
These workers randomly assigned a final sample of 16 clients (mean age
of 67 years) to either immediate or delayed treatment (the latter
involving a 10 week waiting period). Data on SOL revealed considerable
reductions for both groups when active intervention was applied.
Overall reductions of approximately 50% were maintained at 2 month
follow—up. By comparison with Alperson and Biglan's study, Puder et al
have demonstrated that age alone may not be a sufficient factor to
preclude treatment gain. Unfortunately, however, neither study included
placebo groups and it is possible that the differential effectiveness
was simply related to uncontrolled demand characteristics or expectancy
effects.
Treatments Based Upon Paradoxical Intention Therapy
Frankl (1955) was the first to describe the two related therapeutic
techniques of paradoxical intention and dereflection. These procedures
were used in situations where patients were concerned about the
frequency of a response occurring either too often (eg. perspiring) or
too seldom (eg. falling asleep). Since the dereflection procedure
differs from paradoxical intention, only in the direction of change
which the client desires, the term paradoxical intention is now
employed to denote both the prescription to intentionally increase
uncomfortably high frequency behaviours, and to intentionally decrease
uncomfortably low frequency behaviours (Ascher, 1979). It is only
recently that paradox has been adopted into the behavioural literature,
73and its initial incorporation was based upon a rather eclectic view of
therapy (eg. Lazarus, 1971; Fay, 1973). The development of the
performance anxiety—based rationale, hypothesised to account for its
mode of action (Ascher, 1979; Ascher and Turner, 1979), however, has
afforded the technique more general acceptance.
Ascher and Efran (1978) provided the first case reports on poor
sleepers, although only three of their five subjects had a primary
problem of sleep difficulty. Nevertheless, their demonstration of the
effectiveness of paradox was impressive since these were patients who
had previously failed to respond to more conventional treatment
(relaxation and desensitisation). For one subject who responded to
paradoxical intention the original programme was reintroduced and the
demonstration of a reversal effect, followed by improvement once again
when paradox was readministered, provided further evidence for the
specific impact of the procedure. Ascher and Efran reported only sleep
latency measures, although they stated in a footnote that a reduction
in frequency of night—time wakening was also evident, and that
improvements in ratings of sleep quality paralleled changes on sleep
parameters. Other case study material has been reported by Relinger et
al (1978), Relinger and Bornstein (1979) and Espie and Lindsay (1985).
The results of all of these studies are summarised in Table 3.
Relinger et al, employing a time series analysis on a single case,
found that the paradoxical instruction produced and sustained
substantial SOL reduction which was also associated with significant
positive change in ratings of difficulty in falling asleep, restfulness
of sleep, and daytime functioning. The validity of their subject's
sleep complaint must, however, be called into question since, in spite
of a reported 20 year duration of insomnia, the client had never
previously sought professional help. These workers published a further
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75four case studies (Relinger and Bornstein, 1979) for whom insomnia
constituted a more substantial problem. Employing a multiple baseline
design, the average scores for SOL and frequency of wakening were
significantly reduced at post—treatment, as were ratings of difficulty
in falling asleep. Subjects also felt more rested upon wakening but
there were no significant changes in total sleep time or on measures of
daytime functioning. At follow—up 3 months later, all of the
improved variables evidenced continuing gains.
Espie and Lindsay (1985) have recently published six cases of chronic
insomniacs who were treated by means of paradoxical intention. These
workers found a variable response to therapy in that the sleep problems
of two patients were significantly exacerbated by the treatment, to the
point where therapy had to be discontinued, and a third patient
suffered a temporary increment in SOL. The three remaining subjects
did, however, improve in a manner similar to previous reports. Changes
in total sleep time appeared to reflect changes in sleep latency. Espie
and Lindsay suggested that these variable outcomes may reflect the
tendency of some individuals with performance anxiety to redirect their
anxieties into trying to remain awake, that is an active avoidance of
sleep, in order to achieve the therapist's criteria of success. This
may be a mentally arousing process whereas, for the insomniac who
benefits from paradox, more "passive" avoidance of performance effort
may account for treatment gains.
Ascher and Turner (1979) conducted a controlled experimental
investigation in which they compared paradox with placebo and no
treatment controls. Subjects in the paradoxical intention group
reported significant reductions in sleep—latency, had fewer problematic
wakenings in terms of returning to sleep, and exhibited significant
increases in "restedness" after sleep compared with either control
76condition. [These results replicated those of Turner and Ascher (1979a)
— to be reported in the next section]. Ascher and Turner (1980) again
repeated their experimental design, but this time considered
alternative methods for the administration of paradox. Type A
administration provided clients with the standard performance anxiety
reduction rationale; whereas type B involved the use of a "reframing"
procedure where clients were instructed to remain awake for as long as
possible, in order to become aware of the anxiety—provoking thoughts
which they experienced while awaiting sleep—onset. They were told that
these thoughts would later be desensitised. The results of this study
indicated that the conventional procedure was superior in efficacy,
perhaps because the refraining approach implied that therapy would not
begin until after preliminary data collection. The authors did suggest,
however, that reframing may be particularly useful in the case of the
client who failed to understand the performance anxiety model.
Ott et al (1983) conducted an experimental study to test further the
explicit demand characteristics of the reframing procedure. The design
of their experiment was a 2 (feedback/no feedback) by 2 (paradoxical
instruction/no paradoxical instruction) factorial, where "objective"
feedback was provided by means of the "sleep—monitoring unit" (Ott et
al, 1982). The results of the study confirmed their working hypothesis
that patients' self—reports would be influenced by experimental demand,
when these were made explicit and when access was given to actual,
objective sleep data. Unfortunately, however, these workers discussed
their results only with reference to reporting bias, and did not offer
any explanation of the mechanism by which subjects ensured that they
remained awake. A major problem with the reframing procedure is that it
may simply encourage patients in some form of self—administered sleep
deprivation.Fogle and Dyall (1983) also have considered variations on the
instruction which subjects can be given. They allocated their sample to
either conventional paradoxical intention or to an alternative version
where individuals were told simply to "give up" trying to fall asleep
(ie. no direct paradoxical instruction to stay awake). They argued that
sleep efficiency was the best overall measure of outcome, and reported
significant improvements on this variable for each of the experimental
groups. In addition, they found that it was only the "giving up" group
which improved on a self—report measure of sleep performance anxiety.
In spite of the statistical changes which were demonstrated, however,
the improvements in actual sleep parameters were relatively small and
of limited clinical significance. This may reflect the fact that both
treatments were conducted as bibliotherapy. Also, the reporting of only
sleep efficiency changes, obscures the locus of improvement. It is
unclear whether improvements were due to changes in SOL, wakening
frequency, total sleep time, or a combination of these factors.
Furthermore, the relative contributions of such variables to the
treatment outcomes for each therapy were left undetermined.
Comparative Studies of Treatment Outcome
Only four studies comparing the effectiveness of different
psychological approaches have been published in research journals
(Hughes and Hughes, 1979; Turner and Ascher, 1979a; Lacks, Bertelson,
Gans and Kunkel, 1983; Turner, DiTomasso and Giles, 1984). An
additional three earlier studies (Bootzin, 1975; Slama, 1975; Lawrence
and Tokarz, 1976), however, were reviewed in Bootzin and Nicassio's
(1978) paper and are worthy of consideration. Unfortunately, some of
the original data from these reports are missing and the source
manuscripts are unobtainable. The summary results of all 7 studies are
presented in Table 4. The reports will be reviewed chronologically.
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80Bootzin (1975) randomly allocated a sample of 66 recruited subjects to
either stimulus control, progressive relaxation, self—relaxation
placebo or waiting—list control groups. Although self—reports of sleep
latency suggest that these were severe initial insomniacs, they did not
present through clinical channels, and the chronicity of the presenting
problem is not known. Inspection of the data on SOL in Table 4,
indicates that stimulus control produced a mean reduction of 67
minutes, compared with the active relaxation group where improvements
of around 30 minutes were obtained. Bootzin and Nicassio (1978)
reported that in absolute terms after treatment, 57% of those who
received stimulus control averaged less than 25 minutes to fall asleep,
as contrasted with 29% of those who were trained in progressive
relaxation. Importantly, however, 27% of the self—relaxation group and
22% of untreated cases also achieved this criterion of improvement.
Indeed, the post—treatment mean scores for stimulus control were a mere
10 minutes superior to the waiting—list procedure. In spite of the
evident ambiguity of these results, Bootzin and Nicassio, and Borkovec
(1982) have cited Bootzin's study as evidence for the superior
effectiveness of stimulus control treatment. It seems possible,
however, that the apparently therapeutic effect of the passage of time
may reflect the transient nature of insomnia in at least a fair
proportion of these subjects.
The study by Slama (1975) was conducted in Borkovec's laboratory using
groups of undergraduate students who complained of significant sleep
disturbance. It appears from baseline measures that insomnia was
relatively mild (mean SQL < 40 mins). Indeed, the pre—treatment levels
of sleep disturbance are similar to post—treatment scores in some of
the better controlled studies (Lacks et al, 1983; Turner et al, 1984).
Slama included a counterdemand instruction which revealed that both
stimulus control and relaxation were superior to no treatment, even
81under conditions of negative expectancy, although stimulus control was
also superior to relaxation. At post—treatment, however, and after
positive demand, subjects in both therapy conditions were sleeping
similarly well, and improvements were maintained at unspecified follow—
up.
Bootzin and Nicassio reported a third unpublished study, by Lawrence
and Tokarz (1976), where a more severely sleep disturbed student
population was selected. Subjects were randomly assigned to individual
stimulus control, group stimulus control (3 clients seen together),
progressive relaxation and desensitisation placebo. Both stimulus
control approaches were found to be highly effective in reducing mean
sleep latencies to less than 20 minutes. This improvement rate of 75—
90% was considerably higher than the 31% exhibited after relaxation,
although the durability of change was not reported. Taking these first
three studies together, therefore, the preliminary evidence
consistently suggests a preference for stimulus Control over relaxation
therapy.
Hughes and Hughes (1979) recruited 36 volunteers (12 male, 24 female)
through newspaper advertisements. The mean age of their sample was 34.2
years, and although no figures for chronicity of complaint are
available, one of the selection criteria specified a minimum of 4
months duration. Subjects were randomly assigned to one of the four
treatment groups described in Table 4 and submitted a refundable
monetary deposit, before being finally accepted into therapy. Sleep
measures were recorded in daily diaries for a two week baseline
period, and for a further fortnight at post—treatment. Unfortunately,
time in treatment appears to have varied considerably. Both biofeedback
conditions comprised 8 therapy sessions, compared with relaxation
training which involved 4 sessions, and stimulus control which had only
822 sessions. (Hughes and Hughes explained that these inconsistencies
were due to the "complexity of the tasks"). Stimulus control and
progressive relaxation were along conventional lines, as was EMG
biofeedback where subjects attended to actual feedback through
headphones attached to a myograph. The pseudo-biofeedback group,
however, listened to false feedback from a cassette recorder.
Results indicated that all four groups improved significantly with no
significant between group differences. Stimulus control did, however,
produce this improvement very rapidly. Interestingly, biofeedback had
no effect upon EMG values. Indeed, even the lowest post-treatment EMG
levels achieved were not typical of a state of low physiological
arousal. It seems, therefore, that treatment outcome was independent of
a reduction in muscle tension. Hughes and Hughes proposed that a
cognitively-mediated process, similar for all treatments, might explain
their results. This process, it was suggested, might function to reduce
apprehension about sleep and other forms of intrusive worry. A more
adequate evaluation of the placebo treatment would have been possible
had the authors included a simple counterdemand instruction. Other
workers have found that placebo treatments become effective under
conditions of positive expectancy, but are otherwise not superior to no
treatment (Borkovec et al, 1975; Borkovec and Weerts, 1976). The
follow-up data in the Hughes and Hughes study were also unsatisfactory.
Verbal estimates of sleep latency were available for only 12 cases, and
these were summarised as a single follow-up cohort. It is, therefore,
impossible to differentiate between the treatments.
The most influential outcome study to appear in the literature has been
that of Turner and Ascher (1979a). This study represented a creditable
response to the methodological and analytical shortcomings of previous
work. These authors advised caution regarding suggestions that stimulus
83control might be superior to relaxation. Turner and Ascher also brought
the technique of paradoxical intention within the fold of experimental
investigation. Five treatment conditions were investigated ie. stimulus
control, progressive relaxation, paradoxical intention, desensitisation
placebo and waiting-list control. Twenty-five men and 25 women (mean
age 39 years) were recruited via newspaper articles and, following a 10
day baseline period, ten clients were randomly allocated to each of the
experimental conditions. Individual sessions (of uniform length) were
conducted, once weekly for four weeks, and pre and post-treatment
measures were recorded on a modified version of the DSQ. Assessments of
social aquiescence and therapy credibility were also included as part
of the methodological controls. Treatments did not differ significantly
on either of these measures. Unfortunately, the credibility assessment
was completed at post-therapy and was not, therefore, a true reflection
of perceived credibility of the therapy rationales, but rather is
likely to have been contaminated by subjects' actual treatment
responses.
Turner and Ascher employed multivariate assessments for examining
outcome, arguing that MANOVA provided a more conservative approach to
significance testing ( compared with numerous univariate analyses), by
reducing the liklihood of Type 1 error. Their results revealed no
significant between group differences at baseline, on any measure,
however post-treatment comparisons demonstrated significant differences
between the treatment groups and the control groups, although there
were no differences amongst the three active therapies. SOL, ratings of
difficulty falling asleep, and restedness, were the best discriminators
of treatment outcome, whereas total sleep time contributed little
discriminant weight. In addition to these statistical results,
inspection of Table 4 reveals that SOL reductions were of clinical
benefit, being in the range 54-67%. It would appear from this study
84that the three psychological therapies are equally effective.
However, some important issues were not dealt with in Turner and
Ascher's study. Non-clinical subjects were again selected, and it may
be that such clients will readily respond to most therapeutic
endeavours. In addition, Turner and Ascher permitted the uncontrolled
use of sleep medication, and even cited drug intake as a useful
dependent variable. This is unsatisfactory because of the contaminating
effects of varied usage upon sleep pattern. The major criticism,
however, concerns the lack of any data during the process of treatment
or during follow-up. It was not possible to tell at what point
therapeutic effects emerged, or whether treatment gains persisted
beyond the termination of therapy.
Lacks et al (1983a) completed a thorough replication of Turner and
Ascher's work on a more clinically-based sample. Their 64 participants
(48 female, 16 male) were obtained from both newspaper (and other
media) announcements and letters to referring physicians. In spite of
the liklihood that these modes of selection might constitute two
discrepant samples, Lacks et al made no attempt to compare on this
basis, or even to report the relative proportions which the sub-groups
comprised. Similar to a number of previous reports, all subjects were
required to submit a monetary deposit, prior to completing a 7 day
baseline period. On the basis of this pre-treatment assessment,
subjects were labelled as either mild (SQL 15-44 mins), moderate (SQL
45-75 mins) or severe insomniacs (SQL 76-152 mins) and were randomly
allocated, within severity blocks, to each of the treatments outlined
in Table 4. Therapy was conducted in four, weekly, small group
sessions, of approximately 1 hour duration. The counterdemand procedure
was applied to the effect that improvement would not occur until the
final week.
85Lacks et al reported outcome data on only the measure of sleep-onset
latency. The SOL of the stimulus control group was clearly, and
consistently, the lowest at each assessment point after week one, and
this was true for all degrees of insomnia. Overall, subjects receiving
this intervention reduced sleep latency by an average of 52% at Week 3,
and even during the positive demand phase no other treatment exceeded
this level of success. The authors pointed out that, although all
treatment groups continued to decrease their level of initial insomnia
during follow-up, "the major advantage of stimulus control was that
high levels of treatment success were accomplished very quickly". They
concluded that "regardless of the severity of onset insomnia, the
treatment of choice is stimulus control". In consideration of the issue
of severity on a broader basis, their strongest evidence was against
the existence of a negative relationship between severity and outcome,
ie. a severe presenting problem does not contra-indicate therapy.
Lacks et al discussed their results with reference to the study by
Turner and Ascher (1979a). By way of contrast, they pointed out that
paradoxical intention did not appear to be a recommended treatment,
since some of their patients demonstrated increases in mean SOL after
therapy (cf. Espie and Lindsay, 1985). Criticisms of the Lacks et al
study rest upon the subject selection procedures, and the choice of a
single sleep pattern variable as the outcome measure. By their own
admission, these workers referred to the skewed distribution of their
sample, stating that they were largely white, middle class, well
educated, financially able to afford to deposit $40 for four months,
and were all drug-free. At the very least, they were clearly a
motivated sample, since less enthusiastic subjects would be likely to
hesitate at the financial contract. Their study does, however, provide
an influential controlled investigation into the management of insomnia
and has challenged Turner and Ascher's finding of equivalent outcomes
86across therapies. Stimulus control did once again emerge favourably,
at least for SOL reduction.
Finally, Turner et al (1984) have reported a comparative study of 40
referred patients who were treated by either stimulus control,
relaxation, a combination of the two procedures, or waiting—list
control. The mean age of this sample was relatively young (31 years),
and patients had suffered from insomnia for an average of 4 years. The
data in Table 4 reveal that both stimulus control and progressive
relaxation produced a treatment response superior to both the combined
therapy programme and waiting—list control. The average reductions in
SOL for the relaxation and stimulus control groups were, however, only
15 minutes and 21 minutes respectively (a non—significant difference)
and such improvements may be of limited clinical value. Turner et al
also examined a number of other sleep parameters such as total sleep
time, number of wakenings, and ratings of restedness and difficulty
falling asleep, but found no significant changes. They also, again
inappropriately, included drug intake as a dependent variable.
One interesting finding from this study, however, was the failure of
the combined "package" treatment. It might reasonably be expected that
such an approach would prove more powerful than either of the
components alone, but conversely, Turner et al reported an 82% failure
rate. They interpreted these results in terms of De la Pena's (1978)
theory that treating insomniacs with an antagonistic, arousal—reducing
procedure (relaxation) and an (arguably) arousal—increasing one
(stimulus control) would lead to therapeutic failure. De la Pena
regarded the aetiology of primary insomnia as a state of "chronic
stimulus underload", with insomnia functioning to balance this lack of
equilibrium through increments in sensory input. This theory, however,
has attracted little interest in the research literature and has very
87limited empirical support. Perhaps the provision of two sets of
therapeutic instructions, and also the associated rationales, simply
rendered the subjects' task ambiguous with a consequent weakening of
therapeutic response.
Lichstein (1985) has summarised very succinctly the effects of
psychological treatments upon insomnia in stating that "most
psychological treatments are helpful, and no one treatment clearly
emerges as superior to others, although stimulus control has an edge".
The present study was designed to provide further evaluation of
a number of psychological approaches with clinically—presenting cases.CHAPTER 6
OVERVIEW OF THE TREATMENT OUTCOME LITERATURE 
SOME METHODOLOGICAL ISSUES
Chapter 5 provided an extensive review of the available psychological
treatment studies. Interventions, of whatever type, have generally been
positive in their impact, although the degree of measurable change has
been found to vary considerably. Relaxation methods have undoubted face
validity and popular appeal, but appear to be equally effective in
whatsoever form of administration, making it difficult to determine
what is/are the critical ingredient(s), and indeed the mechanism by
which relaxation obtains its effect. Reductions in SOL have been modest
in proportion. Paradoxical intention may be viewed as another anxiety —
reduction procedure focusing, however, more upon cognitive than
physiological state. By comparison with relaxation training, the
literature on paradox is very small and contains no clear statement of
its usefulness. Of all the procedures reviewed, it appears to have been
uniquely capable of exacerbating insomnia for some people. Of the three
major treatments, stimulus control perhaps emerges as the most
promising. Similar to relaxation training, the means by which stimulus
control achieves its effects remain uncertain. As a "package" of
instructions, however, it does seem to offer the greatest potential in
the management of insomnia, regardless of severity. Such a conclusion,
however, must be tempered by the fact that such effects have been
reasonably demonstrated within only one outcome variable, that is SOL.
From a methodological point of view, treatment studies have varied from
the grossly inadequate to the imaginative and well—controlled. Such a
spread of experimental method is inevitable in the historical review of
any clinical condition. More recent reports have identified and
remedied a number of weaknesses in methodology which were previously
89evident. Nevertheless, there remain some serious shortcomings, and it
was partly through a concern to address these that the present study
was undertaken. For the purposes of clarity it will be useful to
consider design features under several headings.
SUBJECT SELECTION
Published reports on insomnia have been largely on non-clinical
subjects and are, therefore, subject to the criticisms commonly
levelled against analogue research. An analogue approach does of course
have its place: being of an exploratory nature, key issues have been
identified and methodological, practical and conceptual questions
raised for further enquiry, but subsequent experimental refinements
have failed to deal with the major issue of the generalizability of
these findings to the patient population. The mere passage of time
appears, rather, to have afforded a status and clinical efficacy to
procedures which may not be empirically justified. Approximately half
of the available reports have been conducted on student populations,
with most of the remainder being the product of "recruitment drives"
through media advertisements, with subjects being partly selected on
the basis of ensured compliance. Importantly, most studies have given
no indication as to whether or not subjects were actively seeking help
for insomnia at the time of selection. Three recent studies utilised a
combination of media announcements and physician referrals (Lacks et al
1983a,b; Puder et al, 1983) and the study by Turner et al (1984)
employed referred clients. These are, therefore, indicative of some
awareness concerning the need more closely to approximate the clinical
population. The greatest part of the literature is, however, based upon
convenient populations.
The practising clinician cannot be satisfied until results are
replicated in studies using unsolicited subjects. Killen and Coates
90(1979) have made the point that "college students  	  do not respond
to treatments in the same way as do persons from the community", but
this argument might also be extended by questioning the assumption that
"adults in the community" equate readily with adults who present at the
clinic requiring treatment. Coates and Thoresen (1980) refer to the
"modest to negative outcomes obtained when (behavioural) strategies are
evaluated with subjects who are older, who have experienced insomnia
for two years or more, who present themselves at clinics for treatment,
or who are referred by physicians". It is estimated that 10% of all NHS
prescriptions in the UK are for hypnotic drugs, which indicates that it
is hardly necessary to solicit candidates.
Patients on Hypnotic Drugs
Past research has generally excluded subjects currently taking hypnotic
drugs. This has the major methodological advantage of eliminating a
potentially confounding variable. The case for the inclusion of such
subjects, however, may be a valid one, for several reasons.
Firstly, a substantial proportion of out—patients attending sleep
clinics make regular use of night—time medication (82% in a study by
Roth, Kramer and Lutz, 1976). There is, therefore, the danger of
selecting out of research studies a large proportion of the clinically
presenting group. Studies may have problems in the generalizability of
results. Secondly, there appears to be sufficient understanding of
hypnotic drug effects to make complete exclusion of such patients
unnecessary. The rebound phenomenon is sufficiently understood to
permit the presentation of accurate information regarding likely
changes in sleep pattern subsequent to withdrawal. Supportive and
educative input may enable patients to tolerate the initial few weeks
more readily, and help to counteract the problem of misattribution
which reinforces the patient's perception of himself as a poor sleeper.
91The literature indicates that a minimum 5 week withdrawal period is
required (see Chapter 5), and research studies should follow this
period with the collection of a stable baseline. In some instances
withdrawal may need to be gradual at the recommended reduction rate of
one therapeutic dose per week (Kales et al, 1974). Such a systematic
programme would be preferable to simply encouraging patients to
discontinue medication, and including them only if they are successful.
Thirdly, an alternative model is also a realistic possibility for those
patients who are unable at first to cease hypnotics. Habituation
quickly develops to most hypnotics, after several weeks of nightly
administration (Chapter 5). It should be possible, therefore, to
maintain such patients on drugs at the habituated level, gather
baseline data, and assuming stability can thereby be demonstrated, to
institute psychological treatment to promote sleep pattern improvement.
Thereafter, greater success may be achieved in "weaning" patients off
drugs at the prescribed rate. This would seem to be a valid procedure,
both methodologically and clinically, since the effects of hypnotics
can be justifiably considered constant if taken at the same dosage
after habituation. Observed treatment effects can then be attributed to
the experimental manipulation per se. This model seeks to ensure that
drug intake becomes a controlled variable. Clearly if pre-treatment
withdrawal proves feasible in a given case then that would be the
option of choice, but both procedures are preferable to either the
total exclusion of drug-using patients or their inclusion on the basis
of a statement that they will not take hypnotics during the
experimental period. Drug level cannot be employed as a dependent
variable (patients self-medicate as required) because of the greater
long-term effectiveness of intermittent use and the contaminating
effects upon data of rebound insomnia.One of the outstanding questions to be addressed by the literature is
the extent to which psychological treatments are effective in routine
clinical work. The above drug-management protocols were, therefore,
adopted in this study in order to answer this question (see Chapter 7).
MEASURES OF CHANGE
There have been a number of problems associated with data collection in
previous studies.
Firstly, the Daily Sleep Questionnaire (DSQ) (Monroe, 1967) has been
the most commonly employed measure in the psychological literature.
Comparisons between EEG and DSQ parameters were made in Chapter 4, from
which it would seem acceptable to view self-report as relatively
reliable and valid for most sleep parameters. Nevertheless, greater
confidence can be placed in those studies which have established DSQ
validity within their reported populations. Unfortunately, this has
been the exception rather than the rule.
Secondly, an equally important shortcoming has been the general, and
sometimes exclusive, reporting of only one outcome variable, namely
SQL. It cannot be assumed that general alterations in sleep pattern
occur as an inevitable effect of SQL change. Furthermore, it is unclear
to what extent quantitative change correlates with changed perception
of sleep quality, restedness, and the insomniac's consideration of
her/himself as a poor or good sleeper.
Thirdly, it is also helpful to be able to predict the point at which a
given therapeutic procedure is likely to exhibit significant change.
The evidence so far suggests that stimulus control operates rather
more quickly than other interventions, but no systematic attempt has
been made to gather the process data which would help to characterise
treatments in terms of within therapy change.
93Fourthly, adequate follow-up is of considerable importance. For the
purposes of most psychological research it appears that follow-up at 3
or 6 months is viewed as reasonable and studies on insomnia seem to
have aimed at this criterion. However, clinical insomnia should be
regarded as a chronic disorder, the natural course of which dictates
that lengthy follow-ups be completed.
One final area of neglect has been the failure to investigate the
generalised changes in day to day functioning which result from
therapy. Some of the psychological treatments used are commonly
regarded as anti-anxiety strategies, and measures of symptomatic
anxiety and depression would prove informative. The daytime
consequences of improved sleep might also be considered. Measures of
concentration level, irritability, daytime coping etc., would be useful.
The present study was designed to make it possible to address these
matters.
DESIGN ISSUES
Two important methodological developments have improved substantially
the quality of experimental control. The first of these is the
imaginative, counterdemand instruction (Steinmark and Borkovec, 1974)
which controls for expectancy effects. It has proven useful in the
discrimination of active versus placebo treatment effects, where the
latter have been demonstrated only under conditions of positive demand.
The adequate control of demand characteristics is of fundamental
importance given that social acquiescence and other non-specific
factors may be responsible for treatment effects. The second creditable
development has been the use of Borkovec and Nau's (1972) Credibility
Evaluation Questionnaire (CEQ). However, this is most useful as a post-
rationale evaluation of expected treatment benefit, rather than the
94sometimes reported mid or even post—therapy evaluation, when perceived
credibility may be contaminated by actual treatment response. An ideal
point at which to administer the CEQ would be during the first week of
therapy, after the programme has been put into practice but before
benefit can be systematically monitored by the patient.
The use of a single therapist across treatment conditions can limit the
external validity of results. A number of studies, however, failed to
find any effects of "therapist factor" in the relaxation and stimulus
control treatment of insomnia (Carr—Kaffashan and Woolfolk, 1979;
Nicassio and Bootzin, 1974; Steinmark and Borkovec, 1974; Tokarz and
Lawrence, 1974). The only study to do so has been that of Turner and
Ascher (1982) who, not surprisingly, found that the level of
improvement achieved by trainee therapists was less than that obtained
by experienced therapists. Of greater concern is the potential for
differing skills and/or enthusiasms to be applied to the various
treatments by a single therapist. In studies where a suitable number of
similarly experienced and skilled therapists is not available, external
validity checks, perhaps in the form of independent ratings of
treatment sessions, would be a useful to ensure that any differences in
treatment outcome are not due to systematic bias in the part of the
therapist.
Most researchers have randomly allocated subjects across the
experimental conditions to provide a strong test of between group
difference. There have not been any controlled studies which have
addressed the important clinical issue of selecting treatments to suit
individual needs. Such a "tailored" approach could be usefully compared
with randomly assigned psychological treatment.
The present study seeks to address these design issues.ANALYSIS OF TREATMENT OUTCOME DATA
The most useful outcome data are those which are both statistically and
clinically meaningful. Analyses may be statistically robust and
significant without necessarily being of great clinical importance.
The traditional comparison of group mean values across experimental
conditions may be particularly suspect since no information is provided
on the variability of treatment outcome amongst subjects in each group.
This information is of considerable interest as clinical research
should drive clinical practice, but may do so only when research
findings are known reliably to predict outcome for the individual case.
A number of workers have made recommendations as to how testing for
clinical significance might be achieved. For example, Kazdin (1977) has
suggested that a return to normal functioning may be a standard against
which to determine the significance of clinical change. This approach
requires that some normative information is available with which to
compare post—treatment scores. The proportion of patients achieving
normal scores after treatment can then be deduced. Other workers have
recommended a 50% change of symptomatic level (Jansson and Ost, 1982;
Lichstein and Fischer, 1985) as a useful criterion. Jacobsen, Follette
and Revenstorf (1984) have also discussed these issues and have
stressed the need for an agreed standard convention which is
"applicable to a wide variety of clinical problems, ----- objective,
relatively free of bias, and sound from both a psychometric and
clinical perspective". Although no such standard has as yet been
determined, some analysis of this type is clearly required.
Analysis of outcome, conducted upon mean values, may be incomplete also
where the mean score is taken to be a representative statistic
descriptive of "typical" sleep pattern. An average weekly SOL of 60
minutes for a given patient suggests that this individual takes around
96one hour to fall asleep each night. Raw score variance, however, may be
considerable (on occasions patients fall asleep very quickly; at other
times SOL may be very lengthy). Indeed, the inherent unpredictability
of what sleep will be like on a given night may have a bearing upon the
complaint of insomnia itself (see Chapter 2). A simple measure of range
or standard deviation would appear to be useful as an index of night to
night variability in sleep. It may be that effective treatment should
improve not only the average sleep pattern but also increase the
predictability of that pattern on a night to night basis. The
employment of both mean and SD scores would make it possible to report
treatment effects in terms of changes in the typical pattern of sleep.
The present study addresses both of the analytical issues outlined
above. Both mean and SD scores for sleep pattern variables will be
analysed in the Results section and the clinical significance of the
results obtained will form a major focus of the Discussion to follow.
In summary, this investigation was designed to determine the usefulness
of various psychological treatments with patients presenting clinically
as insomniac. Drug-taking patients were not excluded, but care was
taken adequately to control the effects of drugs. Both the range of
outcome measures and the summary statistics entered in analyses were
extended to ensure valid hypothesis-testing, and the clinical impact of
treatment changes were assessed. In these ways some of the shortcomings
of past research were overcome.CHAPTER 7
METHODOLOGY OF THE STUDY
SUBJECTS
The subjects were a series of consecutively referred adult out-patients
described, in the terms of a referral letter, as suffering from
"chronic sleep-onset insomnia". All of the patients were GP referred,
and the GP practices in north Lanarkshire and the west end of Glasgow
involved in the study were familiar with making direct referral to
clinical psychologists (Espie and White, 1986a,b; Storrar, 1984). All
GPs had received correspondence explaining the selection criteria and
were encouraged to refer suitable cases.
During the period of data collection 141 consecutive referrals were
received of whom 130 attended initial interview. A further 29 were
excluded by the author as failing to meet the selection criteria
outlined below. This excluded group comprised 11 patients considered to
have sub-clinical sleep problems; 14 who demonstrated significant
psychopathology (9 depressed, 3 alcohol/drug abusers, 1 impotent, and 1
marital problem); and 4 who had clinically diagnosable other sleep
disorders (2 restless legs syndrome, 1 nocturnal myoclonus, 1 sleep
apnea). There remained, therefore, 101 available and suitable cases of
whom 17 were regarded as drop-outs from the experimental design. Eight
of these furnished data for four weeks or less of the treatment period,
6 failed to achieve adequate control over medication and were excluded,
and the remaining 3 repeatedly failed satisfactorily to complete the
Daily Sleep Questionnaire. Drop-outs were evenly distributed across the
treatment conditions and did not represent any form of systematic bias.
This study describes the final sample of 84 patients (57 females, 27
males) who completed the study. Thirty-one subjects were from
98Lanarkshire and 53 were from Glasgow. The mean age of the sample was
45.5 years (range 17-82, SD 15.9), and insomnia had presented
clinically as a problem for an average of 11.8 years (SD 11.6). Further
confirmation of the chronicity of insomnia can be found in that mean
time since first prescription of sleep medication was 9.0 years (SD
10.6). Independent sample T-TESTs revealed that there were no
significant differences on any demographic variable between males and
females, or between the two geographical cohorts. Similarly, ONEWAY
ANOVAs revealed no differences across treatment groups in terms of sex,
age, duration of insomnia, or time since first prescription (see Table
5 for demographic characteristics).
Selection Criteria
1. Sleep-onset latency greater than 30 minutes on average per night.
That is a total latency of at least 3.5 hours over the week.
2. Chronic initial insomnia present for minimum of one year.
3. Previous advice-seeking as evidence of clinical relevance of
insomnia. In practice this constituted written physician referral.
4. Legitimate to treat insomnia in isolation as the main presenting
or primary problem.
5. Able to ensure the withdrawal of all drugs which might interfere
with the experimental design, or to maintain the patient on the
same doseage of the same drugs throughout the period of study.
6. No other ongoing therapy for insomnia, anxiety or depresson.
7. Exclusion of patients presenting as clinically depressed at initial
interview or with scores of 60 or higher on the Zung Depression
Scale (Zung, 1965). Exclusion also if anti-depressant medication
had been prescribed at any time during the 6 months preceeding
referral.
8. Exclusion of patients considered to have drink problems.
9. Exclusion of insomnia problems possibly related to medical
conditions, and of sleep disorders not conforming to categories 1,2
or 9 of the Diagnostic Classification of Sleep and Arousal
Disorders (Sleep, 1979, 2(1) - see Chapter 2).
10. Exclusion of patients non-compliant with either treatment
instruction or adequate record-keeping.
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FIGURE 1:	 Design of the treatment outcome study.
PR Progressive Relaxation
SC Stimulus Control
PI Paradoxical Intention
IR Imagery Relief (placebo)
NT No Treatment
TT Tailored Therapy
100DESIGN AND PROCEDURE
The overall design of the study from referral to follow-up is outlined
in Fig 1. Following screening and final selection a decision was made
concerning patients who were habituated to hypnotic medication, either
to withdraw that medication pre-treatment or to maintain its use during
psychological therapy and withdraw thereafter. This decision was
largely a pragmatic one, withdrawing where possible at the outset, but
if patients were unable or unwilling to persevere with the standardised
5-week withdrawal regime they were assigned to the maintenance design.
The use of these alternative experimental models, therefore, afforded
flexibility which in turn permitted the inclusion of "difficult" cases.
The rationale for these procedures was detailed in Chapter 6. Summary
flow-charts of the two protocols are, however, presented in Fig 2. The
reader should note that the experimental phases are identical in the
two models apart from the timing of the withdrawal regime.
Baseline	 Withdrawal Baseline	 'Treatment	 Follow-up
1/52	 5/52	 2/52	 4/52	 6/52
+	 3/12
4/52	 6/12
SELECTION	 17/12
Baseline	 Treatment	 Withdrawal	 Follow-up 
2/52	 4/52	 5/52	 6/52
+	 3/12
4/52	 6/12
17/12
fig .. 2 Outline of the two experimental models for pre and post-
treatment drug withdrawal 
Of the 84 patients, 58 (69%) were stated, by their GPs, to be "drug-
free". Only 14 of these patients, however, had never been on hypnotic
medication, and it transpired upon further assessment, that
approximately one third of the remainder had not entirely discontinued
medication. In most cases drug use was occasional and low dose. The
author supervised the final cessation of hypnotics for these patients
101and the full pre—treatment withdrawal protocol was not required.
Twenty—six patients were referred with persisting sleep difficulties
who were also on nightly sleep medication. Eleven of these (13% of
total reference group) were allocated to the pre—treatment withdrawal
protocol, and 15 (18% of total) were maintained at habituated levels
while psychological therapy proceeded. The GP of each patient was
contacted by letter in order to secure cooperation with the demands of
the programme being followed.
Prior to psychological treatment, baseline assessments were completed
on the DSQ, in order to provide information on untreated sleep
quantity, pattern and quality. The DSQ functioned as a process measure
and was completed for every night's sleep throughout the experimental
period. The other rating scale measures were included to assess the
generalised effects of sleep loss and other symptomatology and were
used in a pre—post format. The original experimental design allowed for
three psychological treatment groups and two experimental controls (see
Fig 1). Subjects were allocated, according to a predetermined random
list, to either progressive relaxation (PR), stimulus control (SC),
paradoxical intention (PI), imagery relief placebo (IR) or no treatment
(NT). After completion of the main study, however, it was felt
desirable also to include a tailored therapy group (TT) where subjects
received treatment tailored to suit their individual needs. A Sleep
Disturbance Questionnaire was devised for use with this group to
provide a more structured method of evaluating the therapeutic
ingredients appropriate for each individual. Allocation to the tailored
group was by consecutive referral since the randomisation design had
already been completed. Since the tailored therapy condition was not
part of the original study design it will be dealt with as a separate
chapter in the Results section. Descriptive information on the
treatment groups is available in Table 5.
102n _ M/F Age Duration First
prescription*
Relaxation 14 7/7 48.1 (10.6) 16.2 (11.6) 10.4 (11.5)
Stimulus control 14 4/10 44.9 (14.4) 7.8 (13.1) 8.4 (10.1)
Paradoxical 15 3/12 43.7 (15.8) 13.1 (10.6) 8.6 (8.6)
intention
Imagery relief 14 4/10 42.4 (15.3) 11.6 (12.9) 9.1 (11.9)
placebo
No treatment 13 5/8 45.3 (20.9) 13.5 (16.1) 13.0 (15.9)
Tailored therapy 14 4/10 48.6 (18.8) 8.9 (7.0) 5.2 (4.5)
* Of the 84 patients only 14 (17%) had never been on sleep medication
TABLE 5 Demographic characteristics of the six experimental groups. 
(Figures in brackets are standard deviation scores of the mean values)
Treatment Conditions
All active treatments and the placebo intervention comprised a series
of six individual out-patient appointments (of approximately 40 minutes
duration) during the eight-week therapy period, comprising 4 weeks
under counterdemand, and 4 weeks under positive demand.
Counterdemand Instruction 
All patients were given counterdemand instruction (Steinmark and
Borkovec, 1974) during the first four weeks of therapy. They were told
that treatment would take some time to have an effect upon sleep
pattern and that patience and perseverance were essential. They were
informed that experience had shown that fully four weeks of treatment
would pass without benefit, but that thereafter dramatic improvement
would take place. Positive demand instructions were issued from the
fifth week onwards encouraging expectation of change. In order to
reinforce these demand manipulations an "Important Note" was included
in all treatment hand-outs, restating the instructions. The
counterdemand period was extended to four weeks, compared with previous
research, in order to allow for the possibility that with severe
103insomnia therapeutic effects might take longer to achieve.
The rationale and treatment procedures employed were in close agreement
with those applied in previous studies. A brief resume of the
therapeutic instructions for each condition will be provided.
Progressive Relaxation 
Subjects were instructed individually in the application of an
abbreviated progressive relaxation procedure, similar to that of
Bernstein and Borkovec (1973). The exercises comprised tension—release
cycles covering major muscle groups in the arms and hands, neck and
shoulders, face and mouth, back and abdomen, and legs and feet.
Regulation of breathing pattern was also an integral part of the
training procedure, and the cue word "relax" was trained latterly as a
discriminative stimulus according to the cue—control technique (see
Marchetti, McGlynn and Patterson, 1977).
Two in vivo training sessions were administered. Subjects were
instructed while lying down. A relaxation training cassette was
recorded during one of these sessions and was subsequently used for
home practice. Patients were required to practise the exercises daily
and to apply them in bed with the light out. The set of exercises
lasted approximately 20 minutes, but patients were told to continue to
apply the technique until they fell asleep. After the in vivo sessions,
clinic appointments were used to monitor progress, to tailor the
exercises to suit individual needs, and to foster the development of
cue control.
Stimulus Control 
Standard directions were given to each subject, although care was taken
to identify for each individual those behaviours thought to be sleep—
incompatible, and those conducive to sleeping well. The Sleep Behaviour
104Rating Scale (see section on Measures to follow) was helpful in this
respect. The therapeutic instructions were as follows (see also
Bootzin, 1972):—
a) Lie down intending to go to sleep only when you feel sleepy
b) Do not read, watch TV, listen to the radio, etc. in the bedroom
c) If you do not fall asleep within 20 minutes, get up and go into
another room, returning to bed only when you feel sleepy
d) If you cannot fall asleep repeat step c, and do this as often as is
necessary throughout the night
e) Set the alarm and rise at the same time each morning
f) Do not nap during the daytime
Paradoxical Intention 
The paradoxical intention programme was explained using illustrative
examples to help patients understanding of the relationship between
performance anxiety and sleep—onset. They were told that their
paradoxical intention was to remain awake for as long as possible
rather than continuing the effort to fall asleep. They were told,
however, that the environment should be conducive to sleep le. they
were to lie in bed with the lights out, but to keep awake by having
their eyes open. They were not to actively prevent sleep through moving
about or through other overt activities. Patients were instructed to
remind themselves that it was their intention to remain awake whenever
they felt their eyelids closing. Clinic sessions were used to rehearse
these procedures and the rationale given, and to deal with any
practical problems arising from implementation.
Imagery Relief Placebo 
Patients in this group were treated in accordance with the quasi—
desensitisation placebo instructions commonly used in past research
(Steinmark and Borkovec, 1974). The term "imagery relief" was, however,
coined by the author. During the first training session a hierarchy of
105chronologically ordered evening and bedtime activities was constructed,
in such a way as to be typical of the patient's usual routine. The
patient was then informed that these items were an integral part of the
sleep problem itself and that sleep onset would be facilitated by the
desensitisation process and the relief of tensions presumed to be
associated with the nightly routine. A list of mental images was then
elicited from the subject, to be paired off with the hierarchy items in
a deconditioning paradigm. The therapist ensured that the images
selected were pleasant, but on the whole neutral in connotation for the
subject. (A typical example of the hierarchy and list of images used is
provided in Appendix A). It was stressed to the subject that time
should be spent on daily practice of the training programme, but that
under no circumstances should a session occur later than 8.00 pm.
Subjects were trained to concentrate upon the first item of the
chronological list, and once visualisation was achieved, to switch
attention to one of the mental images. This procedure was then repeated
with the next item, and so on until 20 minutes practice had elapsed.
The programme was, therefore, analagous to relaxation
therapy/desensitisation but with the important omission of any known
active ingredient,	 either theoretically or practically. Patients
received no instruction in dealing with sleeplessness per se.
No Treatment
This group functioned as a waiting list control and had minimal
therapist contact. Patients were seen after referral for the purposes
of training in the use of the DSQ. This typically involved two
appointments. Occasional contact by telephone was also made to ensure
that sleep diaries were being completed as required, but at no time was
advice or treatment offered. Subjects were seen again at the end of the
ten week data collection period having thus provided data for the
entire duration of the experimental period. These subjects were told
106that, at the end of the 10 weeks, they would be put on to a therapy
programme, and that gathering data in the meantime would greatly assist
in the assessment of their sleep difficulties. Patients were not re-
allocated within the randomisation design since it was felt unethical
to, by chance, allocate some of them to placebo therapy. In addition,
it was felt unreasonable to require these patients to complete a
further ten weeks of data collection to conform to the study
design. Waiting—list subjects were, therefore, treated on an ad hoc
individualised basis.
In addition to the verbal instructions given during treatment sessions,
each subject was also given a hand—out which summarised the main points
of rationale and procedure for his/her therapy programme. These were
simply take home summaries of the programme as outlined in the
consulting room. The hand—outs were subjected to analysis of
readability, according to the Flesch (1948) formula, and were
standardised for "reading ease" and "human interest" at a level
approximating to that of the "popular" press. A copy of each hand—out
is contained in Appendix B.
At the final therapy session, post—treatment assessments were
completed, and follow—up procedures explained. Follow—up data were
collected on the DSQ for 7 consecutive nights, at 6 weeks, 3 months and
6 months, and 17 months.
Investigation of Therapist Factor
The author conducted all therapy sessions across treatment conditions.
In order to confirm that there was no systematic bias resulting from
the application of differential therapeutic skill across treatments,
external ratings of tape—recorded therapy sessions were provided by an
experienced therapist who was not involved in the study.
107Audio cassettes were made of treatment sessions on a random sample of 9
patients. This group comprised 2 from relaxation training (Cases 5 and
6 in Fig. 3), 3 from stimulus control (Cases 2, 4 and 8), 1 from
paradoxical intention (Case 9), 2 from tailored therapy (Cases 3 and
7), and 1 from placebo therapy (Case 1). A rating instrument was
derived by selecting and adapting items from the Cognitive Therapy
Rating Scale (Young and Beck, 1980). The Young and Beck scale was
designed specifically for the purpose of independently evaluating
therapist skills. Four items were included as ratings for the present
study. These were "interpersonal effectiveness", "collaboration",
"strategy for change" and "application of techniques". Each was rated
on a 7 point scale from 0 through 6. Detailed descriptive criteria were
provided for scoring each item (as in Young and Beck — see Appendix C).
The rater randomly selected the order in which to listen to the tapes
and made his ratings, separately for each patient, immediately after
hearing the relevant material.
The results of this investigation are presented graphically in Fig. 3.
The data points plotted in each section of the graph represent the
ratings made of that particular therapist skill in relation to each of
the 9 cases. Because of the small numbers in each experimental
condition it was not possible to analyse the data statistically. Visual
inspection, however, clearly indicates that there was marked
consistency of skill across patients and across treatments. For
"interpersonal effectiveness" the median score of 4 applied to 6 of the
9 subjects. On the assumption that a score +/— 1 scale point represents
reasonable consistency only Case 4 deviates from the "norm". Similarly
for "collaboration", ratings were consistently within the same range
with this single exception. Case 4 was treated by stimulus control but
consistently failed to comply with certain aspects of the programme.
The audio—tapes, therefore, reflected a degree of antipathy.
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FIGURE 3: Independent ratings of therapist skills across
subjects on four domains of skill derived from
the Cognitive Therapy Rating Scale (Young and
Beck, 1980).
109For "strategy for change", ratings of therapist skill fell within 1
point of the median score for 8 of the 9 patients. It seems that again
skill was being equally applied. A score of 2 was given in relation to
Case 3 (tailored therapy). This patient had completed drug withdrawal
successfully. Unfortunately, tape recordings represented only the first
session of treatment when various therapeutic options were discussed.
Ratings of "application of techniques" were distributed evenly around a
median score of 5. The treatment intervention for five patients was
rated at the median, two other cases were rated as 6, and the remaining
two as 4. There was, therefore, no significant deviation on this rating
according to the above criterion.
Since only 3 out of the 36 ratings made could be considered as evidence
of inconsistency, it can be concluded that the range of therapist
skills investigated were equally evident in each case studied. The
use of a single therapist across treatments is unlikely, therefore, to
account for any systematic difference between groups.
MEASURES
The outcome measures can be sub-divided into two groups. Firstly,
measures of therapeutic process were taken in order to evaluate changes
in the main dependent variables over time; and secondly, "before and
after" testing was conducted to evaluate more general changes in
psychological status associated with the interventions. Assessment
procedures will be described under these headings.
Process Measures
Self-report measures of nightly sleep were recorded throughout the
experimental period on a Daily Sleep Questionnaire (DSQ) based upon
that of Monroe (1967) and subsequent workers (eq. Turner and Ascher,
1101979a). The DSQ comprised nine items completed each morning upon
rising, and a further two items, referring to subsequent daytime
functioning, completed upon retiring to bed (see Appendix D). Subjects
provided estimates of the three main parameters of sleep latency
(mins), total sleep time (hrs/mins) and wakening frequency, and also
recorded the time at which they had gone to bed, their terminal waking
time, and their time of rising. In addition to these quantitative
variables, the DSQ also incorporated rating scale measures of intrusive
anxious thoughts at bedtime, overall sleep enjoyment and restedness
upon rising. These ratings were made on 5-point Likert scales
where 0 represented "not at all" and 4 "very much". Subjects generally
found the ratings simple and straightforward to use. Occasional
difficulties, however, did arise with the semantics of the scales. In
particular, some patients asked what was meant by "enjoyment" of sleep,
and to a lesser extent, "restedness" in the morning. In order to
control for the possibility that different interpretations might be
made, the author routinely explained the intended meanings of the items
and relabelled them, if necessary, with appropriate synonyms.
Therefore, and for example, an "enjoyable" sleep was considered to be a
"good" sleep, and a sleep with which one was "pleased" or "satisfied".
A similar 5-point scale was employed as a measure of daytime
irritability which is a frequently reported correlate of impoverished
sleep. Subjects also kept a record of time spent napping each day. In
addition, patients who were continuing to make use of sleep medication
were required to enter each dose taken on the DSQ so that control of
drug intake could be maintained.
In recent years there has been considerable debate regarding the merits
and demerits of sleep diaries, particularly in relation to objective
descriptors of sleep. Chapter 4 considered these issues in detail. At
present, the arguments for and against both subjective and objective
111assessment continue thereby necessitating; firstly, careful control
over all assessment procedures; and secondly, the appraisal of validity
within each subject population. In this investigation care was taken to
train patients in the use of the DSQ forms, and a validity study was
conducted to evaluate the accuracy of self—reporting.
DSQ Training Procedures 
All patients were given detailed instructions on DSQ recording at the
initial interview. In addition, however, each subject was required to
complete the DSQ for one week in order to become familiar with the
procedures involved in self—monitoring. A second appointment Was
arranged to discuss any problems which had arisen and to examine the
DSQ. Where inconsistencies in records were evident, these were pointed
out and further instruction given to rectify errors. For example, if
estimates of one sleep measure did not "tally" with other measures of
sleep pattern, further training was provided to ,improve the quality of
record—keeping. Subjects were required to estimate sleep parameters to
within 10 minutes, in order to avoid the possibility that "rough
guesses" would be entered to the nearest hour or half hour. It was also
stressed that the record for any given night should be left blank if it
had not been completed within one hour of rising. It was felt that
retrospective guesses would be highly unreliable. This procedure proved
to be permissive, in that it was not regarded as a "failure" to have
blank spaces on the response sheet. Subjects were told to keep the DSQ
and a pencil at the bedside for completion each morning, and were
advised that late entries would confuse the picture and would be liable
to lead to ineffective management.
For 34 patients (40%), data from this first week were regarded as
unsatisfactory and a further two weeks baseline assessment was
completed until satisfactory compliance, according to these criteria,
112was established. At least two weeks of pre—treatment recording was,
therefore, obtained for each subject in the study. Unreliable data
collected during the training period were discarded. Throughout the
remainder of the experimental period patients continued to monitor
their sleep pattern on the DSQ, and were frequently reminded to observe
the above guidelines.
Validity Assessment 
It was decided to employ the "Somtrak" Sleep Assessment Device (SAD)
(Kelley and Lichstein, 1980) as an objective measure of sleep pattern
against which to evaluate self—report. Previous studies have found the
SAD to be a useful measure of both insomniac and non—insomniac sleep
when compared with EEG assessment (see Chapter 4).
The SAD generates a brief, soft tone at pre—set intervals throughout
the night, and simultaneously activates a cassette recorder. The
subject is instructed to respond to the cue tone by stating "I am
awake", thus providing time—sampled data readily convertible to
measures of sleep latency, total sleep time, wakening frequency and
duration, and sleep efficiency. In this study the inter—tone interval
was set at 12 minutes (ie. 5 per hour), the tone duration at 1 second,
and tape recording was for 10 seconds at each assessment point. The
volume and pitch of the tone were set individually for each subject,
within acoustic range yet without being intrusive. Subjects were
instructed to reduce the volume slightly if awakened from sleep by the
tone.
Twenty patients were random sampled (24% of the total group) and asked
to complete a number of nights of home assessment using the SAD. The
number of nights recorded per patient ranged from 2 to 10 with a median
of 6. In this way 110 subject—nights were available for comparison with
DSQ data. SAD recordings were also made randomly across the three
113phases of baseline, counterdemand and positive demand. Decoding of the
SAD cassette tapes was performed using prepared scoring sheets
(Appendix E), which required the rater to enter a tick in response to
each tone depending upon the presence or absence of the criterion
response of "I am awake". A simple categorical decision could thus be
readily made. Nevertheless, an inter-rater reliability check was
conducted on a 20% sample of the subject nights which yielded a 99.2%
agreement rate on the presence/absence of criterion responses.
The 20 patient sample comprised 8 men and 12 women, with a mean age of
43.2 years (SD 13.9) and a mean duration of insomnia of 11.4 years (SD
10.7). Comparison with descriptive data for the total patient group
(Table 5) indicates that this was a representative sample. Table 6
presents the breakdown of DSQ and SAD scores across experimental phases
along with paired T-TESTs which were conducted to evaluate the
significance of differences between the objective and subjective
measures. PEARSON correlations were also computed for each pair of
measures. Inspection of the Table reveals that DSQ estimates of sleep-
onset latency (SOL) were significantly higher than SAD records of the
same nights' sleep during baseline and counterdemand phases. In both
cases the average overestimation was approximately 18 minutes. Under
positive demand, however, the means were not significantly different,
perhaps reflecting the much simpler task which patients had in
estimating reduced sleep latencies within the range 13-52 minutes (ie.
+/- 1 SD). PEARSON coefficients revealed very strong positive
associations between the two measures, consistent across the
experimental period. In each case significance was at the .001 level or
greater. These findings are in keeping with the view that insomniacs
overestimate SOL but tend to do so consistently. The pattern of
improvement evident in SAD scores was also paralleled by self-report,
thus confirming DSQ estimates as a reliable relative index of objective
114Subject Mean SD T df prob Pearson prob
nights
SOL
Baseline DSQ 111.6 75.4
40 2.95 39 .005** .872 .0001***
SAD 94.1 74.5
Counter- DSQ 63.2 53.3
demand 31 2.27 30 .031* .563 .001***
SAD 45.3 32.4
Positive DSQ 30.6 16.9
Demand 38 -1.71 37 .096 .913 .0001***
SAD 32.8 19.7
TOT
Baseline DSQ 4.95 1.64
41 1.26 40 .215 .833 .0001***
SAD 4.76 1.70
Counter- DSQ 5.78 1.65
demand 31 0.60 30 .553 .793 .0001***
SAD 5.66 1.64
Positive IQ 6.57 1.19
Demand 38 2.47 37 .018* .926 .0001***
SAD 6.39 1.16
WAKE
Baseline DSQ 0.85 1.17
40 -4.32 39 .0001*** .620 .0001***
SAD 1.93 2.01
Counter- DSQ 0.83 1.34
demand 30 -5.25 29 .0001*** .429 .018*
SAD 2.67 2.06
Positive DSQ 0.13 0.34
Demand 38 -3.02 37 .005** .053 .752
SAD 0.82 1.37
TABLE 6 Comparison of DSQ and "Somtrak" SAD scores for sleep latency
(SOL) total sleep time (TOT) and frequency of wakening (WARE) on
paired T-TEST and PEARSON correlation measures 
*R< .05 ** < .01 *** < .001sleep latency.
Interestingly, previous reports stating that insomniacs underestimate
the duration of sleep (TOT) were not confirmed. Across the experimental
period there was, in fact, a slight tendency towards overestimation of
TOT. This, however, reached modest significance only during positive
demand. In general, therefore, these patients were accurate in their
DSQ estimates of total sleep time. Correlational data substantiate
this, with coefficients ranging from 0.79 to 0.93, all highly
significant at the .0001 level of probability.
Comparisons between DSQ and SAD for wakening frequency (%AYE) yielded
highly significant between measure differences during each experimental
phase. Patients markedly underestimated their number of wakenings. In
addition, correlational assessment revealed an inconsistent
relationship between self—report and SAD. DSQ was particularly
unpredictive of SAD records in the final stages of therapy when
wakenings were less frequent. It is clear, therefore, that concordance
was poor for this variable. Two ready explanations are available to
account for this result. Firstly, patients were asked to record only
those wakenings which were associated with "difficulty in returning to
sleep". In practice, subjects generally considered arousals of 15
minutes or greater to be disruptive of sleep. It is not surprising,
therefore, that DSQ records should underestimate actual arousal
frequency. Secondly, the time—sampling method employed by the SAD
necessitates the forfeiting of data, particularly for the %AYE
variable, and thus no true objective "standard" was available for
useful comparison. It is worth noting, however, that SAD records are
likely also to be underestimates. It is possible that subjects'
imperception (apart from non—reporting) of relatively brief intra—night
arousals contributed to the tendency towards report of excess TOT
116mentioned above. The evident limitations of the WAKE variable will be
reconsidered at a later point.
In summary, both SOL and TOT were validly estimated by insomniac
patients after training in use of the diary form. Direct interpolation
from the DSQ appears justified for TOT, whereas for SOL (especially
lengthy SOL) the relativity of the self—report data should be borne in
mind. It was not the purpose of this investigation to consider
treatment benefit, although the data are encouraging in this respect.
Before leaving the question of validity it is important to consider
how typical the sampled nights were of subjects' sleep, both
immediately prior to and subsequent to SAD recording. The possibility
that subjects might estimate sleep parameters more carefully and more
conservatively while being monitored is a potential limiting factor to
the above conclusions. The DSQ data on SOL and TOT, provided by the six
patients upon whom inter—rater reliability checks had been conducted,
were selected for this analysis. Individual mean scores for these
variables were computed separately for the 7 nights preceding SAD
assessment and the 7 nights subsequent to assessment, and these values
were compared with mean DSQ scores reported for the period of objective
monitoring. Twelve pairs of DSQ scores were, therefore, available for
each variable. The WILCOXON matched—pairs signed—ranks test was applied
to evaluate the significance of observed differences. For both SOL and
TOT, the critical value of T at p < .05 (n=12) is 14. The observed T
scores of 23.5 and 44.5 respectively, being greater than 14, failed to
reach significance, indicating that mean scores over time could be
regarded as belonging to the same population. In conclusion then, the
sampled nights were representative of "usual" sleep at that time, and
appear not to have been influenced by the monitoring procedure per se.Before and After Measures
Four measures were administered at pre and post—treatment. These were
included to consider any differential impact of the therapies upon
symptomatic anxiety, depression, day to day functioning and behaviour
patterns at or near bedtime. The measures were, respectively, the Zung
Self—Rating Anxiety Scale (ZAS) (Zung, 1971), the Zung Self—Rating
Depression Scale (ZDS) (Zung, 1965), a 10 item Analogue Rating Scale
(ARS) developed for the study, and the Sleep Behaviour Self—Rating
Scale (SBRS) (Kazarian, Howe and Csapo, 1979). Each of the scales is
reproduced in Appendix F.
Zung Self—Rating Anxiety Scale
The ZAS is commonly used in research and clinical practice to provide a
measure of anxiety state. It is a 20 item, 4 point rating scale
covering largely somatic and affective symptomatology. The items were
originally selected from verbatim records of patient interviews and
are, therefore, representative of frequently reported symptoms. Zung
(1971) reported a substantial and statistically significant correlation
between ZAS scores and a clinician rated instrument (r = .74, p < .01),
and split—half correlations were also found to be significant at the
same probability level. The validity and reliability of the ZAS appear,
therefore, to be reasonably attested.
During pilot work for the present study the Taylor Manifest Anxiety
Scale (TMAS) (Taylor, 1953) was also considered but the Zung scale was
finally preferred. There were several reasons for this. Firstly, for
reasons of economy and patient compliance, it was felt that the 20 item
ZAS would be more readily administered compared with the 50 item TMAS
without loss of sensitivity. Secondly, the TMAS is scored only on a
true/false basis rather than the more discriminating four—point Likert
scale in the ZAS. Thirdly, it was noted that errors in scoring of the
118TMAS were more frequent, especially due to the employment of "double
negative" phrasing.
Zung Self—Rating Depression Scale 
Similar to the ZAS, the ZDS is an established scale, comprising 20
items rated on a four point scale. The identical scaling properties of
the two ,Zung scales were found to ease administration, hence one
practical reason for selection of the ZDS. The ZDS represents an early
attempt to provide brief quantification of depressive state, and in his
own work Zung found that his scale was a useful index of clinically
diagnosed depression. He also reported that it was a measure sensitive
to mood change and, therefore, useful as a treatment outcome device
(Zung, 1965). More recently, the reliability and validity of self—
report measures of depression (the ZES included along with six other
scales) have been criticised by Boyle (1985), who questioned their
psychometric adequacy and recommended the development of multivariate
measures of depression. Unfortunately, no such scale has as yet been
published. Another recent report, however, has supported the ZEG in
preference to the Beck Depression Scale (Beck, Ward, Mendelson, Mock
and Erbaugh, 1961), and the MMPI Depression Scale (Hathaway and
McKinlay, 1942). Schaefer, Brown, Watson, Plemel, DeMotts, Howard,
Petrik, Balleweg and Anderson (1985) compared the validities of these
three measures in relation to a number of clinical ratings, including
psychiatric diagnosis based upon ISM III criteria. The ZEG emerged with
the highest validity coefficients (range 0.71 to 0.79) and correlations
with DSM criteria were significantly greater than for either of the
other scales (p < .005, in each case). •
Analogue Rating Scale 
The ARS was developed during pilot investigations. It was felt
desirable to include a measure to evaluate changes in daytime
119functioning associated with treatment of insomnia. Since no such
measure was available, ten commonly reported daytime correlates of
impoverished sleep were selected for inclusion in the scale. Items
included assessments of daytime mood, concentration and general coping,
and these were rated by patients placing a cross at any point along a
10 an line, anchored at either end by "not at all" and "extremely". A
global score (out of 100) and 10 item sub—scores were, therefore,
available for treatment outcome analysis. The author has also used
similar analogue scales in other research studies (Espie, 1986; Semple,
Gray, Borland, Espie and Beastall, 1987) and has found them to be
readily administered and discriminating instruments.
Sleep Behaviour Self—Rating Scale 
The SBRS was developed by Kazarian et al (1979) as an assessment of
sleep incompatible behavior. It was felt to be a useful instrument for
the present study to survey the bedtime behaviour of patients allocated
to receive stimulus control, but also to assess the degree of habit
change associated with therapy of whatever type. Kazarian et al
reported satisfactory internal consistency for their scale (0.75), and
test—retest reliability was found to be high at 0.88. They also found
that the SBRS reliably differentiated between insomniacs and non—
insomniacs on the basis of latency to sleep—onset scores. The SBRS is
rated on a 5—point scale of frequency of engagement in each of 20
targetted behaviours. There were, however, a number of shortcomings in
the original SBRS, particularly in the questionable appropriateness of
some of the items. In this study, therefore, the scale was revised. It
was decided to exclude nine items pertaining to daytime activities
since these appeared to have little validity for the purposes of
evaluating sleep incompatible behaviour. Examples of these are "eating
during the day", "reading during the day", "having sex during the day",
and "talking on the phone during the day". The item of "having sex at
120bedtime" was also omitted. Eight more salient items were then added to
the scale to assess such areas as exercise levels, and mental
reflection and planning at bedtime. The revised scale is presented in
Appendix F, with the additional items asterisked.
Credibility Evaluation Questionnaire 
Borkovec and Nau's (1972) CEQ has already been discussed as an
important methodological control. It was included in the present study
to investigate any perceived differences in the credibility of
treatment rationales. Clearly any such non—specific "treatment" effects
would be of importance in the appraisal of comparative treatment gains.
The CEQ was administered at the end of the first week of intervention
to minimise contamination by emerging therapeutic change. The
questionnaire is reproduced in Appendix G.
STATISTICAL ANALYSIS
All statistical analyses were conducted by means of SPSSX programmes
using mainframe computing facilities. In the Results section SPSSX
commands and (where appropriate) sub—commands will be printed in block
capital script in order to identify the procedures selected. The design
of the study required analysis of two main classes of data, as
previously outlined, ie. process data and pre—post test data. The
reasoning behind the selection of statistical analyses was as follows.
Process Measures
The DSQ generated a considerable quantity of data for each patient ie.
2 baseline weeks, 8 treatment weeks and 4 separate follow —up weeks for
each of 11 DSQ variables. These 11 variables comprised 6 which
described sleep pattern and 5 which referred to aspects of sleep
quality. For each variable, therefore, repeated measures were available
across the time course of the experimental period. There being 5
121treatment conditions in the main study design, the appropriate
statistical analysis was a repeated measures analysis of variance with
treatment type as the grouping factor. This form of analysis generated
main effects for treatment group, for time, and for treatment x time
interaction. The sub-effects of treatment group within time (ie. which
between group differences were significant at which time points) and of
time within treatment group (ie. at which time points did significant
change occur within each treatment) were then examined to explore
further those main effects found to attain significance. This design is
usually termed "split-plot factorial" (SPF); in this study having 5
levels of the between group factor (treatments) and 9 levels of the
within group factor (time points - taking 1 baseline measure and 8
measures during treatment). The reader is referred to Kirk (1968) for
detailed information on the design; identified as SPF-2.4 (p 248 ff).
Repeated Measures Analysis using MANOVA
The required repeated measures model was generated by the SPSSX MANOVA
programme following the detailed recommendations and computing
instructions outlined by O'Brien and Kaiser (1985). The procedures
involved for obtaining main effects will be described in the Results
chapter. At this juncture, however, the reasoning behind the selection
of the MANOVA rather than the ANOVA approach will be summarised. There
are four principal points.
Firstly, one effect of performing separate univariate analyses of
multiple measures on the same subjects may be to inflate the Type 1
error, ie. reach a conclusion to reject the null hypothesis when it
should not be rejected (Bock, 1975; Turner, 1978). This is particularly
problematic in therapy outcome research since it amounts to concluding
that there are true differences in therapy methods when in fact there
are none. One option is to correct conservatively the repeated measures
122ANOVA by adjusting alpha levels. Alternatively, MANOVA may be preferred
and has been regarded as more likely to produce reliable treatment
effects (Hummel and Sligo, 1971).
Secondly, a number of workers have pointed out the statistical
constraints upon repeated measures ANOVA. One such constraint is that
in regular ANOVA it is assumed that repeated observations are
independent. Applications in clinical psychology are, however, unlikely
to meet this "sphericity" condition (Jaccard and Ackerman, 1985).
Successive or adjacent measurements are often more highly correlated
than non—adjacent measures. In addition to equality in correlation
between pairs of repeated measures, the ANOVA model assumes that all
variances of the repeated measurements are equal. This is another
precondition for sphericity. O'Brien and Kaiser (1985) have stated,
however, that "in general, sphericity is unnatural for most repeated
measures data, and we believe that it is commonly violated in most
designs with more than 2 repeated measurements". They quote work by Box
(1954) which established that nonsphericity artificially inflates F
values for omnibus tests of main effects, again resulting in an
inflated Type 1 error rate. Systematic reduction of of the degrees of
freedom for the sampling distribution of the F statistic may be one
solution for the ANOVA approach [eg. Huynh and Feldt's (1976) best
estimator modification is now included in BMDP2v]. In the MANOVA
approach, however, there are no difficulties regarding proper error
terms or modifications to the degrees of freedom.
Thirdly, R.M. Turner (Temple University Medical School) has been
influential in the evaluation of psychological treatments for insomnia
(see Chapter 5) and has argued strongly for the use of multivariate
tests in therapy outcome research (Turner, 1978). Indeed, he chose as
his working example, of the applicability of MANOVA, sleep pattern data
123collected by means of DSQ forms.
Finally, in summarising the available studies comparing modified
traditional tests with MANOVA O'Brien and Kaiser (1985) concluded that
"because no clear—cut power differences exist, the best strategy is to
choose a single method and seek to master it. We believe that method
should be the MANOVA approach". In this study the MANOVA method was
preferred because the author was familiar with SPSSX procedures and
SPSSX uses MANOVA to perform repeated measures analysis. SPSSX does not
generate univariate repeated measures models except for a within group
design (without between group factor) ie. RELIABILITIES procedure. By
default, therefore, SPSSX requires the MANOVA approach, largely for
the mathematical reasons outlined earlier.
Spector (1977) and others have addressed the important issue of how to
follow up significant multivariate effects in order to understand the
data set and identify the source(s) of main effects. Some workers have
argued for the use of discriminant function analysis (eg. Borgen and
Selling, 1978), while others have advocated further exploration via
univariate ANOVAs especially where hypothesis—testing is required
(Spector, 1977; O'Brien and Kaiser, 1985). In this study significant
multivariate effects were investigated using the univariate approach.
The SPSSX MANOVA programme proved very adaptable in this respect (cf.
Table 6 in O'Brien and Kaiser).
Before and After Measures
These measures were administered to patients on 2 occasions, ie. at pre
and post—treatment. Appropriate tests and procedures for paired data
were, therefore, selected to investigate the significance of change
over time within each of the treatment groups. In order to investigate
between group differences, change scores were computed (gain scores
124over pre—test) and subjected to ONEWAY ANOVA. This procedure was
selected in preference to ANCOVA with pre—test score as the covariate
(Huck and McLean, 1975) since the SPSSX ONEWAY programme permits the
use of supplementary range—testing procedures (eg. Scheffe) to identify
the loci of significant effect.sleep quality would
random allocation.
reveal stability over
conditions over time
CHAPTER 8
THE EFFECTS OF TREATMENT UPON SLEEP PATTERN AND SLEEP QUALITY 
Three important matters must be dealt with prior to embarking upon
treatment outcome analyses. Firstly, the stability of baseline scores
over time and their similarity across conditions must be investigated.
Secondly, it is necessary to determine whether or not the demand
characteristics manipulation per se significantly affected response to
treatment. Thirdly, the credibility of the treatments applied must be
established. The reader should note that all of the analyses contained
in Chapter 8 exclude the tailored therapy condition since it will be
evaluated in Chapter 10.
SLEEP MEASURES AT BASELINE
Each subject completed sleep diaries for 14 pre-treatment nights.
Individual mean and standard deviation (SD) scores were computed for
each of the two baseline weeks for the variables sleep-onset latency
(SOL), total sleep time (TOT) and wakening frequency (WAKE) [See
Appendix H, Table (i) for breakdown across treatments]. Mean weekly
scores were also computed for the remaining five items from the sleep
diary. These latter measures are best regarded as "sleep quality"
variables since they provided information on sleep satisfaction and
daytime correlates of sleep. They were as follows - repetitive thoughts
at bedtime (REPTH), feeling of restedness after sleep (RESTED), sleep
enjoyment (ENJOY), daytime irritability (IRRIT) and daytime napping
(NAPDAY) [See Appendix H, Table (ii)]. Analyses of baseline data were
conducted to test the following hypotheses.
1) Neither baseline sleep pattern nor ratings of
differ significantly across conditions due to
2) Sleep diary reports of these variables would
time and no significant differences across
during baseline.
126In order to investigate these hypotheses a repeated measures analysis
was required for each of the 11 variables. The SPSSX MANOVA programme
was applied to generate the repeated measures model utilising the
procedures outlined by O'Brien and Kaiser (1985). These authors
recommend the computation of change scores as time contrast variables
for the within subjects part of the effect of interest, and the use of
these as dependent variables in a regular MANOVA with the grouping
factor acting as the between subjects test. This approach provides
multivariate tests of significance with associated F ratios and
probabilities for the time main effect and the treatment x time
interaction. The available tests are those of Pillai, Hotelling and
Wilks which have similar roots and distributional assumptions and when
converted to F ratios generally reveal similar result (see Srivastava
and Khatri, 1979). For the purposes of this thesis the Pillai's
statistic only will be quoted as standard. Finally O'Brien and Kaiser
recommend that the treatment group main effect is obtained by
conducting ONEWAY ANOVA upon the average score of all data points.
Inspection of the results of these analyses in Table 7 indicates that
neither the treatment nor the treatment x time main effects reached
significance for any variable. It can be concluded, therefore, that
strong similarities existed between the treatment groups across the
baseline period. The main effects for time reached significance at the
.05 level of probability for three of the analyses, namely  TOT, REPTH
and RESTED. Thus for these variables there was a tendency for some
change over time which was independent of treatment group allocation.
Inspection of the data in Tables (i) and (ii) in Appendix H reveals a
slight general shift towards higher TOT and RESTED and lower REPTH at
baseline week two. This may best be regarded as a minor adjustment to
reporting practice, although it will be of interest to see if any trend
continues during the first weeks of intervention. With this proviso the
127Source of Variation MS Between MS Within F Ratio F Prob Ltd Level
SOL mean
Treatment 650.57 2454.37 0.265 0.899 NS
Time 125.92 1807.65 0.069 0.793 NS
Treatment x Time 577.32 1807.65 0.319 0.864 NS
SOL SD
Treatment 293.47 817.47 0.359 0.837 NS
Time 897.91 900.01 0.998 0.322 NS
Treatment x Time 681.21 900.01 0.757 0.557 NS
TOT mean
Treatment 1.072 1.378 0.778 0.544 NS
Time 0.245 0.054 4.505 0.038 *
Treatment x Time 0.055 0.054 1.016 0.406 NS
TOT SD
Treatment 0.121 0.271 0.446 0.775 NS
Time 0.133 0.510 0.260 0.612 NS
Treatment x Time 0.301 0.510 0.589 0.672 NS
WAKE mean
Treatment 1.774 1.195 1.485 0.217 NS
Time 0.251 0.643 0.390 0.534 NS
Treatment x Time 0.731 0.643 1.136 0.347 NS
WAKE SD
Treatment 0.263 0.274 0.961 0.435 NS
Time 0.015 0.421 0.036 0.850 NS
Treatment x Time 0.022 0.421 0.052 0.995 NS
REPTH
Treatment 0.762 0.871 0.874 0.484 NS
Time 2.532 0.495 5.115 0.027 *
Treatment x Time 0.716 0.495 1.446 0.229 NS
RESTED
Treatment 0.337 0.351 0.959 0.436 NS
Time 0.340 0.452 4.141 0.046 *
Treatment x Time 0.340 0.452 0.751 0.561 NS
ENJOY
Treatment 0.869 0.417 2.084 0.093 NS
Time 0.708 0.401 1.764 0.189 NS
Treatment x Time 0.206 0.401 0.513 0.727 NS
IRRIT
Treatment 0.481 0.844 0.570 0.685 NS
Time 0.190 0.352 0.054 0.817 NS
Treatment x Time 0.131 0.352 0.371 0.829 NS
NAPDAY
Treatment 529.28 267.05 1.982 0.108 NS
Time 437.04 247.65 1.765 0.189 NS
Treatment x Time 37.03 247.65 0.149 0.963 NS
TABLE 7 MANOVAs at baseline for the eleven sleep diary variables. F
values based upon Pillai's statistic. Time main effects df= (1,65),,
treatment and interaction effects df = (4,65). * II< .05
128hypotheses can be accepted. It is clear that no systematic between
group differences emerged during baseline. The random allocation
procedure appears to have been successful.
THE EFFECT OF THE DEMAND CHARACTERISTICS MANIPULATION
After baseline assessment each subject received eight consecutive weeks
of treatment under one of the experimental conditions. With the
exception of the waiting—list group this treatment period was sub-
divided into counterdemand and positive demand phases, each of four
week duration. The data can be analysed, therefore, either as a whole
series or as two separate series. The latter possibility, however,
would be appropriate only if the reversal in demand characteristics
produced demonstrable change in the overall pattern of scores over time
(ie. treatment gains observable during positive demand which were not
evident during counterdemand). In order to test these possibilities the
simple effects of time within treatment group were obtained for each
variable. This was achieved via the CONSPLUS sub—command of the SPSSX
MANOVA programme which generates an overall F ratio for the entire
treatment period, and univariate F ratios for the sub—effects at each
data point. Once again the scores entered for each time point were
change scores over baseline. Included in the results displayed in Table
8 are those analyses where the multivariate F probability was
less than .10.
Inspection of the Table clearly reveals that for the vast majority of
variables, change scores first became significant during the
counterdemand phase when negative expectancies were engendered. The
introduction of positive demand had no apparent effect beginning at
Week 5 on any variable as would have been expected had demand
characteristics markedly affected response to therapy. Only 4 of the 20
significant F values refer to treatment changes emerging under positive
129demand. Sufficient explanation of these may be in terms of delayed
treatment response and/or possible false positive results due to F
values in the range .05 to .10. Furthermore, the specific purpose of
including the demand manipulation was to monitor the effects of demand
upon placebo treatment. The data in Table 8 clearly indicate that
little change took place at any time for this group.
Variable Group F Prob Counterdemand Positive Demand
Week Week
1	 234 5678
SOL	 mean Relaxation .016 *	 * *	 *	 *	 *
Stim Control .000 *	 *	 *	 * *	 *	 *	 *
Paradox .016 * *	 *	 *	 *
SOL SD Relaxation .012 *	 *	 * *	 *	 *
Stim Control .001 *	 *	 * *	 *	 *	 *
Paradox .000 *	 *	 * *	 *	 *	 *
TOT mean Relaxation .010 *	 *
Stim Control .014 *	 *
TOT SD Relaxation .003 *	 * *	 *	 *
Stim Control .003 * *
Paradox .078 *	 * *	 *	 *
WAKE mean Paradox .011 *	 * *	 *	 *	 *
WAKE SD Relaxation .097 *	 * *	 *	 *
Stim Control .030 * *	 *	 *
Placebo .093 *
RESTED Relaxation .003 *	 *
Paradox .033 *	 *
ENJOY Relaxation .002 *	 *
Placebo .074
NAPDAY Paradox .084
TABLE 8 Time within treatment group simple effects and sub-effects at
each week during the treatment period. Overall F probabilities are
based upon Pillai's statistic. (* represents a time sub-effect jE < .05)
These results indicated that it was appropriate to consider the eight
week treatment period as a whole in further data analysis. The
alteration in demand characteristics appears to have had little impact.
• 130ASSESSMENT OF TREATMENT CREDIBILITY
In order to investigate the credibility of treatment rationales, the
Credibility Evaluation Questionnaire (CEQ) was completed by subjects in
each experimental condition, excluding the waiting—list group. The
maximum score obtainable on the CEQ was 30. Since mean scores for each
condition fell within the range 24.4 to 25.2 [Appendix H, Table (iii)],
it is clear that each of the treatments was considered highly credible,
and that there was little variation across conditions. ONEWAY ANOVAs on
CEQ scores confirmed that there were no significant between group
differences [F = 0.056; df (3,40); p = 0.983]. Of particular importance
is the fact that patients regarded the active treatments and the
placebo treatment as equally logical and credible.
THE EFFECTS OF DIFFERENT TREATMENTS UPON SLEEP PATTERN
Treatment effects upon DSQ sleep pattern variables will be considered
prior to effects upon sleep quality.
The Hypotheses
3) Each of the three active treatments would be superior to no
treatment during the course of therapy. It was expected that the
development of therapeutic effects might vary amongst treatments.
4) Similarly, each of the active treatments would be superior to
placebo control.
5) No significant differences were predicted amongst the active
treatments.
6) These hypotheses were expected to apply to SOL and TOT variables.
Effects upon WAKE variables were regarded as uncertain since treat-
ment was primarily aimed at reducing initial insomnia.
Descriptive Analysis
A simple descriptive analysis was conducted first of all to provide a
preliminary examination of the data. Table 9 presents mean values for
each sleep pattern variable at baseline and the final experimental week
131across conditions.
Both stimulus control and paradoxical intention produced considerable
reduction in SOL mean and SOL SD with changes in the range 50-70%. By
comparison relaxation training was less effective and more similar to
placebo. For both of these conditions therapeutic change was in the
range 25-35%. Interestingly, untreated patients exhibited exacerbation
of their sleep-onset problem. Sleep duration (TOT) increased by a
modest 10% across conditions with the exception of waiting-list
control. It seems likely, therefore, that this variable will reveal few
between group differences in subsequent analyses. TOT SD, however, was
rather more discriminating. Paradox produced a greater than
40% reduction compared with minimal change in the other active
treatments. Placebo control also effected a substantial reduction
Stimulus Paradoxical	 No
Relaxation Control Intention Placebo Treatment
	
90.5	 85.5 82.7	 72.4	 855	 845 '
96.5
	
57.4	 31.1	 63.5
+14.2
SOL mean post	 35.8
	
% change -36.6	 -62.4	 -50.6	 -25.7
pre	 50.0	 41.9	 47.9	 44.2	 53.6
SOLSD	 post	 37.4	 19.0
	
-54.7	
14.2	 30.6	 63.5
	
% change -25.2	 -70.4	 -30.8	 +18.5
34 . pre	 5.79	 6.10	 5.86	 5	 5.84
TOT mean post	 6.41	 6.66 6.55
	
+ 9.2	
5.82	 5.84
+11.8
	
% change +10.7	 + 9.0	 0.00
pre	 1.41	 1.17	 1.33	 1.23 1.25
1.07 TOT SD post	 1.32	 0.78	 0.94 po
	
.6	
+1.28
-23
	
% change - 6.4	 - 8.5	 -41.4 	 2.4
	
0.93	 1.76 pre	 1.56	 1.16
hAYE	 post	 1.23	 0.44	 0.53	 1.34	
1.01
0.85
mean	 % change -21.2	 -52.4	 -54.3	 -23.9	 -15.8
pre	 0.96	 0.67	 0.82	 0.95
0.94
	
0.75	 0.16 WAKE SD post	 0.60	
0.68
0.63
	
% change -21.9	 -76.2	 -26.8	 - 1.5	 - 7.4
TABLE 9 Comparison across experimental conditions of mean scores 
during baseline (pre) and the final week of treatment (post) along 
with percentage change scores for each of the sleep pattern variables 
132on this measure. Interpretation of change scores for the WAKE variables
is rather problematic due to the relatively low frequency of nightly
wakenings occurring at baseline. Nevertheless, stimulus control and
paradox, as for the SOL variables, emerged as the most effective
interventions. Both placebo and no treatment patients, however, also
reported considerable reduction in wakening frequency.
Since Table 9 considers only pre-post data, more detailed descriptive
information is included in Figs 4 to 9. These graphs illustrate
changes in sleep variables across the eight treatment weeks and permit
visual comparison of the rate of change across conditions. It is of
interest to note that for both SQL mean and SQL SD (Figs 4-5) the
profile of scores for relaxation and placebo conditions is similar,
whereas stimulus control and paradox demonstrated a superior response.
Stimulus control produced immediate changes in these variables and
paradox yielded improvement from the fourth week onwards. For TOT mean
(Fig 6), progressive increases in duration of sleep are evident with
relaxation and paradox, whereas stimulus control appears to have
reduced TOT initially but was associated with improvements similar to
the other active treatments in the latter stages. There was a
comparable gradient of improvement also with placebo treatment. By
comparison, no treatment produced erratic sleep. For TOT SD there was
considerable overlap in treatments over time (Fig 7). Paradox alone
produced consistent improvement over time although all of the other
active treatments and the placebo group improved initially. Placebo and
stimulus control had similar absolute values at post-treatment. Both
WAKE mean and WAKE SD exhibited marked similarity in pattern over time
(Figs 8-9) and visual inspection of the former graph suggests little
systematic between group difference. For WAKE SD, however, greater
variability was evident in placebo and stimulus control interventions,
with stimulus control gradually improving compared with placebo.
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FIGURE 7:	 As Fig. 6, but for variability of sleep duration.
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137Since only tentative suggestions could be made regarding Hypotheses 3-6
on the basis of these descriptive analyses, matters will be left until
the completion of statistical appraisal. Statistical analysis of the
outcome data across time and between treatments required a repeated
measures design which was again conducted by means of the SPSSX MANOVA
programme. As previously described this procedure involved the
computation of change scores as time contrast variables. For the
following analyses, therefore, change scores were derived using the
formula; Baseline Mean - Score at Week n. The baseline mean was
selected as the summary statistic most descriptive of untreated sleep
pattern.
Statistical Analysis
1) Main Effects 
Table 10 presents the results of MANOVAs for the sleep pattern
variables. Both treatment main effects and the treatment x time
interactions were significant for the variables SOL mean and SOL SD.
The former effect indicated overall between group differences in terms
of average treatment response and the latter pointed to the systematic
nature of these differences over time. TOT SD also exhibited a
significant interaction effect. Further treatment within time analyses
were conducted, therefore, on these three variables only, in order to
establish which were the critical between group differences and at
which point(s) during therapy these differences emerged. Since every
variable demonstrated significant time main effects, it was of interest
also to consider thereafter the simple effects of time within treatment
group for all six variables.
2) Treatment within Time Sub-effects 
In order to investigate the treatment within time sub-effects, ONEWAY
ANOVAs across the five experimental conditions were conducted at each
138Source of variation Pillai itY2 df Error df F Ratio F Prob Level
SOL mean
Treatment
Time
Treatment x Time
0.437
0.758
4
8
32
65
58
244
3.696
5.636
1.783
0.009
0.000
0.008
**
***
**
SOL SD
Treatment
Time
Treatment x Time
0.507
0.709
4
8
32
65
58
244
5.339
7.449
1.643
0.001
0.000
0.020
***
***
*
TOT mean
Treatment
Time
Treatment x Time
0.324
0.635
4
8
32
65
58
244
1.779
3.477
1.440
0.144
0.002
0.067
NS
**
NS
TOT SD
Treatment - 4 65 1.050 0.388 NS
Time 0.315 8 58 3.338 0.003 **
Treatment x Time 0.730 32 244 1.701 0.014 *
WAKE mean
Treatment 4 65 2.147 0.085 NS
Time 0.294 8 58 3.015 0.007 **
Treatment x Time 0.403 32 244 0.854 0.695 NS
WAKE SD
Treatment 4 65 0.640 0.636 NS
Time 0.307 8 58 3.211 0.004 **
Treatment x Time 0.464 32 244 1.001 0.471 NS
TABLE 10 Repeated measures analysis of the sleep pattern variables
across the experimental period using MANOVA
(< .05 **II< .01 *** E < .001) 
of the eight data points. Only those sleep variables which had
demonstrated significant interaction effects were included (le. SOL
mean, SQL SD, TOT SD). Both Scheffe range tests and planned contrast t-
tests were applied to identify the loci of significant difference. The
inclusion of both procedures was to maximise the interpretability of
the results through the use of both "conservative" and "sensitive"
multiple comparison tests. The Scheffe test is a post hoc procedure
which has been developed for "data snooping", that is to make all
possible comparisons among mean values to determine the source of an
already demonstrated effect (Scheffe, 1953). It is regarded as
conservative in that it will minimise the false positive "Type 1" error
rate for pairwise comparisons and in this respect may be preferred to
139other a posteriori tests such as that of Tukey [see Kirk (1968) for
extensive review]. It does so, however, at the expense of sensitivity
to potentially important differences.  AS Kerlinger (1976) puts it "to
attain significance, differences have to be rather substantial ---- The
Scheffe test makes things precise in a conservative way (but) ---- one
must examine one's data in detail; one rummages for insights and clues"
(p 235). In recognition of his test's conservatism Scheffe himself has
recommended that screening for significant between group differences be
conducted at both the 5% and 10% levels (Scheffe, 1959).
The (a priori) planned CONTRAST procedure of the SPSSX ONEWAY programme
was also employed further to increase the sensitivity of between group
testing. This approach involves multiple independent t—test
comparisons, a procedure which raises the probability of spuriously
significant results being obtained (Kirk, 1968). The alpha level was,
therefore, set at .01 to control for heightened error rate and the
possibility of overinterpretation of results.
The results of these analyses are presented in Table 11. For SOL mean,
sleep latency reduction during the first two weeks was significantly
greater with stimulus control treatment compared with both no treatment
and paradox (Scheffe p < .05). Smaller effects were also evident in
comparison with relaxation and placebo conditions indicating that
stimulus control was the most effective intervention for rapid sleep
latency reduction. During Weeks 3 and 4, however, these effects
were much reduced as evidenced by the smaller F ratios, and the lack of
significance on Scheffe testing at the .05 level. The extended range
of Scheffe sensitivity at p < .10, along with planned contrasts
suggested, however, that the pattern of treatment effect was similar.
From the fifth to the final week, stimulus control remained the most
effective intervention, with highly significant F ratios again emerging
140df F Ratio F Prob Pair Scheffe Range Planned t
.05 .10 .01
SOL mean
Week 1 (4,63) 4.125 0.005 2 v 5 * * *
2 v 3 * * *
2 v 1 * *
2 v 4 *
Week 2 (4,62) 4.269 0.004 2 v 5 * * *
2 v 3 * * *
2 v 4 * *
Week 3 (4,64) 3.379 0.014 2 v 5 * *
2 v 4 *
2 v 3 *
Week 4 (4,59) 1.643 0.177 (2 v 5) (.02)
Week 5 (4,61) 3.863 0.007 2 v 5 * * *
2 v 4 * *
2 v 3 *
Week 6 (4,60) 2.471 0.054 2 v 5 *
Week 7 (4,61) 4.371 0.004 2 v 5 * * *
Week 8 (4,58) 4.701 0.003 2 v 5 * * *
1 v 5 * * *
SOL SD
Week 1 (4,63) 1.172 0.332 —
Week 2 (4,62) 4.054 0.005 3 v 5 * * *
2 v 5 * *
1 v 5 * *
Week 3 (4,64) 3.954 0.006 2 v 5 * * *
3 v 5 *
Week 4 (4,59) 4.434 0.004 3 v 5 * * *
1 v 5 * *
Week 5 (4,62) 1.590 0.188 —
Week 6 (4,61) 3.409 0.014 3 v 5 * *
1 v 5 * *
2 v 5 *
Week 7 (4,61) 3.087 0.022 3 v 5 * *
2 v 5 * *
Week 8 (4,58) 2.702 0.040 3 v 5 * *
2 v 5 *
TOT SD
Week 1 (4,63) 2.598 0.044 1 v 5 * * *
Week 2 (4,62) 3.518 0.012 1 v 5 * * *
1 v 2 *
Week 3 (4,63) 0.050 0.995 —
Week 4 (4,58) 1.452 0.230 —
Week 5 (4,61) 0.515 0.725 —
Week 6 (4,61) 2.261 (0.073) 1 v 5 *
Week 7 (4,61) 1.613 0.183 —
Week 8 (4,58) 1.343 0.266 —
TABLE 11 ANOVAs conducted upon each sleep. variable during the
experimental period across the five experimental conditions 
(Relaxation=1, Stimulus control=2 Paradoxical intention=3, Placebo=4
Waiting 11st=5). The results of Scheffe and Planned Contrast procedures
are also recorded 
141during Weeks 5, 7 and 8. Range tests indicated that differences
between stimulus control and no treatment were largely responsible for
these effects, although placebo and paradox were also inferior at Week
5. In the final week of treatment relaxation training also emerged as
superior to waiting-list control.
Summarising the data on SQL mean leaves little doubt that the strongest
and most consistently beneficial treatment was stimulus control.
Indeed, range testing on the significant main effects for treatment
group (average response over time) revealed significant differences
between stimulus control and no treatment (Scheffe p < .05) and a
weaker but significant effect for stimulus control compared with
placebo (Scheffe p < .10).
The data on SQL SD were also supportive of stimulus control as superior
to waiting-list during Weeks 2, 3, 6, 7 and 8. Even stronger effects,
however, were generally evident over time for the advantages of
paradoxical intention over no treatment. On three occasions during the
middle weeks, relaxation also appeared to be better than no treatment.
Superiority over placebo, however, was not demonstrated by any of the
active treatments on SQL SD and there were no significant differences
amongst the treatments. Consistent with the above results, the overall
treatment group main effect was accounted for by the superiority of
both paradox and stimulus control over no treatment (Scheffe p < .05).
Summarising so far, it seems that stimulus control reduced both sleep
onset latency and the variability of that latency compared with no
treatment. Paradox appeared to make sleep-onset more predictable (ie.
reduced variability) but it did not necessarily make sleep latency less
than no treatment.
The third variable of interest was TOT SD. Significant F ratios were
142achieved during Weeks 1 and 2, with a near significant effect also at
Week 6. The consistent explanation for these results was a reduction in
TOT SD under relaxation therapy compared with no treatment. It is
perhaps surprising that an initially strong effect on Scheffe range
testing should disappear. It may be that the advantages of relaxation
were short-lived and did not foster maintained habit change.
3) Time within Treatment Group Sub-effects 
Having considered the treatment within time sub-effects which permitted
consideration of important between group differences, it was
appropriate next to consider the complementary information provided by
the time within treatment sub-effects. These analyses provided
information, within each condition, on significant variation from
baseline values across the experimental period. Time within treatment
effects are essentially a series of within subjects repeated measures
ANOVAs, and these were generated via the CONSPLUS sub-command of the
MANOVA programme. These data were presented in simplified form in Table
8 in consideration of the effects of the demand change. Table 12,
however, provides more detailed information, separately for each of the
experimental conditions and illustrates the magnititude of effect
of treatment upon each of the sleep pattern variables.
The immediate visual impact of the Table leaves little doubt that the
three active treatments were associated with significant change over
baseline on the majority of variables compared with the minimal changes
obtained with either waiting-list or placebo conditions. Indeed, for
the waiting-list group the only significant change was in terms of
exacerbation of the SQL SD variable (cf. Fig 5). SQL mean and
SOL SD were the variables most responsive to active treatment.
Significant improvement on both variables occurred immediately at Week
1 with stimulus control and at Week 2 with relaxation. Paradox produced
143Treatment/
Pillai F Prob
2
Weeks of Therapy
7 8
Variable
RELAXATION
1 3	 4 5 6
SOL mean 0.266 0.016 * * ** *** * **
SOL SD 0.275 0.012 * **	 * * *** **
TOT mean 0.280 0.010 ** ** * **
TOT SD 0.320 *** 0.003 ** *** ** *
WAKE mean 0.191 0.116
WAKE SD 0.198 0.097 * ** ** ** *
STIM CONTROL
SOL mean
SOL SD
0.438
0.343
*** 0.000
0.001
***
*
***	 ***
***
*** ***
**
***
***
***
**
TOT mean
TOT SD
0.269
0.321
0.014
0.003 **
WAKE mean 0.109 0.536
WAKE SD 0.243 0.030 * ***
PARADOX INT
SOL mean 0.265 0.016 ** ** ** *** ***
SOL SD 0.405 0.000 ** **	 ** *** *** *** ***
TOT mean 0.215 0.162
TOT SD 0.207 0.078 ** ***
WAKE mean 0.277 0.011 ** ** *** ** ** ***
WAKE SD 0.112 0.511
PLACEBO
SOL mean 0.070 0.816
SOL SD 0.086 0.713
TOT mean 0.097 0.626
TOT SD 0.118 0.468
WAKE mean 0.077 0.767
WAKE SD 0.200 0.093 * *
WAITING LIST
SOL mean 0.225 0.049 (0.14)
SOL SD 0.263 0.017 **
TOT mean 0.192 0.112
TOT SD 0.115 0.490
WAKE mean 0.079 0.753
FAKE SD 0.073 0.796
TABLE	 12 Time within treatment group simple effects and sub-effects
at	 each week	 during	 treatment presented	 separately for each
experimental condition (* < .05 ** p < .01 *** P < .001)
change at Weeks 4 and 2 for SOL mean and SOL SD respectively.
Consistency of improvement over baseline was particularly evident for
SOL mean under both stimulus control and paradox, and SOL SD was also
consistently reduced by the paradoxical treatment. Some variability
over time was evident on both SOL variables during relaxation training,
and also on SOL SD for the stimulus control group.
144In terms of TOT mean and TOT SD, stimulus control had relatively little
impact, except perhaps during the final two weeks. With relaxation,
treatment benefit emerged initially and disappeared during the middle
three weeks of therapy, on both variables, thereafter reemerging fairly
strongly. Paradoxical intention did not achieve a significant F ratio
for TOT mean although it should be noted that percentage improvement
from pre to post-treatment was in fact greatest under paradox (Table
9). TOT SD was generally reduced from Week 2 onwards with paradox
though the overall F ratio was of limited significance.
Frequency of night-time wakening was affected only by paradoxical
treatment, being consistently reduced below baseline from the fourth
week of treatment. For WAKE SD, which is the variability of nightly
arousals over time, both relaxation and stimulus control demonstrated
some change. The overall multivariate test was, however, of greater
significance for stimulus control; perhaps accounted for by the large
change over baseline observed during the final week of intervention.
Addressing the Hypotheses
Having completed all the necessary analyses it is now possible to
address the hypotheses which were outlined earlier. Hypothesis 3 stated
that each of the three active treatments would be superior to no
treatment during the course of therapy. This important hypothesis has
received considerable support. Table 10 revealed that SOL mean, SOL SD
and TOT SD responded differentially to treatments over time and Table
11 identified the superiority of an active treatment over no treatment
as the responsible between group difference. More specifically,
stimulus control was superior to waiting-list on both the SOL
variables, paradox was superior on SQL SD only, and there was some
limited evidence for the advantages of relaxation over no treatment on
TOT SD. These findings were confirmed also by the results presented in
145Table 12, since the strongest within subjects effects were evident on
these three variables. It is noteworthy that stimulus control produced
improvement on both SOL variables at Week 1. Paradox reduced SOL SD
scores from Week 2, but it was not until Week 4 that change over
baseline was obtained for SOL mean. Indeed, stimulus control was found
to be superior to paradox during the first few weeks (cf. Hypothesis
5). The time within treatments analyses also suggested improvements
over baseline on the other sleep pattern variables which appeared not
to be due to the effects of the passage of time alone. These
nevertheless failed to demonstrate significance on between group tests.
In terms of Hypothesis 4, stimulus control was the only treatment to
demonstrate superiority over placebo, doing so consistently on the
variable SOL mean. Placebo patients were found, however, from the time
within treatments analysis, to present with a markedly stable sleep
pattern over time with only one significant improvement over baseline
being achieved out of the 48 comparisons made (6 'variables times 8 data
points). Again, Table 12 suggests that the active treatments were
generally superior to placebo on most variables. Between group
comparisons, however, failed to reach significance apart from the
superiority of stimulus control over placebo on SOL mean.
Only one significant difference was found amongst the active treatments
thus Hypothesis 5 was largely confirmed. The initial superiority of
stimulus control over paradox is, however, of some interest (see Espie
and Lindsay, 1985) and will be addressed later. Hypothesis 6 was
broadly confirmed in that SOL and TOT variables were more sensitive to
changes over time and to between group differences than were WAKE
variables. Only the time within treatment effects yielded significant F
ratios for the WAKE variables, the strongest being for the reduction of
WAKE mean via paradox. No significant between group difference emerged.
146THE EFFECTS OF DIFFERENT TREATMENTS  UPON SLEEP QUALITY
The Hypotheses
The hypotheses concerning the sleep quality variables were similar to
those proffered regarding sleep pattern.
7) Each of the active treatments would be superior to no treatment
during the course of therapy.
8) Each of the treatments would also be superior to placebo control
during therapy.
9) No significant differences would be found amongst the active
treatments.
10) The above hypotheses were expected to apply to each of the
variables REPTH, RESTED, ENJOY, IRRIT and  NAPDAY.
Descriptive Analysis
Initial inspection of the raw data for each variable suggested that
there were few significant differences across treatments throughout the
experimental period. For this reason simple descriptive analysis will
not be presented in the text. Tabulated data are, however, available in
Appendix H [Tables (iv) to (viii)]. Statistical analyses of the sleep
quality data were identical to those described in the previous section.
It should be noted, however, that four of the five variables (all
excluding NAPDAY) comprised rating scale data rather than continuous
scales. It was decided, nevertheless, to use MANOVA and associated
procedures rather than non-parametric techniques because of the
detailed information on sub-effects which could be readily obtained by
this method. Consequently, it was decided to regard as tentative any
conclusions based upon relatively weak statistical effects.
Statistical Analysis
1) Main Effects 
Table 13 presents the MANOVA repeated measures analyses with main
147effects for each of the sleep quality variables. Treatment main effects
yielded modestly significant between group differences for the
variables REPTH and NAPDAY, but neither of the interactions approached
significance for these variables. To investigate these treatment main
effects, planned comparisons tests were conducted which revealed that
relaxation training produced a greater average reduction in REPTH than
did placebo control (Scheffe p < .10), and stimulus control was
associated with less daytime than the waiting-list condition napping
(Scheffe	 p < .10).	 The only treatment x time effect to come close	 to
significance	 was for the variable ENJOY (p = .065).	 No other F	 ratio
yielded a probability value < .10.
Source of Variation	 Pillai	 Hyp df	 Error df	 F Ratio F Prob Sig Level
REPTH
Treatment	 -	 4	 65	 2.654	 0.041	 *
Time	 0.224	 8	 58	 2.096	 0.051	 NS
Treatment x Time	 0.373	 32	 244	 0.784	 0.794	 NS
RESTED
Treatment	 -	 4	 65	 1.151	 0.341	 NS
Time	 0.382	 8	 58	 4.490	 0.000	 ***
Treatment x Time	 0.570	 32	 244	 1.268	 0.162	 NS
ENJOY
Treatment	 -	 4	 65	 1.868	 0.127	 NS
Time	 0.371	 8	 58	 4.362	 0.000	 ***
Treatment x Time	 0.637	 32	 244	 1.445	 0.065	 NS
IRRIT
Treatment	 -	 4	 65	 0.762	 0.554	 NS
Time	 0.201	 8	 58	 1.831	 0.089	 NS
Treatment x Time	 0.411	 32	 244	 0.886	 0.647	 NS
NAPDAY
Treatment	 -	 4	 65	 2.559	 0.047	 *
Time	 0.141	 8	 58	 1.188	 0.322	 NS
Treatment x Time	 0.477	 32	 244	 1.033	 0.424	 NS
TABLE, 13 Repeated measures analysis of the sleep. quality variables 
across the experimental period using MANOVA (* R<.05 *** /I< .001)
2) Treatment within Time Sub-effects 
ONEWAY ANOVAs across treatments were conducted, therefore, at each week
of the experimental period for the variable ENJOY only, in order to
148identify any loci of significant effect. The only significant between
group effect to emerge from this analysis was at Week 6 where
relaxation was superior to placebo on Scheffe testing at the .05 level
[F = 3.123, F Prob =.021, df (4,61)].
3) Time within Treatment Group Sub-effects 
Table 13 also revealed highly significant time main effects for RESTED
and ENJOY. Time within treatment group effects were, therefore,
investigated by means of the CONSPLUS sub-routine for each of these
variables. The results of those analyses achieving significance p < .10
are available in Table 14 which is a development of part of Table 8
presented earlier in the chapter. Relaxation therapy produced highly
significant improvement over time in restedness after sleep and sleep
enjoyment. The time sub-effects indicated a similar pattern of change
in the variables commencing at Week 2. Paradoxical intention was
associated with weaker overall effects than relaxation. During the
final three weeks of therapy restedness increased and there was a very
small effect for NAPDAY at Week 8. The only other minor effect was for
the placebo group where a small increase in sleep satisfaction was
evident but again only during the final week.
Pillai F Prob	 Weeks of Therapy 
1	 2	 3	 4	 5	 6	 7	 8
Treatment/ 
Variable
RELAXATION
RESTED
ENJOY
PARADOX
RESTED
NAPDAY
PLACEBO
ENJOY
	
0.321	 0.003
	
0.326	 0.002
	
0.240	 0.033
	
0.204	 0.084
0.209	 0.074
	
**	 *** * ***
	
** ***	 *** ** ***
TABLE 14 Time within treatment group simple effects and sub-effects 
for the sleep quality variables where overall F  probability < .10
(* II< .05 ** E 1i *** II< .001)
149Addressing the Hypotheses
In summary, it can be concluded that the five sleep quality variables
demonstrated little differential response to the treatments over time.
In terms of Hypothesis 7, none of the active treatments demonstrated
systematic superiority over no treatment on any variable. Stimulus
control did, however, produce greater average reduction in daily
napping than did waiting—list (treatment main effect), and changes over
time within treatments were evident with relaxation and to a lesser
extent with paradox for measures of sleep satisfaction. These were not
paralleled in the untreated group. Relaxation therapy appears to be the
best treatment for improving reports of sleep quality.
Comparisons with placebo yielded similarly limited significant findings
(Hypothesis 8). Relaxation significantly improved sleep enjoyment
relative to placebo but only at Week 6, and relaxation was again
responsible for the significant treatment main effect for REPTH, being
modestly superior to placebo. Interaction effects did not reach
significance for any variable.
No significant differences were found amongst active treatments
(Hypothesis 9). It was, however, of interest to find that stimulus
control, which emerged favourably from the analysis of sleep pattern
variables, appeared to produce no complementary sleep quality changes.
Finally, it is clear that only RESTED and ENJOY were useful in
discriminating across and within treatments (Hypothesis 10). Treatments
made little if any reliable impact upon anxious thoughts at bedtime,
daytime irritability and daytime napping.CHAPTER 9
MAINTENANCE AND GENERALISATION EFFECTS AND PREDICTORS OF OUTCOME
This chapter begins with analyses of sleep diary follow-up data in
order to investigate the maintenance of treatment effects. Only those
variables which exhibited significant change during therapy are,
therefore, relevant for consideration. Symptomatic and behavioural
ratings gathered pre and post-treatment will then be analysed to
investigate generalised changes associated with the treatment
programmes. Outcome will then be considered as a function of
demographic and clinical factors, to investigate possible predictor
variables. Finally, the effectiveness of the drug withdrawal programmes
will be considered.
THE MAINTENANCE OF TREATMENT EFFECTS
Patients in the three active treatments were contacted on four separate
occasions to provide follow-up data by completion of one week's sleep
diary. Routine follow-ups were at 6 weeks, 3 months and 6 months, and
all subjects were also contacted at some point from the ninth month
onwards for "long-term" follow-up. The mean time since treatment for
this final assessment was 16.8 months (SD 9.2; range 9-41). Return
rates were satisfactory across treatments with 77% of patients
returning forms at 6 weeks, 58% at 3 months, 56% at 6 months and 70% at
17 months. The increased return rate for the final follow-up was due
to repeat contacts stressing the importance of making a return. It was
hypothesised that:-
11) Follow-up assessments would reveal durability of post-treatment
improvements for each of the psychological therapies.
Table 15 presents summary data during baseline, the final therapy week,
and at each of the follow-up times. Only sleep diary variables which
151had demonstrated significant treatment response were included [see
Appendix I, Table (ix) for complete print-out]. Inspection of the Table
reveals that not only were treatment effects maintained during follow-
up, but often they were extended. Continued improvement was
particularly evident with relaxation training across all follow-up
points, although each of the treatments was associated with further
gain on some variable. Paired T-TEST comparisons were conducted (from
post-treatment to follow-up point) within each condition for each
variable and these confirmed the general pattern of maintenance. No
significant deterioration over post-treatment values was found for any
variable. The only significant changes to emerge were with paradoxical
intention where total sleep time increased during the first three
follow-ups and remained higher than post-treatment at 17 months.
Ratings of sleep restedness were also significantly higher at 6 month
Treatment/ Follow-up
Variable Baseline Final Week 6 Week 3 Month 6 Month 17 Month
RELAXATION (n = 14 13 11 8 10 9	 )
SOL mean 90.5 57.4 48.1 45.3 37.5 45.1
SOL SD 50.0 37.4 27.9 30.2 16.3 30.6
TOT mean 5.79 6.41 6.73 6.65 6.81 6.61
TOT SD 1.41 1.32 1.02 1.07 0.92 1.45
RESTED 1.57 2.21 2.32 2.34 2.12 2.32
ENJOY 1.55 2.13 2.37 2.24 2.24 2.24
STIM CONTROL (n = 14	 12	 10	 7
SQL mean	 82.7	 31.1	 25.6	 29.9
SQL SD	 41.9	 19.0	 15.9	 19.0
TOT mean	 6.10	 6.66	 7.05	 7.05
WABE SD	 0.67	 0.16	 0.34	 0.54
PARADOX	 (n =	 15	 13	 12	 10
SQL mean	 72.4	 35.8	 36.4	 28.7
SQL SD	 47.9	 14.2	 21.8	 14.7
TOT mean	 5.86	 6.54	 7.00 *	 7.10 *
TOT SD	 1.33	 0.78	 0.94	 1.22
WARE	 1.16	 0.53	 0.62	 0.43
RESTED	 1.92	 2.33	 2.37	 2.50
TABLE	 15	 Mean scores on sleep diary variables during
6
37.3
22.3
6.98
0.29
8
40.7
23.9
7.14 *
0.98
0.73
2.61 *
baseline
9	 )
53.3
32.0
6.76
0.35
12 )
37.9
23.7
6.83
1.08
0.51
2.30
the
final therapy week and at each of the follow-up assessments, presented
separately within each of the active treatments (* 2 < .05 T-TEST) 
152follow-up. Given the multiple T-TEST comparisons involved in the
overall analysis, however, the significance of these increments should
be regarded with caution. Nevertheless, inclusion is useful to provide
sensitivity to potentially important trends.
Significant between group differences were thought to be unlikely given
the high levels of maintained improvement in each condition.
Nevertheless, ONEWAY ANOVAs across treatments were conducted on change
scores from final week to each follow-up point, using baseline scores
as covariates. The only significant effect was for TOT SD where, at 3
month follow-up, relaxation was modestly superior to paradox [F =
3.63, F Prob = .048, df(2,18); Scheffe p < .10]. Examination of
the data in Table 15 reveals that TOT SD was continuing to reduce in
the relaxation group compared with a temporary relapse towards baseline
under paradox. It seems likely that this is a spurious result.
In summary then, it is encouraging to note the strong continuing
benefits of treatment during follow-up. Hypothesis 11 was, therefore,
confirmed. There was a general trend towards further improvement,
especially during the first months after treatment, but no significant
relapse occured even 17 months after treatment.
GENERALISED CHANGES ASSOCIATED WITH TREATMENT
In addition to DSQ measures subjects completed rating scale assessments
before and after treatment. Several tentative predictions were made:-
12) Relaxation and paradoxical intention, being recognised treatments
for anxiety, would reduce state anxiety (ZAS) relative to
other interventions.
13) Improvements in mood (ZDS) were expected after each of the active
therapies, but not after the control procedures.
14) Only stimulus control would significantly reduce a measure of
sleep-incompatible behaviour (SBRS).
15) Active treatments would be associated with improvements in a wide
range of daytime functions CARS). Control groups would not.
153Prior to the consideration of pre-post change, pretest values on the
ZAS, ZEG, SBRS, ARS and ?RS items were subjected to ONEWAY ANOVA across
treatments to investigate potential baseline differences between
groups. The results of these analyses indicated that the experimental
groups were functioning similarly at pre-treatment on these measures.
None of the F ratios approached significance [Appendix I, Table (x)].
The possibility of sex differences in these symptomatic and behavioural
measures was also considered, but independent sample T-TESTs again
produced no significant effect [Appendix I, Table (xi)].
Table 16 presents mean scores for pre and post-treatment along with
results of paired T-TESTs within each of the experimental conditions.
The significance of each test result is presented in relation to three
probability criteria in order to provide both conservative and
sensitive consideration of the effects obtained.
Inspection of the Table reveals that each active treatment was
associated with significant reduction in Zung Depression Scale (ZDS)
scores, thus confirming Hypothesis 13. In each case improvement was of
around six scale points, although the strongest effect was for the
relaxation group. Significant changes on the Zung Anxiety Scale (ZAS)
were also obtained with paradoxical intention and with placebo although
the latter group averaged a score reduction of less than three points.
Even the paradoxical intention group failed to achieve significant
score reduction according to the more conservative criteria.
Nevertheless, this result partly confirms Hypothesis 12 ie.
improvement via paradox. Relaxation subjects did generally reduce
anxiety level but not significantly.
The total score from the Analogue Rating Scale (ARS), as expected, also
reduced significantly under each active treatment (Hypothesis 15) with
paradox achieving the most reliable change. In addition, each
154Treatment/
Variable pre post SE diff T df Prob Sig Level
RELAXATION
ZAS 36.5 32.6 2.72 1.44 12 .175 NS
ZDS 42.2 35.5 1.62 4.09 12 .002 **
SBRS 42.1 40.4 1.51 1.17 12 .264 NS
ABS 51.0 40.9 3.01 3.36 12 .006 **
ABS 2 5.83 4.56 0.42 3.04 12 .010 **
ABS	 3 4.55 6.35 0.64 -2.82 12 .016 *
ABS	 7 3.98 5.64 0.35 -4.77 12 .000 ***
ABS	 9 2.65 5.81 0.76 -4.19 12 .001 ***
STIM CONTROL
ZAS 37.4 34.2 2.20 1.48 11 .168 NS
ZDS 45.3 38.9 2.05 3.08 11 .010 **
SBRS 41.6 33.0 2.74 3.14 11 .009 **
ABS 53.4 41.8 4.85 2.39 12 .033 *
ARS	 9 1.92 4.74 0.73 -3.88 12 .002 **
PARADOX
ZAS 36.0 30.7 1.96 2.70 13 .018 *
ZDS 39.8 34.6 1.61 3.23 13 .007 **
SBRS 45.4 43.9 1.60 0.94 13 .365 NS
ABS 47.4 37.3 2.93 3.43 13 .004 **
ABS	 9 2.59 5.76 0.73 -4.34 13 .001 ***
ABS 10 4.53 6.26 0.65 -2.68 13 .019 *
PLACEBO
ZAS 39.9 37.0 1.26 2.30 10 .047 *
ZEG 39.1 39.1 2.39 0.00 10 .999 NS
SBRS 52.2 52.3 2.36 -0.04 10 .967 NS
ABS 46.6 39.2 5.49 1.35 10 .211 NS
ABS	 9 1.36 4.49 1.27 -2.46 10 .036 *
WAITING LIST
ZAS 41.5 41.8 1.40 -0.19 10 .850 NS
ZDS 42.3 43.1 1.18 -0.71 11 .494 NS
SBRS 45.4 44.2 0.55 2.17 11 .058 NS
ABS 49.7 52.1 2.20 -1.09 12 .300 NS
ABS	 1 5.05 4.62 0.19 2.25 12 .048 *
TABLE	 16 Mean	 scores	 for pre	 and	 post-treatment	 rating	 scale
assessments and results of paired T-TEST comparisons for each of the
experimental conditions (* p < .05 ** < .01 *** p < .001)
experimental condition produced some change on at least one  ABS
item [only significant effects are reproduced in the Table - see
Appendix I, Table (xii) for all ABS item scores]. Relaxation reduced
"worrying" (ABS 2) and improved daytime function in terms of "coping
with work" and "concentration" (ABS 3 and 7). The latter improvement
was highly significant. Ratings of "sleeping well" (ABS 9) also
improved very significantly with relaxation, but also with stimulus
155control and paradox. Placebo subjects, however, improved only modestly
on this variable. Paradoxical intention was associated with some
increase in "confidence" (ABS 10) and the waiting-list group were
slightly less "energetic" (ARS 1) at post-treatment. The remaining four
items from the ABS exhibited no significant change with any
intervention.
The only group to exhibit significant improvement on the Sleep
Behaviour Rating Scale (SBRS) was the stimulus control group. This was
as expected (Hypothesis 14). Analysis of SBRS item scores for the
stimulus control group demonstrated significant change (WILCOXON; p
< .05) on only three items, ie. Item 1 "reading in bed", Item 17 "light
off immediately in bed" and Item 18 "light on until almost asleep".
Since the latter two were perfectly inversely correlated the most
significant alteration from pre-bedtime routine was not to read in bed
and to go to sleep immediately [see Appendix I, Table (xiii) for full
analysis].
In order to consider the possibility of differential response to
therapy on these pre-post measures, ONEWAY ANOVAs were conducted across
treatments. Computed change scores (before - after scores) were used in
this analysis to control for any minor variation in pre-treatment
values. The results of those analyses yielding F ratios p < .10 are
presented in Table 17, along with the results of range testing
procedures. Inspection of the Table reveals that both relaxation and
stimulus control were superior to no treatment in reducing ZDS scores,
with the difference between relaxation and waiting-list contributing
more strongly to the overall effect. Each of the active treatments and
also the placebo demonstrated significant improvement over no treatment
on "sleeping well" (ABS 9). The only other analogue item with F
probability < .10 was "coping with work" (ABS 3) but no significant
156between group differences emerged. Stimulus control demonstrated modest
but consistent superiority over each of the other conditions on  SBRS.
Results
Appendix
Variable
of	 the
I [Table
df
remaining,
(xiv)].
F Ratio
non—significant	 ANOVAs can be
F Prob	 Pair	 Scheffe Range	 Planned
found	 in
t
.05	 .10 .01
ZE6 (4,57) 3.994 0.006 1 v 5
2 v 5
SBRS (4,57) 3.158 0.021 2 v 4
2 v 3
2 v 5
2 v 1
ARS 3 (4,53) 2.259 0.076
ARS 9 (4,59) 4.320 0.004 1 v 5 * * *
3 v5 * * *
4 v5 * * *
2 v5 * *
TABLE 17 ANOVAs on rating scale change scores across the experimental 
conditions (Relaxation=1, Stimulus control=2, Paradoxical intention=3, 
Placebo=4 Waiting—list=5). The results of range tests are also
presented 
In terms of the hypotheses, the between group effects were supportive
of the specific impact of stimulus control upon SBRS scores (Hypothesis
14). There were no differential responses on ZAS (Hypothesis 12) and
ZDS revealed relative improvements in mood, only when relaxation and
stimulus control were compared with no treatment (Hypothesis 13). ARS
total scores did not discriminate between groups and the only item
score which did so referred to "sleeping well". This was not a measure
of generalised function (Hypothesis 15).
POSSIBLE PREDICTOR VARIABLES
It was of interest to identify any variables which might be predictive
either of initial clinical presentation or of treatment response.
Both demographic and clinical variables were considered in an attempt
to evaluate such potential predictive factors. Since this was a
157retrospective investigation, no hypotheses were forwarded. A
correlational analysis was conducted, calculating a PEARSON co-
efficient for the relationship between each potential predictor
variable and the sleep diary measures. Both baseline and change
(baseline - final week) scores were considered. Table 18 presents
results for those variables achieving significance p < .01.
Relationships significant at the 5% level only were considered to
contain an unacceptably high error variance component [coefficients
generally less than 0.25; see Appendix I, Table (xv) for complete
analysis].
Out of the greater than 100 co-efficients computed, inspection of the
Table reveals that only 14 achieved significance. Age and duration of
insomnia bore little relationship either to baseline presentation or to
outcome. The number of years since hypnotics were first prescribed
(MEDPAST), however, was inversely related to several baseline
measures. There was a significant tendency for TOT SD, WAKE SD and
IRRIT to reduce with lengthier drug histories, and correspondingly, for
RESTED to increase. This may suggest that sleep pattern becomes more
predictable and evokes less emotional reaction in patients who have for
longer made use of drugs as a coping strategy. Outcome measures of WAKE
SD and REPTH, however, revealed less improvement for patients with
longer drug histories. Therefore, no clear pattern emerged.
TOT SD WAYESD WESD REPTH REPTH RESTED IRRIT
Base	 Base	 Change Base Change Base	 Base
AGE	 -.281 *
DURATION	 -.302 *
MEDPAST	 -.296 * -.304 * -.338 *	 -.357 *	 .286 * -.359 *
ZAS pre	 .444 **	 .650 **
ZDS pre	 .311 ** .299 * -.323 * .641 **
TABLE 18 Predictor variables and their relationship with baseline and
outcome sleep diary measures. Pearson co-efficients and probability
values (*II< .01 ** 2 < .001) are displayed 
158It is of particular interest to note that no predictive relationships
were demonstrated with any of the mean values for SOL, TOT and WYE.
These measures, which have been regarded as the standard summary
descriptors of sleep pattern, appear not to vary systematically with
age, chronicity of insomnia or symptomatic anxiety and depression.
The strongest and most consistent predictor variables were the clinical
rating scales, although these were correlated only with sleep quality
variables. Pre-treatment scores on both Zung scales were positively
correlated with REPTH and ERRIT ie. the greater the symptomatology the
greater the pre-bedtime worry and daytime irritability. Additionally,
the ZES was inversely correlated with RESTED (greater mood disturbance
predicted less restedness after sleep). These findings would appear to
make clinical sense. Greater ZDS score was, however, also modestly
associated with greater reduction in pre-sleep anxiety (REPTH).
In summary, none of the demographic or clinical variables were good
outcome predictors. Affective measures were consistently related to
qualitative report at baseline but did not predict sleep pattern. The
relationship between drug history and sleep was indeterminate. Most
sleep pattern variables were not associated with any predictor
variable.
The presence or absence of ongoing drug therapy was also considered as
a potential predictor. The methodology chapter described the programmes
for drug withdrawal. Fifteen patients were maintained on medication
throughout the experimental period, with the remainder being finally
drug-free (11 after structured pre-treatment withdrawal and many others
after less formal but supervised withdrawal). A categorical analysis
was conducted involving chi-square testing via the CROSSTABS procedure
for the variable sex, and independent T-TESTs with drug status as the
grouping factor for the remaining demographic and all of the sleep
159diary variables. No significant between group differences emerged on
any baseline sleep parameter or gain score at post-treatment.
Similarly, drug status was not significantly different across sex, age
and duration of insomnia [results available in Appendix I, Table
(xvi)]. These results indicate that subjects who remained upon
hypnotics had sleep difficulties and treatment responses similar to
drug-free patients.
Although drug status has not proven to be a predictor variable, it
would be appropriate to present data on the management of drug-using
patients at this point.
THE DRUG WITHDRAWAL PROGRAMME
Twenty-six patients participated in a formal programme of withdrawal;
11 pre-treatment and 15 post-treatment. Unfortunately complete data are
not available for every case. Five cases of pre and five cases of post-
treatment withdrawal will, therefore, be presented to demonstrate the
two models (Espie, Lindsay and Brooks, 1987).
Allocation to withdrawal programme was based solely upon compliance. In
practice, subjects unwilling or unable to cease medication were
allocated to the post-therapy regime. Description of each subject along
with SQL mean data across experimental phases are presented in Tables
19 and 20. Inspection of the Tables confirms that these 10 patients
were similar to the total study sample in terms of sex and age
distribution, and mean duration of insomnia. Baseline SQL was
substantially higher for this sample of post compared with pre-
treatment withdrawal subjects, but scores for these patients as a whole
fall comfortably within the range for the main study population.Pre—treatment Drug Withdrawal
Patients in the pre—therapy group had a mean baseline SQL of 64 minutes
which increased by greater than 50% during the first two withdrawal
weeks. Thereafter, there was a rapid and consistent return to baseline
levels. Psychological therapy produced an average 47 minute reduction
in SQL, and patients completed therapy taking an average of 25 minutes
to fall asleep. Improvements were maintained at both Fl (6 months) and
F2 (mean 13 months). These summary statements appear to be fairly
accurate also for individual responses.
Statistical analyses were conducted, firstly, by means of the SPSSX
RELIABILITIES procedure to generate a Friedman's non—parametric ANOVA
across the time points from baseline to the final withdrawal week. This
approach computes the Chi—square statistic and revealed a near
significant overall effect [Chi—square = 9.43; df = 5; p = .090].
WILCOXON tests for paired samples were then applied to test for
significant differences between baseline and scores at each withdrawal
week. The only significant effect was at Week 2 where SOL was
significantly higher than at baseline (z = —2.02; p = .043). This
confirms that there was a significant rebound effect during the
second week, but not thereafter. Comparison between pre and post-
treatment scores revealed significant SQL reduction (WILCOXON z =
—2.02; p < .05). No significant relapse was found between post—therapy
and either of the follow—up weeks. It should be noted, however, that
subject 2 had resumed medication at F2.
Post—treatment Drug Withdrawal
The post—treatment group received psychological intervention prior to
drug withdrawal. Therapy was associated with an approximate 50%
reduction in SQL which just failed to reach significance at the 5%
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(r3 4-1 U)level (z = —1.75; p = .079). Since the Wilcoxon test is a signed—rank
procedure it is likely that the lack of improvement in one subject
(case 10) was responsible for this result. Nevertheless, substantial
improvements were recorded for the other patients. Friedman's ANOVA
from post—treatment across drug withdrawal produced a
significant overall effect [Chi—square = 13.28; df = 5; p = .021].
Inspection of the group mean data suggested that rebound effects were
present during the first four weeks of withdrawal, with a return to
near baseline at Week 5. WILCOXON tests were applied to identify the
loci of significant effect. Significant increments in SQL were
found at Weeks 1 and 2 (in both cases z = —2.02; p = .043),
with lesser effects evident at Weeks 3 and 4 (in both cases z = —1.75;
p < .08) and at Week 5 (z = —1.83; p < .07). The result for Week 5 is
surprising since mean SQL was only 15 minutes greater than the post-
treatment value. The Wilcoxon test, however, does not take into account
the degree of difference between measures, and since four of the five
W5 scores were higher than post—treatment, an inflated z score was
perhaps obtained. Statistical analyses were not conducted at follow—up
because of missing data in one case, but more importantly, the
resumption of medication in three cases at F2.
The results from both withdrawal programmes are encouraging. Effective
pre—treatment withdrawal was supplemented by psychological therapy to
establish an improved sleep pattern, and the five cases presented
suggest that treatment benefits were largely retained for this group.
Those who were unable to stop hypnotics initially presented with
lengthier sleep latency difficulties and experienced rebound SOL
effects for a longer period. The type and doseage of drug taken,
however, did not appear to discriminate between groups. Psychological
treatment enabled these patients successfully to stop medication but in
three cases relapse occurred and medication was resumed within
163approximately I year. It is noteworthy that SOL scores at the final
withdrawal week, for the latter group, were higher than baseline sleep
problems for the pre—treatment withdrawal group. Greater clinical
problems may be expected, therefore, when patients experience
protracted withdrawal reactions. Booster therapy may be one option
to maintain treatment effectiveness for this group. The implications of
these drug—management models will be discussed later.CHAPTER 10
AN EVALUATION OF TAILORED THERAPY
This chapter presents, firstly, information on the assessment and
treatment of the 14 consecutively allocated patients in the tailored
therapy condition; and secondly, evaluation of this approach compared
with the randomly allocated treatment groups.
THE DEVELOPMENT OF THE SLEEP DISTURBANCE QUESTIONNAIRE
On the basis of individual presenting characteristics of sleep pattern,
bedtime habits, and personal coping style, an attempt was made to
predict which form of intervention would be most appropriate. To
formalise clinical judgement in this matter, a Sleep Disturbance
Questionnaire (SDQ) was compiled as a brief, structured interview
assessment of potential contributory factors. Three items were selected
from clinical experience to assess each of the areas of physical
tension, sleep incompatible behaviour, anxious "effort to sleep", and
general cognitive intrusion. Patients were allocated to relaxation
training,	 stimulus control,	 paradoxical	 intention,	 cognitive
restructuring therapy (Beck and Emery, 1979) or a combination of these
procedures, depending upon the profile of scores obtained on the SDQ.
The cognitive therapy option was included since it had been the
author's experience that problems with mental control and reasoning
were frequent insomniac complaints. Each of the 12 statements in the
questionnaire was rated on a 5-point scale from "never true" to "very
often true" to indicate how characteristic the item was of the
subject's typical sleep pattern. The maximum subscale score was 15, and
the total score maximum was 60. In order to clarify further the
allocation to treatment, patients were asked to select the single item
which was most relevant to their sleep problem and to comment on any
165other factors which were not included in the assessment (The SDQ is
presented in Appendix J). The SDQ was, therefore, primarily a clinical
tool to aid the consistent appraisal of aetiological factors.
Completed questionnaires were available from a group of 42 insomniacs
(11 male, 31 female), comprising both those in the tailored therapy
group and other patients attending their GP for management of insomnia.
The mean age of the sample was 46.8 years (SD 18.0). Comparison with
demographic data for the main study suggested that this was a
representative group. The most commonly selected single items were Item
5 "I find it hard to let go and relax" (26%), Items 2 "My mind keeps
turning things over" and 3 "I can't get my sleep into a proper routine"
(each 17%), and Item 10 "I am unable to empty my mind" (14%). These
four items, therefore, accounted for 74% of all choices.
In order to investigate the presumed factor structure of the SDQ, the
data were submitted to FACTOR ANALYSIS (FA) using Principal Components
Analysis and Varimax rotation. In spite of the relatively small sample
size (n = 42) the Kaiser—Meyer—Olkin measure of sampling adequacy (MBA)
(see Kaiser and Rice, 1974) yielded a value of 0.701 which is greater
than the critical value of 0.500. Thus the correlation matrix was
acceptable for factor—analytic purposes according to the MBA approach.
Three factors emerged from FA satisfying the SPSSX default criterion of
having eigenvalues greater than or equal to 1.000. These factors,
together accounting for 68.3% of total variance (Table 21) were
Factor	 Eigenvalue	 % Variance	 Cumulative %
1	 4.780	 39.7	 39.7
2	 2.162	 18.0	 57.7
3	 1.278	 10.7	 68.3
TABLE 21 Factors extracted from the SDQ under Principal Components 
Analysis 
166accepted for further analysis. Inspection of the complete factor
extraction table [Appendix K, Table (xvii)] indicates that the
remaining factors not only had eigenvalues less than 1.000 but each
also explained less than 10% of total variance. Thus the decision to
restrict extraction to three factors was confirmed.
The rotated factor matrix is presented in Table 22. Given the
relatively small n of cases, a correlation of 0.50 was selected as a
minimum criterion for significant factor loading. It was hoped that
this would be a reasonably conservative procedure.
Factor 1 Factor 2 Factor 3
Item	 2 .90537* .09700 -.01654
Item 10 .88744* .03683 .07730 _
Item	 6 .84749* .18342 -.10656 _...
Item 12 _ .73933* -.44722 -.03357
Item	 5 .69872* .05278 .55866* _
Item	 4 _ .63777*
,
.11913 .27770
Item	 8 _ .56147* .45514 .17058
Item	 7 _ .07275 .81256* -.25665
Item	 3 .02013 .75622* .22923
Item 11 .07772 .52823* .26732
Item	 1 -.11789 .32289 .78737*
Item	 9 .57879* -.15500 .63337*
TABLE 22 Rotated factor matrix showing SDQ item correlations and
loading on each of the three principal factors. * Items loading r > .50
Inspection of Table 22, with reference to the SDQ (Appendix J) reveals
that Factor 1 accounted for more than one-third of total variance. It
can be regarded as a "mental anxiety" factor, with all of the cognitive
restructuring items (2,6,10) and paradoxical items (4,8,12) loading at
167highly significant levels. Interestingly, Items 5 and 9 loaded
significantly on both Factors 1 and 3. The likely explanation for this
in the case of Item 5 is that ambiguity of wording ("I find it hard to
let go and relax") permitted subjects to construe it either in terms of
mental or physical relaxation. There is, however, no clear explanation
for the significant correlation of Item 9 with Factor 1. The remaining
items had minimal loadings on Factor 1 (all p < .12).
Items 1 and 9, along with Item 5, loaded significantly upon Factor 3
yielding a relatively "pure" factor of "physical tension". The highest
of the nine other coefficients for Factor 2 was only 0.28. The wording
of Item 5 has now been amended to read "I find it hard to let go and
relax my body", to clarify its intended emphasis upon physical
relaxation.
Factor 2 may be described as "sleep pattern problem", since all three
stimulus control items (3,7,11) loaded significantly. No other items
reached the criterion level of 0.50 on this factor. Items 1, 8 and 12,
however, merit comment having coefficients within the range 0.30 to
0.50. It is perhaps not surprising that difficulties in attaining a
"comfortable position in bed" (Item 1) should be positively associated
with the stimulus control model. Being comfortable in bed could be
readily regarded as a state discriminative of rapid sleep—onset. The
combination of effort to sleep (Item 8) and the absence of worry about
the consequences of sleep loss (inverse of Item 12) may also be in
keeping with a "sleep pattern problem". The emphasis underlying Factor
2 may be that of a resistant to change habit disorder ie. behavioural
pattern problem, but without concomitant affective disturbance.
The results of FA, therefore, broadly confirm the clinical judgements
which were based upon the SDQ. Relaxation and stimulus control items
loaded as expected on separate factors, but a third "cognitive" factor
168comprised all items referring to both performance anxiety and
dysfunctional thought. These findings suggest that a Three Systems
Model with behavioural, physiological and cognitive elements, may be
appropriate in the investigation of aetiological and maintaining
factors.
PROCEDURE
Using the SW to allocate the 14 patients, 4 received relaxation, 4
stimulus control, 2 paradoxical intention and 4 cognitive restructuring
as the principal intervention. In some cases (where appropriate and
indicated by the SDQ) subjects also received instruction based upon
elements of the other procedures. This was in order to approximate
closely what would normally happen in clinical practice. Therefore, and
for example, "cognitive restructuring" at times comprised elements of
paradoxical intention , stimulus control or relaxation training where
the score on another sub—scale of the SDQ was noticably elevated. The
experimental phases for the tailored group were identical to those in
the design of the main study. Patients were required to complete the
same process and outcome measures, and they received the same pattern
of out—patient appointments as did subjects in the main study.
ASSESSMENT OF TREATMENT CREDIBILITY
The Credibility Evaluation Questionnaire (CEQ) was administered to
patients in the tailored therapy condition in order to permit
comparison with the main group study. Eleven out of the 14 subjects
completed the CEQ and the mean score obtained was 25.7 (SD 3.95).
Comparison with scores for the randomly allocated groups [Appendix H,
Table (iii)] suggests little difference in patients' perception of
credibility. ONEWAY ANOVA across the five treatment groups (3
randomised active treatments, placebo	 control, and	 tailored
169therapy) confirmed	 this result [F = 0.159; df(4,50); p = 0.958].
THE EFFECTIVENESS OF TAILORED THERAPY
No specific predictions regarding the comparative effectiveness of
tailored and untailored treatment were made. Clinical practice
frequently assumes the superior effectiveness of individualised
programmes, however, this assumption was unsupported by Turner et al's
(1984) unsuccessful attempt to maximise treatment gain by combining
relaxation and stimulus control instructions. Lichstein (personal
communication, 1986) has also reported limited gain in the use of
tailored treatments for insomnia.
Descriptive Analysis
In evaluating outcome, the comparison of greatest interest was that
between the tailored group and the three active treatments (combined)
ie. tailored psychological treatment versus randomly assigned
psychological treatment. Table 23 presents a descriptive summary of DSQ,
variables for this comparison, incorporating pre and post—treatment
values and percentage change scores. Placebo and no treatment scores
are also presented.
Inspection of the Table indicates that, for both SOL variables, post -
treatment change was greater in the random therapy group compared with
the tailored group. Indeed, the tailored condition demonstrated a
response more similar to placebo on these variables. TOT mean and TOT
SD revealed modest treatment effects for both tailored and untailored
groups and these effects were similar to placebo. The pre—treatment
mean value for TOT in the tailored group was noticeably lower than in
any of the other conditions. Tailoring was associated with reductions
approaching 50% on WAKE mean and WAKE SD compared with around 40% in
the random treatment group, but in all conditions wakening was
1705.84
5.84
44.2
30.6
-30.8
5.34
5.82
+ 9.0
1.23
0.94
-23.6
53.6
63.5
+18.5
1.25
1.28
+ 2.4
infrequent at baseline.
Random Therapy Tailored Therapy Placebo No Treatment
(n =	 43	 14	 14	 13	 )
SOL mean pre	 81.7	 85.3	 85.5	 84.5
post	 42.1	 55.8	 63.5	 96.5
%ch	 -48.5	 -34.6	 -25.7	 +14.2
SQL SD	 pre	 46.6	 57.0
post	 24.0	 40.7
%ch	 -48.5	 -28.6
TOT mean pre	 5.92	 4.50
post	 6.53	 5.17
%ch	 +10.3	 +14.9
TOT SD	 pre	 1.30	 1.32
post	 1.06	 0.98
%ch	 -18.5	 -25.8
WAKE mean pre	 1.22	 1.53	 1.76	 1.01
post	 0.75	 0.77	 1.34	 0.85
%ch	 -38.5	 -49.7	 -23.9	 -15.8
WAKE SD pre	 0.82	 1.12
	
0.95
	 0.68
post	 0.52	 0.61
	
0.94
	
1.41
%ch	 -36.6	 -45.5	 - 1.5	 - 7.4
REPTH	 pre	 1.41	 1.56	 1.92	 1.64
post	 1.11	 1.00	 1.90	 1.41
%ch	 -21.1	 -35.9	 - 1.0	 -14.0
RESTED	 pre	 1.77	 1.66	 1.70	 1.93
post	 2.23	 1.69	 2.01	 1.87
%ch	 +26.0	 + 1.8	 +18.2	 - 3.1
ENJOY	 pre	 1.90	 1.76	 1.71	 2.06
post	 2.33	 1.97	 2.12	 2.16
%ch	 +22.6	 +11.9	 +24.0	 + 4.9
IRRIT	 pre	 1.41	 1.28	 1.46	 1.43
post	 1.12	 1.04	 1.14	 1.18
%ch	 -20.6	 -18.8	 -21.9	 -17.5
NAPDAY	 pre	 6.85	 6.75	 6.46	 19.9
post	 4.44	 0.00	 3.82	 16.5
%ch	 -35.2	 - 100	 -40.7	 -17.1
TABLE 23 Comparison between randomly allocated and tailored treatments 
of mean scores during baseline (pre) and the final week of treatment 
(post) along with percentage change scores for each DSQ variable
Results for the sleep quality variables failed to demonstrate any
general pattern of superiority. Tailored therapy produced greater
reduction in REPTH and NAPDAY (though napping was a very minimal
171problem), whereas for RESTED, ENJOY and IRRIT any superiority tended
towards the random approach. Considerable changes after placebo
treatment, on all but one of the sleep quality variables, further
suggested that between group differences were at best modest.
There being little evidence, therefore, for the existence of important
final outcome differences between tailored and randomised treatments it
was felt unnecessary to conduct a complex repeated measures analysis.
The following statistical analyses were, however, conducted.
Statistical Analysis
Baseline Measures 
Examination of the data in Table 23 indicated that a significant
between group difference might emerge at baseline on the variable TOT
mean. In order to investigate this possibility, and to consider whether
or not other variables might differ across groups, mean scores for each
DSQ variable were submitted to ONEWAY ANOVA with treatment type
(random, tailored, placebo, no treatent) as the grouping factor. Two of
the 11 variables yielded significant F ratios. TOT mean was indeed
associated with a highly significant effect [F = 5.08; df(3,80); p =
.003] which Scheffe testing revealed was accounted for by significant
differences between tailored and random therapy (p < .05), and to a
lesser extent between tailored therapy and no treatment (p < .10). In
both cases tailored therapy subjects slept for shorter periods on
average. The other significant baseline difference was for NAPDAY
and was modest by comparison [F = 2.72; df(3,80); p = .050]. No
treatment subjects napped significantly more than random therapy
subjects (Scheffe p < .10). The results of the other non—significant
baseline analyses are available in Appendix K [Table (xviii)].
172Treatment Outcome 
In order to evaluate the comparative outcome of treatments ONEWAY
ANOVAs across treatment type were conducted upon change scores
(baseline value — score at final therapy week) for each DSQ variable.
The results of these analyses are presented in Table 24. Inspection of
the Table reveals that significant between treatment effects were
achieved for only 3 of the 11 variables. Improvements in SOL mean were
significantly greater in the randomised treatment group compared with
no treatment and modest effects (p < .10) were also found for this same
between group comparison on SQL SD and RESTED. Of greatest importance,
however, was the failure to find any significant benefit for tailored
therapy over any other condition. Tailored therapy was never superior
to random therapy. Random therapy demonstrated superiority over no
treatment on some variables but tailored treatment did not.
Variable df F Ratio F Prob Pair Scheffe Range Planned t
.05	 .10	 .01
SOL mean (3,72) 3.624 0.018 1 v 4
SQL SD (3,72) 2.200 0.097 1 v 4
TOT mean (3,72) 1.142 0.339 —
TOT SD (3,72) 0.501 0.679 —
WAKE mean (3,72) 0.873 0.460 —
WAKE SD (3,72) 1.715 0.173
REPTH (3,73) 0.643 0.581 —
RESTED (3,73) 2.436 0.073 1 v 4
ENJOY (3,72) 0.685 0.564 —
IRRIT (3,71) 0.595 0.620
NAPDAY (3,72) 1.452 0.236
TABLE 24 ANOVAs on change scores for each of the sleep diary variables 
across treatment types (Random therapy=1, Tailored therapy=2, 
Placebo=3 No treatment=4). Results of range tests are also presented
One final analysis was conducted to consider the impact of tailored
therapy. A repeated measures ANOVA, within the tailored condition, was
generated by means of the SPSSX RELIABILITIES procedure to provide data
comparable with the time within treatment analyses conducted for the
individual treatments in the main study (see Tables 12 and 14). The
results of this analysis can be found in Table 25 [see Appendix K,
173Table (xix) for DSQ data at each therapy week].
These results confirm the relatively limited impact of tailored therapy
upon the sleep diary measures. Neither SOL mean nor SQL SD were
significantly reduced from baseline values during the course of
treatment, apart from a temporary reduction in sleep latency during
Weeks 2 to 4. A modestly significant increase in TOT mean emerged at
Week 2 and was maintained until the end of the treatment period.
TOT SD, however, was unaffected over time by tailored treatment.
Comparison of these results on sleep pattern with those obtained from
relaxation, stimulus control and paradox (Table 12), suggests that the
tailored approach was of limited value. Having already established
that tailored therapy was not superior to the combined random therapy
group, it is now evident that it compared even more unfavourably with
the more powerful specific effects of individual treatments. Reductions
in both WAKE and WAKE SD, however, were highly significant over time
with tailored therapy and were at least comparable in magnitude with
the treatment effects demonstrated in Table 12. Tailored treatment was
the only treatment approach to reduce significantly both mean and SD
scores for intermittent wakening.
1	 2
df	 (1,13)	 (2,26)
SOL mean
SOL SD
TOT mean
TOT SD
WAKE mean
WAKE SD
REPTH	 **
RESTED
ENJOY
IRRIT
NAPDAY
Weeks of Therapy
6	 7
(6,78)	 (7,91)
**	 ***
***	 ***
8
(8,104)
***
***
3
(3,39)
**
4
(4,52)
*
**
5
(5,65)
**
TABLE 25 Repeated measures ANOVA providing time within treatment group
sub—effects on each DSQ variable for the tailored therapy condition 
* < .05 **	 < .01 *** < •001
174In terms of sleep quality, tailored therapy yielded minimal change.
Early reduction in REPTH was not maintained and significant effects at
the 5% level occurred at single data points only, for the variables
ENJOY and NAPDAY. Relaxation training, therefore, remains the most
favoured intervention for measures of sleep quality (cf. Table 14).
In conclusion, tailored psychological therapy was not superior to
randomly allocated psychological therapy. Between group testing only
confirmed the benefits of the randomised group over no treatment; an
effect not paralleled in the tailored therapy condition. Previous
analyses have already explored the impact of the specific treatments
which comprise the random group. Repeated measures analysis within the
tailored condition revealed consistent improvements on only three
measures of sleep pattern, namely TOT mean, WAKE mean and WARE SD.
Tailored therapy was, however, the only intervention to reduce both
wakening frequency and variability of wakening. Sleep quality measures
did not demonstrate any useful improvements over time.
BEFORE AND AFTER MEASURES
In consideration of the generalised changes associated with tailored
therapy paired T-TEST comparisons were conducted from pre to post-
treatment on the ZAS, ZES, SBRS and IRS. The results of these analyses
are presented in Table 26.
Variable	 pre	 post	 SE diff	 T	 df	 Prob	 Sig Level 
ZAS	 36.0	 32.3	 1.27	 2.89	 10	 .020	 *
ZES	 39.2	 36.3	 3.20	 0.90	 10	 .393	 NS
SBRS	 48.6	 39.7	 8.10	 1.10	 10	 .305	 NS
ABS	 52.3	 46.6	 3.95	 1.45	 10	 .186	 NS
ABS 9	 1.70	 5.34	 1.06	 -3.45	 10	 .009	 **
Table 26 Mean scores for pre and post-treatment rating scale
assessments and results of paired T-TEST comparisons for the tailored 
therapy condition (* Q<.05 ** < .01)
175Inspection of the Table reveals that tailored therapy was associated
with a modest but significant reduction in anxiety level (ZAS) but had
no substantial impact upon depressed mood (ZDS) or on generalised
daytime functioning (ARS). The only ARS item score to improve
significantly was ARS 9 "sleeping well". Tailored therapy subjects,
therefore, regarded sleep as having improved on this global measure.
The results of the remaining, non-significant results on ARS items are
available in Appendix K [Table (xx)]. At post-treatment, scores on
the SBRS had reduced by approximately 9 points on average. However, the
variability of response across subjects is evident from the relatively
high SE of difference between means, rendering the T-TEST comparison
non-significant.
Comparison of Table 26 with Table 16 (Chapter 9) indicates that
tailored therapy produced less change on pre-post assessments than any
of the three other active interventions. Indeed, even placebo control
was associated with significant reductions in state anxiety and with
improved rating of sleep. ONEWAY ANOVAs on change scores across the  six
experimental conditions (5 from main study plus tailored therapy) were
also conducted. The only significant effect to emerge, in addition to
the between group effects reported in the previous chapter (Table 17),
was for ARS 9 where Scheffe testing revealed a significant difference
between tailored therapy and no treatment (p < .05) [F = 6.366; df
(5,66); p = 0.006]. Clearly there were no particular advantages
conferred upon the pre-post measures by the use of the tailoring
procedure.CHAPTER 11
DISCUSSION 
Discussion of the results of this study will be organised around a
number of important themes, and each theme will form a section of this
chapter. The areas of interest are as follows:—
1. The study population
2. Psychological treatments and their effects
3. The issue of clinical versus statistical significance
4. Some important methodological issues
5. Recommendations for clinical practice
6. Suggestions for further investigation
THE STUDY POPULATION
General Characteristics
One of the principal criticisms levelled against previous studies was
their failure to investigate treatment effects within clinically
presenting groups of insomniacs (Chapter 6). Tables 1-4 clearly
demonstrated that subjects had been recruited largely via
advertisements, thereby imposing restrictions upon the generalizability
of results. An essential part of the selection process in this study
was that each subject was referred by a GP through normal clinical
channels. Results are, therefore, directly applicable to clinical
practice.
The final sample of 84 patients had an average age of 45.5 years and
had experienced severe insomnia for a mean of 11.8 years. Both in terms
of age and chronicity, therefore, these subjects differed from the
great majority in previous reports who have tended to be younger and
have had more recent problems with sleep. Certainly, this study
comprises the largest sample of chronic insomniacs ever investigated in
the psychological treatment literature.Average SOL at baseline also reflected the more clinical presentation
of insomnia in the present study. Patients took an average of around 83
minutes to fall asleep, by comparison with which, those past reports
which have compared outcome across different psychological treatments
(Table 4) have generally described sleep latencies some 15-45 minutes
shorter on average. Only one (unpublished) study has reported on
similarly lengthy SOL (Bootzin, 1975).
Only 14 patients in the final sample of 84 (17%) had never been users
of hypnotic medication. The group as a whole, therefore, were typical
of the insomniac out-patient poulation in making regular use of
sleeping tablets. The mean period since first prescription was 9 years,
and 26 subjects (31% of total) required a formal programme of drug
withdrawal due to long-term dependence. Treatment effects were
investigated, therefore, within a group who posed considerable
management problems in general practice.
It would be of interest to compare insomniacs with other attenders at
psychology clinics in primary care settings. A number of workers have
found that the typical psychology caseload comprises mainly patients
with anxiety/stress disorders or interpersonal problems (Koch, 1979;
Jerrom, Simpson, Barber and Pemberton, 1982; Espie and White, 1986a).
The Espie and White study presented an analysis of 1165 GP referrals to
the clinical psychology service in Lanarkshire. Two-thirds of these
cases were female, and the mean age for the total sample was 37.4
years. The sex distribution of the insomniac group in the present study
was very similar to that of this large reference group; 68% being
female and 32% male. Interestingly, however, insomniacs appeared to be
older by an average of around 8 years (mean 45.5 years - see Table
5). This age difference was accounted for by the relative paucity of
very young adults along with the much higher proportion of elderly
178subjects in the insomniac group. Espie and White reported that only 8%
of the total out—patient group were aged 60 or over; this compares with
over 20% in the present study. It is, of course, in keeping with the
literature on prevalence rates to find that insomnia was more strongly
associated with the older agegroups who experience shorter and more
disturbed sleep than younger adults [see Chapter 1, and McGhie and
Russell (1962) for information on the local population]. Part of the
normal change in sleep pattern with age is an increased frequency of
night—time wakening. The typical patient in this study experienced
troublesome wakenings at the rate of approximately 9 per week (mean of
around 1.3 per night — see Table 9). Unfortunately it is not possible
to compare this figure with other studies, which have defined
differently the criteria for including wakenings/arousals. Those few
psychological treatment studies which have reported on intermittent
insomnia have employed WASO (wake time after sleep onset — total
minutes awake during the night) as the dependent variable. These data
were not collected on the DSQ in this study (methodological issues
concerning the sleep diary will be dealt with later).
Psychological Disturbance
Insomniacs have been characterised as mildly depressed worriers
(Chapter 3). It was the author's clinical impression that some patients
suffered from anxiety and/or mild depressive symptoms. Clinically
depressed subjects were, of course, excluded. The average score on the
ZAS was around 38, and on the ZD6 was 41. Although no formal comparison
with anxious and depressed patients, respectively, has yet been
conducted, reference to the original papers may be useful.
Zung (1971) reported that normal control subjects obtained an average
ZAS score of 27, whereas an "anxiety disorder" group had a mean score
of 47. The insomniac group's average score of 38 is, therefore,
179intermediate and coincides with the point on Zung's distribution which
is 1 SD below the mean for the anxious group. The author has been
involved in treatment studies of anxious patients in the local
population. Lindsay, Gamsu, McLaughlin, Hood and Espie (1987) found
that pre-treatment ZAS scores for a group of 40 patients with
generalised anxiety was around 52. It would seem reasonable to
conclude, therefore, that the insomniac group experienced anxiety
levels in the mild to moderate range.
As far as ZEG scores are concerned, Zung (1965) reported that a control
group of 100 subjects scored 26 on average, whereas a depressed group
of 56 patients had a mean score of 59 before treatment. The insomniacs
in this study presented with a mean ZIP'S score of 41, which once again
is intermediate between the normal control and depressed populations.
It is also of interest to note that Espie (1986) reported an average
ZEG score of 52 at pre-treatment in a small group of obsessive-
compulsive patients who were habitual relapsers. Clearly, the subjects
in this study were not suffering from major depressive disorder but,
consistent with previous studies, they were mildly depressed relative
to the general population norm.
Selection/Attrition Issues
The 84 included subjects represented 60% of the 141 referrals received.
Detailed explanation concerning the loss of subjects was provided in
Chapter 7. In summary, half of the subject loss was due to the
operation of strict selection criteria, and half due to subjects
dropping out. Of the "drop-outs", however, considerably more than one-
third failed to attend even the first appointment. The true "drop-out"
rate amongst assessed and suitable subjects was only 17 out of 101
patients. This attrition rate is at least comparable to clinical
research studies in any field of application. As previously stated,
180"drop-outs" were evenly distributed across the experimental conditions.
It is particularly noteworthy that waiting-list subjects were prepared
to monitor and record sleep pattern for fully 10 weeks before receiving
help. Indeed, a number of individuals regarded the exercise as helpful
and informative.
In conclusion, the goal of selecting-in a representative sample of the
clinically presenting chronic insomniac population was achieved. It is,
therefore, possible to discuss the results obtained in such a manner as
to be directly applicable to routine clinical practice.
PSYCHOLOGICAL TREATMENTS - THEIR EFFECTS UPON SLEEP PATTERN AND QUALITY
In this section, the effects of the various psychological treatments
upon DSQ variables, as presented in Chapters 8 and 10, will be
discussed in some detail. Treatment conditions will be dealt with
separately under sub-headings and a summary/conclusion will be provided
for each form of intervention.
Relaxation Training
The literature on insomnia, reviewed in Chapter 5, revealed that
relaxation approaches have been the most commonly reported, partly
because relaxation preceded historically other forms of management.
Relaxation has generally had a positive impact upon initial insomnia
and it was concluded in the literature review that there was little to
differentiate amongst the range of techniques available. In this study,
perhaps the best known form of abbreviated progressive relaxation
(Bernstein and Borkovec, 1973) was used.
Subjects treated with relaxation reduced initial SQL mean by around
one-third on average, but completed therapy still taking approximately
one hour to fall asleep; an outcome similar to placebo treatment (Table
1819). Superior outcome on the SQL variable was demonstrated, however, by
both stimulus control and paradox, which achieved final week SOL scores
of 31 and 36 minutes respectively. Table 12 revealed that the within
group repeated measures effect was nevertheless significant for
relaxation (unlike placebo treatment). Treatment effects were more
consistent over time with the stimulus control and paradoxical
approaches. Statistical comparison of these between group effects
was presented in Table 11, which revealed that in spite of the apparent
advantages over relaxation of the stimulus control and paradoxical
treatments, between group differences on SQL did not generally achieve
levels of significance. The sole exception to this was at Week 1 where
stimulus control was superior to relaxation (Scheffe p < .10). SQL for
the waiting-list group increased by 14% at post-treatment which
contributed to the superiority of relaxation over no treatment during
the final therapy week (Scheffe p < .05).
In terms of sleep-onset variability from night to night (SQL SD),
reductions under relaxation therapy (around 25%) were once again modest
when compared with the two other active interventions (stimulus control
55%; paradox 70% ; Table 9). Placebo also produced changes of slightly
greater magnitude than relaxation. The advantages of relaxation appear
limited, therefore, to comparisons with the no treatment control group.
Statistical evaluations of between group comparisons revealed the
modestly significant advantages of relaxation over waiting-list at
Weeks 2, 4 and 6 (Table 11), but Table 12 revealed that the untreated
group deteriorated significantly at Weeks 2 and 4 which perhaps
accounts for these between group effects.
As far as sleep latency is concerned, therefore, the impact of
relaxation training, was comparatively limited. Improvements over time
did emerge but were somewhat erratic from week to week. Changes with
182relaxation were more similar in magnitude to placebo and both stimulus
control and paradoxical intention appear preferable although between
group effects were not statistically significant. Fluctuations towards
deterioration in the untreated control group largely accounted for the
apparent benefits of relaxation over waiting-list.
For total sleep time (TOT mean), relaxation was associated with an 11%
increment and patients completed therapy obtaining 6.41 hours on
average per night (Table 9). This outcome was comparable with each of
the other treatment conditions including placebo. Within treatment
analysis (Table 12) indicated that significant changes with relaxation
were concentrated during the final 3 weeks of therapy, indicating that
relaxation took some time to increase TOT. Comparison on this form of
analysis with the other experimental conditions, however, revealed that
improvements by other means were equally limited. Treatment x time
interaction failed to reach significance for TOT; a finding which is
supportive of the view that changes were limited and similar across
treatments.
The significant interaction main effect for TOT SD was accounted for
largely by superiority of relaxation over no treatment. Significant
effects were demonstrated at Weeks 1, 2 and 6 (Table 11). The strength
of the sub-effect at Week 6 was, however, much reduced compared with
the earlier weeks and Table 9 revealed that the magnitude of reduction
at final outcome was only around 6% with relaxation training. Treatment
effects were, therefore, extremely short-lived. Interestingly and by
comparison there was a marked reduction with paradox during Week 8
(Table 12), accounting for the 41% pre-post change score (Table 9).
As regards measures of sleep duration, therefore, relaxation-induced
changes were modest. An initial reduction in the variability of the
nightly sleep period was not paralleled by gains in TOT. Latterly,
183however, the sleep period did increase by approximately 40 minutes.
Comparisons with other experimental conditions are suggestive of
marginally greater overall benefit under relaxation although
differences are likely to be clinically negligible.
Relaxation was associated with reductions in WARE mean and WAKE SD of a
little more than 20% (Table 9). These changes were considerably less
than those for stimulus control and paradox. Within treatment simple
effects failed to reach significance for the relaxation group at the
.05 level on both variables. WAKE SD, however, did achieve an F
probability < .10 reflecting a modest reduction in variability of
wakening during the middle weeks of treatment only (Table 12). Stronger
within group effects were evident for paradox (WAKE) and stimulus
control (WAKE SD). It can be concluded that relaxation did not produce
any useful impact upon measures of intermittent wakening. The other
psychological treatments were somewhat more effective although
treatment x time interactions for both WAKE mean and WAKE SD were far
from significant (p > .40; Table 10).
In spite of the above, relatively limited, effects of relaxation upon
sleep pattern, relaxation did prove to be the best intervention for
effecting change in the sleep quality variables (Table 14). The
treatment group main effect for REPTH was accounted for by a modestly
significant difference between relaxation and placebo. This result
indicated that relaxation was associated with a greater average
reduction in pre—sleep anxiety. However, neither treatment x time nor
time main effects were significant for REPTH.
Highly significant time main effects for RESTED and ENJOY (p < .001;
Table 13) were largely accounted for by significant improvements over
time with relaxation training (Table 14). Increments in these measures
of sleep satisfaction were observed from Week 2 onwards. Stimulus
184control was not associated with any significant improvement on these
variables, and paradox achieved significant change only upon RESTED,
and only during the final three treatment weeks. Interaction main
effects (Table 13) were again, however, non—significant, indicating
that between group differences were not of sufficient magnitude to
obtain statistically significant results. Relaxation did not
significantly affect reports of daytime irritability or daytime
napping.
Conclusions Regarding Relaxation Training 
Compared with other active treatments, changes in sleep latency under
relaxation were modest. Limited changes also in total sleep duration
and wakening frequency suggest that relaxation did not have a dramatic
impact upon presenting sleep pattern. Nevertheless, patients were more
likely to be satisfied with their sleep when relaxation techniques were
applied. Relaxation appears to be the best treatment for modifying
subjective perceptions of sleep quality. There are a number of possible
explanations for the "mechanism" of effect here. Subjects may have
become less anxious about their disordered sleep and learnt to value a
state of relaxation even if not sleeping. Alternatively, relaxation
training may have enabled patients to "get more out" of the sleep which
they obtained, either objectively [eq. greater proportion of SWS
(deep sleep)] or subjectively (feeling more refreshed). Another
explanation might lie in increased coping during the daytime which, in
turn, might have fostered more positive evaluation of sleep. These
possibilities are worthy oF further investigation.
The psychological treatment literature on relaxation has generally
reported its high levels of face validity. Patients with psychological
problems often confess to "difficulties in relaxing" and the training
procedures are aimed directly at modifying this complaint. In addition,
185it is possible that the demand characteristics associated with
relaxation are somewhat different to, for example, stimulus control.
The latter technique, comprising strict behavioural instructions,
perhaps offers little which might be regarded as "therapeutic" or
"supportive". Relaxation by contrast has more general application, and
it may be implicit in the process of therapy that subjective anxieties
and concerns are likely to alter. Interestingly, paradoxical intention,
which can also be regarded as an anxiety—reduction technique, did
produce some benefits in terms of "restedness", although to a lesser
degree than relaxation training. It is an interesting possibility,
therefore, that relaxation techniques may have a greater capacity to
reduce "complaining behaviour" even though other psychological methods
are superior in improving actual sleep pattern. This is a matter to
which reference will be made at a later point.
Stimulus Control
Past research has marginally favoured stimulus control over other
behavioural treatments. In the present study this treatment emerged
without doubt as the best approach for reducing SQL mean scores.
Stimulus control was associated with a 62% reduction in sleep latency,
with patients completing therapy requiring approximately 31 minutes to
fall asleep. This improvement represented an absolute reduction of 51
minutes, which was substantially greater than with any other condition
(Table 9). Inspection of Table 12 revealed that dramatic reduction in
SOL was an immediate phenomenon and was maintained from Week 1 until
the end of treatment. Indeed, of all the variables investigated under
any treatment condition, changes in SQL by means of stimulus control
were the most statistically powerful. The highly significant
interaction effect reported in Table 10 referred, almost exclusively,
to the consistent superiority over time of stimulus control relative to
186other forms of intervention (Table 11). In particular, stimulus control
emerged as superior to no treatment throughout the experimental period.
Superiority over placebo control, and also over paradox presented
strongly at first, although this waned during the middle weeks of
therapy, and was absent from Week 6 onwards. The overall treatment
group main effect confirmed that the major differences were between
stimulus control and no treatment (Scheffe p < .05), and between
stimulus control and placebo (Scheffe p < .10). There is no clear
reason for the non—significant between group effect at Week 4 (Table
11).
It is evident from the results on SQL that stimulus control represents
by far the most cost—effective approach to reducing sleep latency.
Although 8 weeks of treatment were provided there was little additive
effect on this variable from the second week onwards. By comparison,
although substantial changes emerged with paradoxical intention these
were not significant until Week 4.
Reductions in SQL SD were also associated with stimulus control
treatment. Changes from pre to post—treatment approached 55% (Table 9),
greater than any treatment other than paradox. Improvements over time
on SQL SD emerged at Week 1 for the stimulus control group although
strongly significant effects were obtained only at Week 3 and from Week
6 onwards (Table 12). Consideration of between treatment effects
revealed that stimulus control was superior to waiting—list at various
points from Week 2. The magnitude of effect, however, was generally
less than that of paradox versus no treatment (Table 11).
The stimulus control instruction to refrain from going to bed until
"sleepy tired" may be, however, a virtual guarantee of reduced SQL.
Assuming that patients generally stayed up later rather than went to
bed earlier, they would be automatically excluding from estimates of
187SOL, that period of time which extended beyond "usual bedtime" at
baseline. In other words patients may have been falling asleep quicker
simply because they were going to bed later, at which time they were
more tired. Measures of sleep latency should, therefore, be
investigated in parallel with measures of the duration of the sleep
period.
Inspection of Table 12 revealed that increments in TOT mean were not
achieved under stimulus control until the final two weeks of therapy.
Indeed Fig 6 indicated that there was an average tendency towards
reduction in total sleep especially during Weeks 3 and 4, and not until
Week 5 did TOT demonstrate any marked improvement over baseline. It
seems possible, therefore, that the mechanism of action of stimulus
control involves initial and dramatic SOL reduction in association with
restriction of sleep duration. Thereafter overall sleep pattern change
does develop. It may be partly through this element of sleep
"deprivation" that the sleep pattern later develops a strong and
predictable rhythm. The immediate effectiveness of stimulus control in
terms of SOL is, therefore, limited by latent impact upon sleep time.
It seems likely that patients would require to remain in therapy until
these effects are demonstrated, rather than simply going by reports of
SOL.
According to Table 9, stimulus control was associated with a greater
than 50% reduction in WAKE mean and a reduction of 76% in WARE SD. In
spite of these apparently large improvements, however, within treatment
effects (Table 12) failed to demonstrate any significant repeated
measures effect for WARE mean, and the significant result (p = .03) for
WAKE SD was accounted for mainly in the highly significant reduction at
Week 8. These results also may be suggestive of the later readjustment
of sleep pattern after perseverance with stimulus control therapy.
188Stimulus control made no impact upon any of the sleep quality variables
and in this respect compared unfavourably with the other active
treatments. This is a surprising result given the evident improvements
in sleep pattern associated with the treatment. Clearly the
relationship between actual sleep pattern and qualitative measures is
an uncertain one, highlighted particularly by the diverse effects of
relaxation and stimulus control. With relaxation, qualitative
improvements were reported in the relative absence of pattern change,
whereas with stimulus control, substantial sleep pattern improvement
was unaccompanied by qualitative change. It would be useful at this
point to develop further the tentative model introduced in the
preceding section.
It seems feasible that progressive relaxation is associated with an
anxiety reduction/ subjective change locus of intervention whereas the
stimulus control approach fits in better with a didactic/sleep habit
change model. Stimulus control offers no advice on anxiety—management.
Indeed, subjects are not encouraged by the treatment to consider
qualitative aspects as relevant variables for change. The advice given
may be, in fact, less than neutral as regards subjective concerns since
patients are required to focus entirely upon overt behaviour. Stimulus
control may be envisaged, therefore, as a component of a broader
didactic approach where patients are educated about normal sleep
pattern, the importance of strong habit formation, and the facilitation
of normal sleep pattern restructured within suitable boundaries. Of
course a didactic approach should, in itself, be anxiety reducing in so
far as it provides accurate information to modify inappropriate
attitudes and beliefs. In the present study, however, "didactic
treatment" was not specifically applied, but rather such elements of
information as seemed appropriate were given to subjects along with
whatsoever form of intervention. The usefulness of the didactic
189approach will be further discussed later.
Conclusions Regarding Stimulus Control 
The effects of stimulus control upon measures of sleep latency were
impressive, both in terms of immediacy and magnitude of impact. There
was some evidence to suggest, however, that gains on these measures
were associated with an initial reduction in sleep duration, probably
due to a delayed bedtime and to the anchored rising time affecting
opportunities for "catching up" on sleep loss. Latterly, however,
patients in this group did sleep significantly longer than at baseline.
Habit-restructuring perhaps takes some time to achieve. Therefore, it
may be premature to regard stimulus control as effective solely on the
basis of, albeit dramatic, early SOL reductions. Because of the absence
of change via stimulus control on measures of restedness and sleep
enjoyment there may be limitations to the treatment's applicability. It
appears crucial to identify predictors of help-seeking for insomnia. If
complaints are based upon lack of restedness for example, then stimulus
control is likely to miss the mark. A more broadly-based didactic
treatment will be proposed at a later point in order to address this
critical clinical issue.
Paradoxical Intention
Paradoxical intention has only recently been adopted into the
behavioural literature. Available studies have produced rather
conflicting evidence regarding its usefulness (see Chapter 5). It is,
therefore, of particular interest to consider its effectiveness within
the clinical population in the present study.
In terms of SOL mean, patients in the paradoxical intention group
completed therapy taking an average of 36 minutes to fall asleep. This
outcome figure is similar to that of stimulus control, although the
190percentage reduction over baseline was somewhat less (51% compared with
62%) because of the lower baseline SQL scores in the paradoxical group.
Nevertheless, paradox was clearly superior to relaxation and to both
control groups on a simple pre—post analysis (Table 9). Inspection of
Table 12 revealed that significant reductions in SQL were obtained from
the fourth week of treatment. These improvements appeared both from
this Table and from Fig 4 to be highly consistent during the last 5
weeks. In spite of the relatively low SQL scores during these latter
weeks and the significant within group repeated measures effect (p
< .02; Table 12) between group testing revealed that improvements via
paradox never achieved levels significantly superior to waiting—list
procedure. Possibly this was due to the lower baseline values in the
paradoxical group leaving less room for change.
It is interesting that in the short—term paradox did not produce
significant improvement. Indeed, Table 11 revealed that stimulus
control was superior to paradox, particularly during the first 2 weeks
of treatment. Inspection of Fig 4 suggested that the impact of paradox
was delayed for a number of weeks although scores during the final
weeks were similar to stimulus control. One clue to a potential
explanation for the delayed effect can be gleaned from the study by
Espie and Lindsay (1985). These workers reported on several case
studies and commented upon the variability in therapeutic response
evident with paradox, particularly during the early weeks of treatment.
It seemed from the data presented that some subjects experienced
initially exacerbated SQL whereas others improved rapidly. It seems
possible, therefore, that there are differing modes of response to the
paradoxical treatment.
In order to consider further this possibility, treatment effects during
the first 2 weeks were examined for each of the active conditions. The
191results of this simple analysis are presented in Appendix L
[Table (xxi)]. Inspection of these data indicate that, in 6 cases
treated by paradox, significant increments in SOL occurred during early
therapy (an increment of at least 33% was regarded as substantial).
Exacerbation of at least similar magnitude was, by comparison, found in
only 2 relaxation treatment cases and there were none in the stimulus
control group who deteriorated significantly. Although these data can
only be considered as suggestive, it seems that paradox has the
potential to exacerbate initial insomnia in a manner which the other
approaches do not.
Espie and Lindsay (1985) have already outlined a number of possible
explanations for the diversity of therapeutic response with paradox but
these are worth reiterating here. Firstly, the instruction to remain
awake may be followed literally by some patients, thereby temporarily
increasing SQL. Paradox does not provide specific advice on how to
avoid "effort to sleep", therefore, some subjects may refocus
performance anxiety into an "effort to remain awake", perhaps employing
sleep-incompatible imagery to ensure waking cognition even when
physically relaxed. This may account for some subjects reportedly
finding it "too easy" to remain awake.
A second explanation stems from the possibility that counterdemand
instructions may be interpreted as literal demands to report no
improvement, amounting therefore to a development of paradoxical
strategy. Patients may wish to achieve the experimenter's apparent
criterion of success.
Thirdly, some patients may be predisposed to respond adversely to
paradox. Those who present with severe intrusive thinking may find that
paradox encourages their state of cognitive alertness. Conversely,
those patients who can readily identify with "effort to sleep" and who
192can successfully avoid that effort without undue arousal will respond
best. Unfortunately, the tailored group in the present study included
only two patients selected to receive paradoxical instruction,
therefore, comparison of random and tailored assignment, specifically
in relation to paradox, was not possible.
Clearly further studies are required to address the merits and demerits
of these explanations. Clinically, however, therapists ought to be
aware of the potential for albeit temporary exacerbation of SOL under
paradoxical intention. Furthermore, it is self evident that the more
severe the initial insomnia the more troublesome will be deterioration
with any therapy.
Paradoxical intention was perhaps the most effective treatment for
reducing SOL SD. A 70% pre—post reduction was obtained (Table 9),
greater than even that of stimulus control. The within treatment simple
effects (Table 12) revealed consistent and highly significant
reductions from the second week of treatment onwards. These effects
were also reflected in between group testing (Table 11) where paradox
was superior to no treatment across the experimental period. Paradox
was not superior, however, to any other treatment group. It should be
noted that reduction in sleep latency variability refers to raw score
variance (night to night variability) for any one subjct and is not,
therefore, at odds with the argument above of variability, across
subjects, in terms of initial treatment response. The fact that SOL SD
reduced	 prior	 to SOL mean hints	 at	 modification	 to
predictability/stability in sleep latency occurring as a prelude to
latency reduction per se. This may be because paradox operates more
quickly upon "deviant" nights to "normalise" them before reducing that
norm itself.
Similar to the other treatments the effects of paradox upon the
193duration of sleep were limited. Percentage gains in TOT were comparable
with other forms of intervention (11.8%; Table 9), although the within
treatment effect did not achieve significance (Table 12). Nevertheless,
inspection of the mean scores for TOT in Fig 6 do suggest a modest
gradual increment, especially during the latter weeks. On average,
patients finally slept for 42 minutes longer than at baseline.
The 41% reduction in TOT SD associated with paradox (Table 9) was
clearly a final week effect (see Table 12). The repeated measures
analysis failed to achieve significance at the .05 level.
Paradox was the only treatment to achieve a significant time within
treatment simple effect (p = .011) for WAKE mean. It did so
consistently from the fourth week of treatment although the post —
therapy change score was little different from that of stimulus
control. The demonstration of improvement over time with paradox does,
however, suggest that this is a fairly reliable treatment benefit.
Interestingly, however, no parallel changes in WAKE SD were achieved.
Paradoxical intention significantly improved the level of restedness
associated with sleep, during Weeks 6, 7 and 8 (Table 14). Parallel
improvements in ENJOY, however, were not demonstrated and there were no
significant reductions in REPTH or IRRIT. Daytime napping was modestly
reduced during Week 8 only, and the repeated measures effect failed to
reach significance at p < .05. As suggested earlier, it is possible
that the more closely treatments approximate to anxiety—management
models, the greater will be the change in subjective/qualitative
ratings. Paradox was not as effective in this respect as relaxation
training, although it appeared to be superior to stimulus control. Once
again, however, between group effects at no point reached significance.Conclusions Regarding Paradoxical Intention 
Paradox produced significant reduction in sleep latency when the group
was considered as a whole. Initial individual responses, however, were
found to vary and persistence with treatment was crucial for ultimate
benefit to be obtained in some cases. It seems important to assess the
potential for exacerbation of SOL with this treatment. Predictors of
such a response may be extreme performance anxiety, and/or the use of
counterdemand or other instructions which might occasion an overly
literal understanding of the paradoxical prescription. There may be a
subtle clinical skill involved in paradox; to encourage subjects to
remain awake but yet not to become actively aroused. The ideal may be a
"passive" avoidance of sleep—onset. Reductions in nighttime wakening
with paradox are encouraging and worthy of further investigation.
In terms of the proposed model, paradoxical intention may be regarded
as intermediate in that it can be construed as both anxiety—reducing
and habit—restructuring in its mode of action. It was the only
treatment to modify both sleep pattern and sleep quality variables to
any marked extent. For the former, absolute improvements (ie. at final
week) were as great as those for stimulus control although between
group testing favoured stimulus control (compared with the control
conditions). For sleep quality, improvements were not as great as with
relaxation, although both relaxation and paradox were superior to
stimulus control.
Tailored Therapy
Designing treatments to match individual presenting characteristics
appears clinically to be eminently sensible. Comparative outcome
studies, however, have not evaluated the tailored approach. The results
from this study are, therefore, of particular interest.Table 23 revealed that the results of tailored therapy were generally
disappointing. A mean pre-post score reduction of approximately 35% for
SQL mean compared unfavourably with the total random therapy group
(49%), and even less favourably with the most effective randomised
treatment (stimulus control; 62%; Table 9). In absolute terms tailored
treatment was similar in effectiveness to placebo and relaxation, and
SQL remained some 20-25 minutes greater than paradox and stimulus
control at post-treatment. Pre-post change scores were not
significantly greater under tailored therapy than with no treatment on
a simple (non-repeated measures) ?NOVA (Table 24) and time within
treatment simple effects for SQL indicated little systematic change
over time (Table 25).
Outcome for SOL SD was also unimpressive. Reductions of under 30% again
paralleled the results obtained for placebo and relaxation, and
amounted to less than half that of stimulus control and paradox (Table
23 cf. Table 9). The within treatment repeated measures analysis failed
to achieve significance at any point across therapy.
Improvements in TOT mean were, however, greater in percentage terms
with tailored treatment than with any other condition. A 15% increment
was obtained pre to post-treatment (Table 23) compared with a range of
9-12% for the 3 individual psychological treatments (Table 9). Time
within treatment analysis revealed modest gains emerging consistently
from Week 2 onwards. Baseline TOT was, however, significantly lower in
the tailored group, and in absolute terms the gains in sleep duration
via the various approaches were similar to within a few minutes. Pre-
post change was not significantly different between any pair of
conditions (Table 24).
TOT SD reduced by 26% under tailored therapy (Table 23) but there was
no between or within group significant effect. The above benefits in
196sleep duration were not paralleled, therefore, by increased stability
in sleep length over time.
Tailored therapy was the only treatment to effect significant change
over time in both of the WAKE variables (Table 25 cf. Table 12).
Reductions greater than 45% were achieved on both WAKE mean and WAKE SD
(Table 23), with significant improvement emerging at around Week 4.
Although between group effects proved to be non—significant, these
results were encouraging for the tailored approach.
It was particularly surprising to find that tailoring of treatment was
associated with minimal change on all measures of sleep quality. In
circumstamces where intervention arguably should be regarded by
patients as highly valid one might expect much greater subjective
change. However, the results suggested the converse. Random allocation
produced greater qualitative improvement, especially so for the
relaxation and paradoxical treatments (Table 25 cf. Table 14).
Conclusions Regarding Tailored Therapy 
Tailoring conferred little added benefit to random treatment comprising
the same active psychological treatments. The sole exception to this
statement might be in terms of wakening frequency and predictability
since only tailored treatment reduced both of these variables. For the
remaining variables, both quantitative and qualitative, one or other of
the three active treatments emerged as preferable. Although these
between group differences failed to achieve statistical significance
there can be little doubt that stimulus control, for example, given at
random is more likely to reduce SOL mean than is even a carefully
constructed individual programme comprising less effective techniques.
The same could be said for relaxation in relation to measures of sleep
satisfaction. In other words, to the extent that tailoring strayed from
providing the most effective treatment technique it represented a
197dilution of therapeutic effect. It must be concluded, therefore, that
the locus of prediction for treatment outcome lies more within the
power of the techniques per se than within individual presenting
characteristics. Finally, it should be noted that the tailored therapy
condition included 4 patients (out of 14) who were treated with
"cognitive restructuring" methods since these appeared (from SDQ
analysis) to be positively indicated. Such an approach has seldom been
adopted in the management of initial insomnia, and with hindsight it
may have been better to limit the tailoring to the three interventions
employed in the main study. Examination of the raw data indicates that
stimulus control patients in the tailored group responded better than
the remainder, and that relaxation and cognitive restructuring patients
did relatively poorly. It seems justifiable to conclude that tailoring
is simply a watering down of the best therapeutic techniques. Perhaps
tailoring which is based upon stimulus control principles plus
additional elements as required would present a more powerful tailoring
option.
THE ISSUE OF CLINICAL VERSUS STATISTICAL SIGNIFICANCE
Prior to dealing critically with some important methodological issues
and formulating general guidelines for good clinical practice, it would
be useful to consider the question of clinical significance. This
section will review the evidence for the clinical utility of the
results so far presented and discussed.
Most straightforwardly, the results obtained in this study are
directly relevant to the clinical population. There is no problem of
generalizability and the results are valid against the presenting
criterion of clinical need. In this sense the results are of clinical
significance. Several other sources of evidence regarding clinical
significance may also be examined.
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Although the principal database (the DSQ) was of the self—report type,
objective monitoring by means of the "Somtrak" SAD confirmed previous
work in establishing the validity of self—report as a relative index of
delayed sleep—onset. Indeed, the accuracy of self—report against the
SAD standard was remarkably high given the difficulties inherent in
estimating lengthy SOL (Table 6). Estimates of sleep duration were very
similar to SAD recordings. Measures of intermittent wakening were, as
expected, discrepant due to the differing criteria in operation for
self—report and time—sampled monitoring. Since the DSQ measures were
thus corroborated, the results from the study can be regarded with
confidence as being relatively free from reporting artefact.
Table 6 also presented DSQ/SAD sleep pattern scores which confirmed
treatment induced changes across the experimental phases in this
randomly selected group of patients. SOL as measured by the SAD reduced
from 94 minutes at baseline to 33 minutes in the final weeks of
therapy, TOT increased from 4.76 to 6.39 hours, and %AYE reduced from
1.93 to 0.82 nightly wakenings. SAD recordings, however, were made of
different subjects across phases and these results, therefore, do not
reflect a repeated measures model. Nevertheless, SAD scores were
consistent with the results obtained on the DSQ in the main study when
psychological treatments were applied.
It was also possible to calculate from SAD records a measure of sleep
efficiency for each phase of the experimental period (sleep efficiency,
expressed as a percentage, refers to the proportion of time asleep in
relation to total time spent in bed). At baseline, average sleep
efficiency was 68% (SD 21.3). This rose to 78% (SD 17.4) during the
first four weeks of treatment and to 88.5% (SD 6.8) during the final
treatment phase. This steady increase in efficiency, accompanied by the
199reduced variance (SD), is also indicative of clinically significant
improvement. Sleep efficiency less than 85% is a widely accepted
criterion of significant sleep disturbance. Patients in this study,
therefore, appear to have completed therapy with sleep patterns which
fell within normal limits. During the course of treatment, SAD measures
of efficiency shifted from the significantly deviant/clinical into the
normal/sub-clinical range.
Evidence from Follow Up Data
Data presented in Chapter 9 confirmed that treatment-induced changes in
sleep pattern and quality persisted during the follow-up period without
significant relapse (Table 15). Improvements were maintained, not only
in the relatively short-term, but also up to 17 months post-treatment.
These later follow-ups in particular are of outstanding clinical
importance since they point to the enduring benefits available via
psychological management. Where chronic clinical complaints are
concerned early evaluations of maintained gains are likely to be of
limited value, and are not necessarily predictive of longer-term
prognosis. No previous insomnia treatment study has attempted to gather
such a large body of follow-up data so long after the end of treatment.
The encouraging long-term outcome, therefore, adds very substantially
to the clinical applicability of the psychological procedures. This is
especially so since, in many cases, conventional medical management had
been of only transient benefit.
In presenting the evidence on behalf of prolonged effectiveness it is
recognised that some patients resumed medications, particularly where
dependence had been problematic and a formal withdrawal programme was
required. Tables 19 and 20 recorded 4 out of 10 such patients as
resuming drugs after a number of months. Patients' self-report from
those who had lesser problems with dependence suggested that less than
20010% resumed at least occasional use of drugs. More objective data on
post-experimental period drug use were not always available to the
author. Where possible, GPs were asked to corroborate patients' reports
of being drug-free, but in some cases patients may have had access to
stored supplies of hypnotics which had not been recently prescribed by
the GP. Short of random blood-testing it is impossible to be
certain about the reliability of self-report given that there may be a
tendency for social acquiescence towards non-reporting of drug intake.
During the experimental period itself much stricter (although probably
not absolute) control was of course feasible. Regular contact and
accurate information regarding the effects of sleeping-pills upon
sleep, along with the precondition of control over the supply of pills
to be exercised jointly by the GP and the author, probably minimised
the unsanctioned use of medication.
Follow-up return rates in the range 56-77% compare well with other
psychological treatment studies and permit reasonable confidence in the
positive conclusions outlined above. There is of course the possibility
that relapsers might have been less likely to return follow-up
assessments, in which case the results obtained would be an
overestimate of maintenance effects. This is a problem confronting all
research studies which rely upon solicited progress reports. Taking
these potential limiting factors into account, however, the
consistently positive findings, over 4 follow-up times and across all
variables and treatment conditions, remain impressive. The follow-up
data are strongly supportive of the clinical worth of the various
psychological procedures.
Measurement of Clinical Change
There has developed in recent years (since Bergin and Strupp, 1972) a
considerable literature reflecting the concern of some practitioners
201that strictly "scientific" analyses fail to tackle material of clinical
importance. As Barlow (1981) has put it, "At present, clinical research
has little or no influence on clinical practice" (p 147). Jacobsen et
al (1984), in reviewing the question of statistical versus clinical
significance, have made two major criticisms of psychotherapy outcome
data reporting. Firstly, statistical comparisons between experimental
conditions are generally based on average improvement scores which
provide no information on therapy changes for individuals; and
secondly, "significance tests" impose criteria for determining
treatment effects which often have unestablished clinical relevance.
Hence studies may either overestimate or underestimate the clinical
significance of the results obtained.
As outlined in Chapter 6 a number of approaches for testing for
clinical significance have been suggested. Kazdin (1977) has argued
that a change in therapy is clinically significant when the patient
moves from the dysfunctional to the functional range on whatever
variable is used to quantify the clinical problem. With such a
"distributional" model, it should be possible to deduce the relative
proportion of subjects who return to normal funtioning after
intervention. This approach does of course presuppose that normative
data are available to establish cut—off points for the functional and
dysfunctional distributions.
An alternative approach has been to determine the proportion of
subjects who improved at post—treatment and to compare with the
proportion who did not improve. This tackles the issue of individual
variability in response. Some workers have further categorised
improvement eg. "markedly", "moderately", "slightly" (Hand et al, 1974;
example quoted in Jacobsen et al), and others have defined significant
improvement as a change over baseline of greater than 50% (eg.
202Lichstein and Fischer, 1985).
In the present study it was decided to apply some of the above criteria
to evaluate clinically significant change on the variable SOL mean.
This variable was selected since it is generally accepted in the
literature that SQL less than or equal to 30 minutes is an appropriate
cut—off point for normal functioning. For measures of TOT and Vaa
there is no such accepted convention. Also these latter measures tend
to be age—related making calculation both complex and spurious.
Appendix L [Table (xxii)] contains raw SOL data for subjects in the
relaxation, stimulus control, paradoxical intention, and tailored
therapy conditions, during baseline and at the final therapy week and
presents an analysis of clinical significance according to each of the
three following criteria:—
1. Proportion of patients achieving absolute (ie. any) reduction in
SQL magnitude at post—treatment
2. Proportion of patients achieving SQL reduction of at least 50%
3. Proportion of patients achieving final SOL less than or equal to 30
minutes
Table 27 below presents a summary of the results from Table (xxii) and
permits comparison of the clinical impact of the various psychological
treatments.
Treatment 
	
Absolute Reduction 50% Reduction  SQL <= 30 Minutes 
Relaxation
	
71%
	
21%
	
7%
Stimulus control
	
100%
	
64%
	
71%
Paradox
	 80%	 47%	 40%
Tailored therapy
	 71%	 50%	 43%
TABLE 27 Proportion of subjects in each of the active treatment
conditions achieving SQL reductions of clinical significance according 
to three criteria 
203Consistent with the results presented after statistical analysis
(Chapter 8), stimulus control emerged as the most effective treatment
according to all three criteria. Every patient improved to some extent
and almost two-thirds reduced SOL by greater than half. Seventy-one
percent also achieved sleep latencies of 30 minutes or less at post-
treatment. Paradox by comparison was less considerably effective on
each measure. Only 40% achieved the 30 minute SOL cut-off. Relaxation,
however, compared even less favourably. Only around 20% of patients
managed to halve baseline SOL after eight weeks of treatment, and only
1 patient (7%) achieved the 30 minute criterion. Almost 30% of patients
failed to improve at all at post-treatment with relaxation. Clearly
relaxation was clinically useful as a means of reducing sleep latency
for only a minority of cases.
The results for the tailored group are particularly interesting.
Chapter 10 presented various statistical analyses from which tailored
therapy emerged as a poor treatment option. It compared unfavourably
with both stimulus control and paradox and appeared to be no more
effective than the relaxation and placebo groups. The results presented
in Table 27, however, are rather more supportive of the tailored
approach. Although only 71% of cases demonstrated improvement, a
relatively high proportion of those who did improve achieved the
criterion of 50% SOL reduction. For the sake of comparison, all 14
patients improved under stimulus control, 9 of whom achieved 50% SOL
reduction; only 10 tailored therapy cases improved, but of these 7
achieved 50% improvement. The problem with tailored therapy appears to
be that 30% (4 patients) did not improve at all, and this effect
contributed to the comparative ineffectiveness of the treatment in
statistical terms. Forty-three percent of tailored cases achieved final
SOL of 30 minutes or less which was both absolutely and relatively
superior to paradox, and again compares favourably with stimulus
204control once non-responders are accounted for.
The four non-responders were treated as follows. Two received
relaxation, one received paradox, and the fourth received cognitive
restructuring. It seems likely, therefore, that as previously
suggested, treatment response was largely dictated by the power of the
treatment applied. Tailored therapy was indeed tantamount to a watering
down of the most effective interventions for SQL reduction.
Nevertheless, clinical outcome was good for almost half of the
patients, slightly better than for paradox, but somewhat less than for
stimulus control.
The Generalised Benefits of Treatment
Chapter 9 presented analyses of various pre-post measures in order to
consider the generalised changes which were associated with each
treatment approach. Significant improvements on measures of anxiety,
mood and daytime performance clearly contribute to the clinical value
of treatments for insomnia. These generalised effects will be
discussed under a number of headings.
Anxiety State 
In keeping with the hyperarousal model of aetiology it might be
anticipated that successful treatment of insomnia would be associated
with reduction in physical and/or cognitive measures of anxiety. In
this study, the ZAS was employed to assess this area of functioning and
certain items from the ?RS were also relevant to the assessment of
anxiety. Tables 16 and 26 presented pre-post data on the ZAS revealing
that all experimental conditions (excepting waiting-list) were
associated with a reduction in mean ZAS scores. Paradox produced the
greatest absolute reduction, and similar to tailored therapy, change
was moderately significant (p <= .02). Rather surprisingly, however,
205relaxation training did not yield statistically significant change on
the ZAS although mean score change was as great as that of the tailored
approach. Greater variability around mean values rendered the overall
effect non—significant. Placebo was associated with a modestly
significant reduction in anxiety state on this measure.
It has been proposed that relaxation and paradox may follow an anxiety
reduction/subjective model whereas stimulus control represents a habit
restructuring/behavioural approach. It is in keeping with these
proposals that stimulus control failed to demonstrate significant ZAS
reduction and that paradox did produce significant change, not only on
ZAS, but also a significant increase in "confidence" (ARS 10) at post-
treatment. Relaxation, however, would also be expected to modify
anxiety state. Had patients been trained in the application of
relaxation as a daytime coping strategy then perhaps changes would have
emerged which were more consistent across patients and more substantial
in magnitude. Nevertheless, relaxation was the only treatment to
reduce significantly reports of "worrying" (ARS 2). Improvements in
anxiety state were also obtained with tailored therapy. Given the
relatively high proportion of anti—anxiety treatments (relaxation,
paradox, cognitive restructuring) compared with habit retraining
(stimulus control) this result is also consistent with expectation. The
small but significant reduction in ZAS score with placebo treatment may
be accounted for in that the rationale underlying placebo was that of
desensitisation, and although no active ingredients were included,
practice sessions occurred in the early evening, perhaps explaining the
small impact upon daytime anxiety state.
In terms of clinical utility, therefore, it was encouraging to note
that generalised anxiety reduction may accompany psychological
treatment for insomnia. The magnitude of change was, however, limited,
206partly reflecting initial levels of only mild to moderate anxiety
disorder in this population.
Mood Disorder 
All three active treatments in the main study were associated with
highly significant (p < .01) reductions in ZDS scores (Table 16).
Neither placebo nor waiting—list control groups changed significantly.
A three point reduction for tailored therapy failed to achieve
significance on statistical testing (Table 26). The findings for the
active treatments are encouraging. None of the patients in the study
were undergoing, nor did they require, specific treatment for
depressive illness. Levels of symptomatology were at the mild end of
the clinical range. It seems untenable, therefore, that recovery from
"depression" could be responsible for observed improvements in sleep
measures. Rather it is probable that these mood improvements were
consequences of the successful treatment of sleep disorder. It seems
justifiable to regard the insomnia as primary and these mild depressive
symptoms as secondary; the latter improving in relation to reduced
sleep difficulty. The author would stress that there is no assumption
being made here that, where insomnia and depression coexist, the
insomnia should ordinarily be tackled as primary. Simply, in
circumstances where mood disorder is mild and insomnia severe and
chronic it seems clinically sensible to treat the insomnia and expect
mood to somewhat improve.
In spite of the ZDS changes it is noteworthy that certain ARS items
relevant to mood (ARS 5 "irritable"; ARS 6 "downhearted/sad"; ARS 8
"warm and affectionate") did not change significantly with any form of
intervention. Possibly overall ZDS reductions were influenced by
changes in those items bearing an obvious relationship to sleep pattern
(eg. 4, 10, 13; see Appendix F). Item by item analysis, however, was
207not conducted since it was not regarded as of central importance.
Daytime Functioning 
Measures of daytime performance and coping were included in the ?RS.
Once again the three psychological treatments in the main study were
associated with significant reductions in total ARS score, indicative
of general improvement in global functioning. Both the tailored therapy
and placebo groups also improved, but not significantly, and the no
treatment group deteriorated slightly (see Tables 16 and 26). All
interventions (excluding no treatment) improved ratings of "sleeping
well" (ARS 9), with active treatments achieving probability levels
p < .01, and placebo p < .05. Relaxation was associated with the
greatest spread of improvement when specific ARS items were considered.
In addition to the reduction in "worrying" already mentioned, a
significant improvement in "coping with work" (ARS 3) and a highly
significant increment in "concentration" CARS 7) were achieved. These
findings are in keeping with the other qualitative reports of these
patients that they were more rested after their sleep. The only other
positive ARS item change was the modest increase in "confidence" CARS
10) associated with paradoxical intention. The other ARS items failed
to discriminate change although the untreated control group did report
being slightly less "energetic" (ARS 1) at the end of the experimental
period.
The daytime improvements outlined above are of obvious practical
importance. However, given that insomnia is usually defined as an
inability to obtain adequate sleep (that is, adequate in relation to
daytime needs), greater change might have been anticipated, and with
all of the active treatments. There are two possible reasons for the
failure to demonstrate more broadly-based changes. Firstly, the concept
of "adequacy of sleep" is a subjective one, and perceived daytime needs
208may be realistic or otherwise. Undoubtedly there are insomniacs who are
dissatisfied with the sleep period per se, regardless of its
relationship to the daytime. Equally, others may make unreasonable
demands of their sleep in terms of resolving daytime problems for which
more highly developed problem—solving skills are the appropriate
solution.
Secondly, the measures of daytime functioning in the present study were
perhaps not sufficiently sensitive or specific, adequately to assess
changes. Global pre—post measures do not pick up the specific
relationship between sleep pattern changes and daytime correlates.
Also, there were no daytime performance measures included in the DSQ
(eq. tiredness, concentration) and the only measure of daytime mood
(irritability) did not discriminate between or within groups.
A number of methodological improvements will be suggested in the
section to follow.
.	 Pre—bedtime Behaviour Pattern 
As expected, stimulus control was the only treatment to significantly
reduce SBRS scores, doing so to a greater extent than any other form of
intervention (Table 17). The SBRS, therefore, proved to be a sensitive
and useful clinical instrument for use in relation to habit—
restructuring. The fact that other effective treatments (eq. paradox)
demonstrated minimal reduction in sleep—incompatible behaviors at post-
treatment does, however, challenge the assumption of the operant model
that stimulus factors dictate sleep pattern. Indeed, the behavioural
change evidenced on the SBRS under stimulus control by no means proves
that these changes were responsible for the treatment effects.
Conclusions Regarding Clinical Significance 
Results based upon self—report data were corroborated by the SAD
209validity study. Objective records confirmed that significant sleep
pattern changes emerged, resultant from psychological treatment. Sleep
efficiency increased by around 20% and the insomniac sub-group in the
"Somtrak" study obtained final sleep patterns which were within the
efficiency range of the normal population.
Lengthy follow-up data established that the effects of psychological
treatment were persisting and, therefore, of considerable practical
clinical impact. Relapse towards drug-use was a recognised problem in
only a small percentage of cases, although where withdrawal had proven
particularly difficult there was a greater likelihood of post-discharge
drug use. The lack of methodological control over drugs during follow-
up may be a limiting factor to interpretation of the data. Long-term
outcome was, nevertheless, very encouraging.
Statistical tests may not yield clinically meaningful results. Analysis
of clinical significance according to three criteria confirmed the
clinically significant impact of stimulus control in at least two-
thirds of cases. Paradox was effective for less than 50% of subjects
according to these criteria, and relaxation emerged very unfavourably
at 20% or less. Tailored therapy, however, was certainly as clinically
effective as paradox and considerably more so than relaxation. These
results conflict with the statistical analyses of Chapter 10 where
group average responses for the tailored condition were deflated by a
non-responsive sub-group. It seems that tailoring therapy may indeed be
useful clinically with the proviso that the procedures considered for
tailoring are of attested merit.
Treatment-related improvements were not confined to sleep pattern or
reports of sleep quality. Psychological treatments significantly
reduced levels of depressive symptomatology, and anxiety reduction (on
either ZAS or ABS scales) was a feature of treatments other than
210stimulus control. The latter treatment was associated with marked
behavioural pattern change prior to bedtime. Measures of daytime
functioning require attention in order to evaluate adequately the
correspondence between nighttime and daytime measures. Nevertheless,
relaxation in particular appeared to afford patients generalised
benefit in terms of concentration and work performance.
SOME IMPORTANT METHODOLOGICAL ISSUES
Issues of Experimental Control
Reference has already been made to the very satisfactory compliance of
patients in the waiting-list group, in spite of minimal contact. Some
previous studies have, however, required subjects to submit monetary
deposits (refundable upon good data recording) and to send in sleep
diaries by postal return in order to ensure compliance. The author
would suggest that there were two critical issues in this study which
were predictive of compliance. Firstly, specific training in record-
keeping was essential. Patients are much more likely to want, and to be
able, to comply with a task which is unambiguous. A training period
helps to define for subjects what are the basic criteria for self-
monitoring, and gives constructive feedback on performance. Secondly,
patients who are highly motivated are much more likely to comply. This
may seem very obvious, however, studies which have employed solicited
subjects may have to rely heavily upon external controls (eg. deposits)
to maintain motivation. By contrast, spontaneously presenting patients
demonstrate motivation through their help-seeking actions. The subjects
of this study being chronic insomniacs appeared capable of both
patience (being long-term sufferers they did not generally expect or
demand immediate "cure") and perseverance (they were prepared to follow
instructions for the sake of longer-term benefit).The results for the untreated group demonstrated unequivocally that
spontaneous remission did not account for treatment effects in the
present study. Such slight changes over time as did emerge in fact
tended towards deterioration (Tables 9, 12, 16). Figs 4-9 suggested
a degree of instability over time in this group's sleep pattern which
is perhaps supportive of the view that variability is a "normal"
function for sleep—disturbed groups and, as proposed in Chapter 2, this
may contribute to subjective dissatisfaction with sleep.
Subjects in the waiting—list group did not re—enter the study for
active treatment since it was felt unreasonable to require them to
complete a further, lengthy experimental protocol. All patients did,
however, receive psychological treatment on an individual basis, in
many cases via stimulus control since this emerged as an effective
approach. Data have not been presented on these treatments since there
was no uniformity of approach. Formal analysis, therefore, was not
attempted.
Patients in the quasi—desensitisation placebo group regarded the
treatment rationale as a credible one, and no less so than the active
psychological interventions. This finding is consistent with previous
studies which have employed this placebo strategy (eg. Turner and
Ascher, 1979a; Lacks et al, 1983a). Similarly, there were no
significant differences amongst the active treatments on the CEQ.
Results cannot, therefore, be attributed to differential expectation or
motivation based upon the perception of treatment instructions.
Although modest gains were achieved on most sleep pattern variables
under placebo treatment (Table 9), within group repeated measures
effects failed to achieve significance (Tables 12 and 14). Statistical
appraisal of treatment effects therefore, supported non—improvement
over time. It can be concluded then that placebo effects are unlikely
212to offer a competing explanation for the impact of the psychological
treatments. Between group effects, however, achieved sufficient
magnitude for statistical significance only for the comparison of
stimulus control with placebo.
Furthermore, it is clear from the results that placebo group patients
did not improve significantly even under conditions of positive demand.
This finding is in contrast to some previous work which reported that
the engendering of positive expectancy produced significant
improvements in the sleep pattern of placebo subjects, whereas only
active treatments instituted change during counterdemand (Borkovec et
al, 1975; Borkovec and Vieerts, 1976). It is probably a reflection of
the severity of insomniac complaints in this study that such demands or
suggestions made no impact upon outcome. Table 8 demonstrated that
active treatment effects generally emerged under negative demand and
that on no occasion did they commence at Week 5 when the positive
demand instruction was first issued. The demand manipulation was,
therefore, a useful inclusion in this study in order to rule out the
competing explanation of experimental demand. The use of both placebo
and demand manipulations, therefore, provided a useful double
methodological control over non—specific treatment effects.
One further potentially confounding explanation for the results was
dealt with in the evaluation of "therapist factor". It was regarded as
feasible that using a single therapist across conditions might bias
outcome in favour of treatments with which the therapist was most
familiar or in which he exercised greatest skill. Chapter 7 described a
study conducted to investigate this possibility, the results of which,
presented in Fig 3, indicated that there was no evidence to support
systematic bias in terms of interpersonal and collaborative skills, or
213in terms of explanation and application of treatment programmes.
Certainly this study was conducted on only a small (10%) random sample
of the total population, and greater confidence may have been possible
via more comprehensive evaluation. Nevertheless, the study did not hint
at the need for more detailed investigation. Most previous reports have
failed to consider therapist effects of this type as a competing
explanation for outcome. Those which have, have reported non-
significant effects (see Chapter 6) with the exception of the Turner
and Ascher (1981) study where experienced clinicians were found to make
better therapists than trainees. This clearly did not present a
difficulty in the present study.
To summarise so far, the methodological controls used in this study
appear to have functioned well. The waiting-list and placebo groups
respectively controlled for passage of time and non-specific treatment
effects, and the demand manipulation further controlled for therapy
demands to report improvement. All interventions were regarded as
highly credible and the therapist applied treatments in an equally
skilled manner.
Application of Techniques
In spite of the comprehensive methodology it could be argued that
patients in different groups applied the treatments with differing
degrees of consistency or motivation, thus accounting for the various
effects demonstrated. The fact that CEO scores were high and similar
does, of course, argue against this, but nevertheless the possibility
is deserving of some discussion.
Clinical experience indicates that some patients carry out therapeutic
directions/homework better than others, and that where procedures are
"inconvenient" there may be a greater tendency for such failure to
214comply. The present study was no exception to this observation. It is,
of course, part of the therapist's clinical skill to encourage and
facilitate implementation of therapeutic procedures in the home
environment. Working towards between session change is an indispensible
aim in psychological treatment.
In this study the author had to rely upon patient self—report to
determine whether or not procedures were being carried out as required.
Adherence to the demands of the stimulus control programme could be
checked upon by detailed examination of the DGQ (eg. bedtime, waking
time, rising time, daytime napping) and some patients did require
correction if they took a broad "interpretation" of the rules eg. by
waiting longer than 20 minutes before rising, or sleeping beyond waking
time at weekends. Similarly, some of those in the paradoxical intention
group found the instruction to remain awake difficult to apply since it
demanded a reversal in attitude which did not come naturally. It is
also difficult to be sure that relaxation subjects practised their
exercises as prescribed, and that placebo patients always did their
"imagery relief" training programme in the early evening.
One possible solution might have been to ask spouses to record or
report on homework practice. This would have provided useful, and
(arguably) independent corroboration of self—report. However, practical
difficulties concerning the fact that spouses generally fall asleep
faster than their insomniac partners, and the possibility that reports
would be biased towards confirming patients' report, would be likely to
confound this assessment. On balance it seems unlikely that patients in
any one condition would be particularly inconsistent in the application
of the procedures. The fact that the patients as a group were reliable
DSQ reporters in relation to the SAD external criteria suggests that
other forms of reporting may also be reasonably credible.
215One recent and interesting development is noteworthy before leaving
this matter. Lichstein and Hoelscher (in press) have developed a
relaxation assessment device (PAD) which appears to subjects to be a
standard cassette player but which also, discretely, records tape
playing time. Their preliminary investigation of the PAD indicated that
anxious patients practised exercises on 4.4 nights on average out of
the targetted 7, and that hypertensive patients practised fully up to
criterion. They concluded that practice is highly correlated with
motivational state. Such a device may prove to be a useful assessment
option also for the insomniac group.
Measures of Outcome
Validation of the sleep pattern measures in the DSQ was discussed in an
earlier section. Mean scores for SQL and TOT appeared satisfactory,
however, it was noted that measures of wakening frequency required
further consideration. In this study patients were required to record
only the number of wakenings per night which were associated with
"difficulty in returning to sleep". This measure was designed to
quantify the "problem" wakenings, rather than those, perhaps frequent,
brief arousals which present as a part of the normal sleep of older
subjects. Kales et al (1984) in a large descriptive study found that
difficulty in falling asleep either initially or during the night was
descriptive of the presenting insomniac group (see Chapter 1).
Nevertheless, the measure of problem wakenings alone may have been
inadequate. Patients often complained of the broken quality of their
sleep which is likely to be a reflection of frequent short arousals.
Clearly, there are problems inherent in the accurate numerical
estimation of wakenings, some of which are barely (if at all)
perceptible. There are, however, a number of measures which might be
useful in future studies, in addition to the one employed.
216The most widely used self-report sleep-maintenance measure has been
that of WASO (wake time after sleep-onset). This measure is an estimate
of the total time spent awake during the night after sleep commenced.
The author has recently used WAS° for cases of intermittent insomnia
(Espie and Lindsay, 1987) and patients appear to find it a sensible and
descriptive measure. Another useful measure may be a qualitative rating
of either "brokenness" or "depth" of sleep. Such a rating has seldom
been applied, in spite of its obvious face validity in characterising
the problem. Turner and Ascher (1979a) asked subjects to rate
"difficulty in returning to sleep", but found that this measure did not
demonstrate significant change after treatment. In addition, it seems
unlikely that such a rating could be an improvement upon a numerical
estimate of problematic wakenings. EEG assessment is the only sure
method of obtaining reliable information on both the frequency and
duration of nighttime arousals. Where access to such facilities is not
available, measures of WASO and "brokenness" of sleep would appear to
be useful.
In addition to weekly mean values for SOL, TOT and WAKE, measures of
standard deviation were also calculated in this study. The objective in
doing so was to describe sleep pattern, not only in terms of the
(possibly artificial) "average night's sleep", but also in terms of the
variability in the individual's sleep from night to night. It had been
the author's observation that insomniacs often slept well for at least
part of the time, but that "bad nights" occurred, often unpredictably.
Variability, therefore, may be part of the norm which predicts clinical
complaint. Such variability was indeed evident at baseline, especially
for SOL where the typical sleep latency was around 80 minutes and
typical raw score SD was +/- 45 minutes (Table 9). Interestingly, of
the 3 treatment x time interactions to achieve significance, two were
for measures of variability (SOL SD, TOT SD) and only one was for mean
217score (SQL). Since mean values for WAKE were less than 10 per week at
baseline the measure WARE SD was perhaps irrelevant. It is suggested
that, in the interests of demonstrating that a consistently improved
sleep pattern has emerged after intervention, both mean and SD scores
should be used as outcome measures, certainly for assessments of sleep
latency and duration. The inclusion of these in this study has yielded
novel information never before presented in the insomnia literature.
There may be a parallel here between the clinical importance of knowing
what proportion of patients improve with a given treatment (variability
across persons) and the clinical importance of knowing how predictable
improvements are for a given night (variability over time).
Stimulus control and paradoxical intention were particularly effective
in reducing significantly both SQL mean and SQL SD (Tables 9, 11, 12).
This is an important finding since previous studies, employing only
mean values, have fostered conclusions along the lines that "subjects
took X minutes to fall asleep at baseline which Was reduced by Y% to Z
minutes SQL at post—treatment". The impression thus conveyed is that
sleep has changed from being predictably poor to being predictably
good. A more accurate picture, however, may be that of highly
unpredictable sleep pattern (often poor but not always) being
stabilised and improved. In an unpublished report Espie, Lindsay and
Hood (1986) examined SQL data of the 14 subjects treated by stimulus
control in the present study. They found that 47% of baseline SQL
values fell within the post—treatment range, suggesting that therapy
may have acted to "normalise" scores from the top half of the original
distribution. That is, they were brought into line with the "good"
nights which existed all along.
With the possible exception of the measures of wakening frequency then,
the DSQ measures of sleep pattern used in the study appear to have been
218satisfactory. The inclusion of both mean and SD scores allowed for more
informative analysis than is possible using mean values alone.
Relaxation therapy, and to a lesser extent paradox, produced some
improvement on sleep quality variables whereas stimulus control was not
associated with significant change. These results have been interpreted
in terms of the specific modes of action of anxiety/subjective change
treatments compared with habit/behaviour change approaches.
Nevertheless, it must be concluded that sleep quality reports emerged
as less sensitive outcome measures than had been anticipated. A number
of comments are appropriate.
Firstly, the variables RESTED and ENJOY were synonymous with a
"refreshing, satisfying, good" sleep. Patients were asked to provide a
rating on a 5-point scale. Given that there may be rather more of a
categorical basis to sleep pattern (ie. good and bad nights) it might
have been useful to obtain reports of dichotomous choices such as
satisfactory/unsatisfactory, acceptable/unacceptable or simply
good/bad. Such forced choices would perhaps get round the tendency of
patients to "hug" the middle ground of linear scales and to fail to use
the breadth of ratings available.
Secondly, subjects were required to complete the DSQ soon after rising.
This was essential for retrospective estimation of sleep parameters.
However, it may be that more valid assessment of restedness would be
achieved through ratings made some while later, perhaps mid-morning,
when people are better able to judge the value of the previous night's
sleep in relation to performance. Indeed, there is no evidence to
support the view that good sleepers feel rested immediately upon
rising. Clearly investigation of the timing of such assessments would
be welcome.Thirdly, REPTH did not discriminate well between or within groups. The
only significant finding on this variable was the modestly significant
treatment main effect accounted for by the greater average reduction in
pre—bedtime repetitive thoughts associated with relaxation compared
with placebo. Although this finding is consistent with the proposed
model, neither interaction nor time main effects were significant, and
paradox (also an anxiety reduction approach) was not associated with
significant change. A number of studies were reported in Chapter 2
(section on cognitive hyperarousal model) which found that insomniacs
presented with persistent cognitive intrusions prior to falling asleep.
Perhaps the wrong question was asked in the present study. Items from
the SDQ which were commonly selected descriptors of sleep disturbance
may prove to be more useful, eg. Item 2 "mind keeps turning things
over", Item 10 "unable to empty mind" (see Chapter 10). In addition,
the performance anxiety based rationale for paradox perhaps demands a
more specific question relating to pre—sleep mentation. This study did
not include any measure of performance anxiety per se. Again the
relevant items from the SDQ can now be forwarded as valid process
measures.
Reference has already been made to measures of daytime functioning.
Pre—post assessment (ARS) was rather insensitive and this form of
evaluation does not provide useful information on the relationship
between nightime sleep and subsequent daytime functioning. Although it
was not the purpose of this study to consider this issue in any detail,
a number of recommendations can be made.
The application of both objective and subjective process measures of
daytime performance and fatigue would seem to be appropriate. It is to
this area that a number of influential researchers in the USA have been
turning of late. The multiple sleep latency test (MSLT) was developed
220at Stanford University during the 1970's as an objective measure of
daytime sleepiness. Subjects are required to spend the day at the sleep
laboratory and take a series of short naps at about 2-hourly
intervals. Sleepiness is measured by how long it takes them to fall
asleep. Due to the impracticability of the MSLT, however, other workers
at Memphis State University have been conducting pilot tests of other
more convenient strategies for determining daytime sleepiness. These
include auditory discrimination, abstract logic, visual focusing and
mental arithmetic tasks, along with pupillometric measures (see
Lichstein, 1984).
The increasing emphasis upon daytime effects is, of course, a
reflection of the move towards more didactic models of treatment (eg.
Bootzin, Engle-Friedman and Hazlewood, 1983; Bootzin and Engle-
Friedman, in press; Lacks and Rotert, 1986) and the accompanying
evidence that a proportion of insomniacs do not suffer daytime
sleepiness, although they do have an unsatisfying sleep experience
(Lichstein, 1984).
Where sleep laboratory methods or performance/cognitive assessments of
daytime functioning are not feasible, future studies might consider the
extension of diary reports to provide self-report information on
sleepiness, concentration, and work performance. It may be a limiting
factor to the present study that it is not possible to discriminate
between the two insomniac subgroups of those with insomniac sleep
pattern and daytime correlates, and those with disturbed sleep pattern
but without significant daytime consequences.
GUIDELINES FOR CLINICAL PRACTICE
Guidelines for clinical practice will now be presented based, not only
upon the results of this study, but upon an integration of these
221results and the most recent other research evidence. In considering the
issue of good clinical practice several key questions require to be
addressed:-
a) What constitutes "improvement" for this patient?
b) Is improvement in these terms a valid and achievable goal?
What informational/educational input is required?
c) Which psychological intervention(s) predict the best outcome?
The first question raised concerns the individual patient's perception
of his/her problem and his/her personal view on what outcome would
constitute satisfactory improvement. The term "sleep-onset insomnia" is
a convenient generalisation which enables discrimination of this sub-
type from other categories of sleep disorder. However, within this
group of patients, emphases upon and interpretations of the problem are
likely to differ. Some are concerned primarily about the "abnormality"
of their sleep compared with their peers, and consequently feel that
sleep requires to improve. Others compare current with former pattern
and hope for a reinstatement to previous norms. Another sub-group are
over-anxious and find the sleep experience per se unsatisfying (or even
aversive) and desire to become "good sleepers". Still others complain
of excessive tiredness and regard treatment as a way of resolving
daytime performance deficits. Clearly perspective varies, and this is
not an exhaustive list. Another important facet of presentation
concerns the focus of complaint. Some present the problem in terms of
sleep parameters (latency, total time, etc.), others in terms of
unacceptable sleep quality.
The first rule of clinical practice must be, therefore, to recognise
that insomnia is not a unitary phenomenon. The application of a
treatment technique, without re-forming the patient's perceptions of
sleep, may be invalid. The absence of subjective improvement after
stimulus control, for example, is likely to be a limiting factor to
222applicability with patients who are demanding of qualitative change.
Equally, modest reductions in sleep latency after relaxation training
will possibly dissatisfy the patient who wishes to fall asleep rapidly.
Intervention is not, however, simply a matter of modifying variables in
line with patient demand. As any therapist knows, success with such an
approach can be elusive since complaints have a habit of re-emerging in
another form. Rather, there is need for thorough assessment in order
that complaints and expectations may be validated, and if validated,
treated.
The second question of interest, therefore, concerns this validation
procedure, and the subsequent agreement between the patient and
therapist of relevant and achievable targets for change. Reference has
already been made to the importance of training patients in the
recording of sleep pattern, and of establishing the clinical
significance of the presenting complaint. In routine practice objective
validation by means of EEG assessment is seldom feasible. The "Somtrak"
SAD, however, appears to be a useful, non-intrusive objective device to
corroborate self-report. Validation also applies, however, to three
other equally important aspects of reporting.
Firstly, practitioners must employ a developmental perspective in
assessment. Sleep patterns are closely related to age, and for older
people, often unwelcome shifts in sleep occur. The shifts may be
gradual and imperceptible or sudden and striking, however, the
individual who fails to interpret these changes as part of a normal
developmental process may be liable to conclude that sleep has become
pathological. Subjective reports must be validated , therefore, against
the criterion of "normality".
Secondly, clinicians should employ a 24-hour view rather than limiting
interest to the sleep period. It may be that patients who fail to
223demonstrate significant daytime dysfunction cannot validly be
considered as insomniac against the criterion of "adequate sleep".
Lichstein (1984) has suggested the label "insomnoid" for such people
who present with a discrepancy between biological sleep needs and sleep
goals.
Thirdly, consideration must be given to the role of sleep within
overall functioning. Clearly some patients exhibit diminished cognitive
and performance ability as a direct consequence of sleep loss. Others,
however, may exhibit daytime deficits which are quite independent of
sleep sufficiency and may falsely attribute causation to insomnia. Such
subjects are likely to set invalid goals for their sleep pattern.
Validation of complaint requires also, therefore, to be conducted
against attributional criteria.
It is only through attention to these matters that agreement can be
reached between patient and therapist on appropriate methods of
intervention and appropriate measures of change. It is in this
connection that the educational/didactic model has a crucial role.
In the last few years a number of studies have been published which
have investigated the usefulness of didactic treatment (Lichstein,
1980; Bootzin et al, 1983; Bootzin, 1985; Bootzin and Engle—Friedman,
in press; Lacks and Rotert, 1986). Intervention has generally involved
educating patients about sleep needs in relation to age and daytime
requirements, and so identifying reasonable targets for change.  A
further feature has been the emphasis upon sleep efficiency as a
suitable, but much neglected measure (Lichstein, 1984). Perhaps too
much attention has been paid to increasing the numerator of this ratio
(ie. total sleep) and insufficient effort made at reducing the
denominator (time spent in bed).Bootzin and Engle-Friedman have conducted the only comprehensive
controlled study incorporating the didactic approach. They compared
three active treatment conditions with a waiting-list control group in
a sample of 53 older insomniacs (mean age 59 years). A "sleep
information" group received support, sleep hygiene advice (cf. Lacks
and Rotert, 1986), and sleep education. A second group received this
support and information plus progressive relaxation training, and the
third treatment group received the didactic package plus stimulus
control instruction. Their results showed improvement in all three
treated groups in terms of improved sleep pattern, increased restedness
and self-efficacy, and reduced depression scores (Beck Depression
Inventory). Bootzin and Engle-Friedman regarded the increases in self-
efficacy and decreased concern regarding sleep as being of particular
importance since the goal of all of the treatments was to help
insomniacs see themselves as people who could cope with sleep
disturbance, rather than be victims of it. Some differential treatment
effects did also emerge. The addition of either relaxation or stimulus
control to the didactic treatment resulted in significantly increased
sleep efficiency, and sleep latency reduction was significantly greater
with stimulus control than with the other two interventions. This
pattern of results was maintained at lengthy follow-up.
In the light of these results it would seem to be clinically useful to
include routinely in therapy, a preliminary assessment and intervention
along didactic lines. The qualitative/subjective improvement obtained
in the Bootzin and Engle-Friedman study through this approach was also
reported in earlier single case reports (Lichstein, 1980; Bootzin,
1985). It may be that the inclusion of didactic training along with
stimulus control in the present study would have yielded qualitative
gains which the stimulus control approach alone did not produce.
225The third question raised earlier concerned the efficacy of the various
specific psychological treatments. Results in the present study
favoured stimulus control as the means by which the most rapid SOL
reduction may be obtained, although gains in total sleep duration did
not emerge until some weeks later. Reservations regarding the stimulus
control approach were in terms of its insensitivity to the subjective
concerns of the patient. The practising therapist, therefore, should be
aware that patients may regard this treatment as a rather "clinical"
and strict programme of retraining, and that they may fail to report
greater satisfaction with sleep at post-treatment. However, stimulus
control instruction appears to be particularly compatible with the
didactic model. The two approaches may offer, therefore, a powerful
combination of procedures.
Stimulus control aims to maximise the control of the "sleep system"
over sleep by ensuring that biological drive cues bedtime and that
sleep requirements achieve equilibrium in a regular pattern preceding a
set waking time. The essence of the didactic approach is to educate
patients to the possibility that such natural sleep requirement may be
less than they would aim for, partly because sleep needs are age-
correlated. The recognition that sleep goals are not entirely
determined by biological need/capacity, but also are responsive to
other demands, may foster a re-attribution process and result in
greater satisfaction with sleep. Without the educational process,
stimulus control may appear to subjects to be a harsh discipline which,
although effective in modifying sleep pattern, does little for extant
anxiety and misinformation. The therapist is, therefore, encouraged to
apply didactic and stimulus control procedures in tandem to facilitate
both quantitative and qualitative change.
It has been proposed that relaxation and paradoxical intention are more
226likely (than stimulus control alone) to modify subjective report since
they follow an anxiety-reduction model. Qualitative change may of
course be enhanced for these treatments through an additional didactic
process. The usefulness of paradox appears, however, to be limited by a
"risk factor". That is, a proportion of patients respond unfavourably
although latterly sleep pattern gains may match those obtained via
stimulus control. It is recommended, therefore, that practitioners
attempt to assess the individual's ability to defer sleep-onset without
undue arousal as part of the selection process for paradoxical
strategies. It seems that the clinical utility of the technique may
rest upon the passive avoidance of falling asleep as opposed to the
deliberate induction of high arousal. Assessment of this subtle
difference, however, may not be easy. one possibility might be by means
of biofeedback training. Patients could be trained in de-arousal of
physiological functioning along conventional lines, and then trained to
develop "fine control" over arousal levels in the relaxed state so
that, by degrees, "avoidance training" could be achieved.
Alternatively, and perhaps more simply, Fogle and Dyall's (1983)
variation on paradoxical strategy might be worthy of consideration. In
their approach patients were told to "give up" trying to fall asleep
rather than trying to "stay awake". Interestingly, Fogle and Dyall
reported that the paradoxical giving-up strategy was more effective in
reducing performance anxiety than was the conventional procedure.
Where care is exercised in the selection and training of patients,
therefore, the practitioner is likely to find paradox as effective as
stimulus control. In addition, some reduction in wakening frequency may
be expected through paradox although other techniques of "worry
control" may be preferable (cf. Espie and Lindsay, 1987).
The clinician should be aware of the severe limitations of progressive
227relaxation in producing clinically significant change in disturbed
sleep pattern. In this study only one in five subjects achieved a
reduction of 50% or more in SOL. The positive indications for the use
of relaxation appear limited to those situations where sleep complaint
relates to a dissatisfaction with the enjoyment of sleep. Relaxation
training appears to improve patients' attitudes towards sleep rather
than affecting sleep parameters per se, but it also has some advantages
in terms of daytime improvement of concentration and coping. It is
possible that such benefits would be matched by the use of didactic
treatment in association with either stimulus control ar paradox. The
simple provision of a relaxation tape for home practice is a common
clinical expedient. In itself this cannot be expected to substantially
modify sleep pattern, but patients will probably report feeling a bit
better about their sleep and about general daytime functioning.
Tailoring treatment offers little benefit over the best conventional
treatments given at random. Didactic input would; of course, need to be
appropriate to the individual's presentation, and in this sense be
tailored, however, beyond that stimulus control first and then paradox
appear to be the treatments of choice. The usefulness of cognitive
restructuring programmes remain to be evaluated adequately. These
guidelines may go against clinical judgement in some cases, since
individualised treatments have intuitive appeal. The evidence from this
study, however, is supportive of selecting on the basis of treatment
effectiveness rather than individual presentation. Clearly there are
implications here for the validity of presumed aetiological factors in
the individual's presentation.
Finally, it is worth reiterating that the clinician should be able to
manage the drug-using patient as well as those who are drug-free. Here
also the role of the therapist as educator is paramount to obtain
228compliance, maintain motivation, and encourage accurate attribution.
The models of drug withdrawal outlined have received preliminary
support both methodologically and clinically. The practising therapist
should make use of these to ensure adequate control of medication and
to maximise the effectiveness of psychological treatment.
SUGGESTIONS FOR FURTHER INVESTIGATION
Guidelines for clinical practice have been laid down, representing a
synthesis of the results of this study and other recent developments.
However, there remain significant gaps in the current understanding and
treatment of insomnia. The following suggestions, therefore, are made
to focus research attention.
Firstly, the identification of valid predictors of insomniac complaint
must be a priority concern. In spite of the burgeoning literature, no
clear or comprehensive "formula" can be given; although the expectation
of such may be unrealistic. The phenomenology of insomnia is complex
and it appears that biological, developmental, social, emotional and
performance factors may all be implicated. Dysharmonies between
objective and subjective criteria of evaluation are particularly
problematic. It is not easy to quantify a "good sleep", even for the
individual; and far less for the insomniac group as a whole. Sub-
classification into objective and subjective insomnia (Borkovec et al,
1978) or insomniac and insomnoid (Lichstein, 1984) have been proposed
and these are worthy of further consideration. In particular the latter
categorisation is promising since it recognises the validity of sleep
complaints which relate to dissatisfaction with the sleep experience
itself.
An attempt was made in this study to identify variables predictive of
clinical presentation and of treatment response. Rather surprisingly,
229neither age nor chronicity of insomnia were significantly correlated
with severity of sleep disorder or intensity of qualitative reports.
This was perhaps due to the "categorical" nature of the presenting
group, ie. by selection - severe, clinical insomnia. Nevertheless, a
range of ages and durations of insomnia were represented. Longer use of
medication did, however, appear to be predictive of somewhat more
stable and restful sleep from night to night. Affective measures were
also of some predictive utility. More anxious and/or depressed patients
suffered greater pre-sleep cognitive intrusion and were more irritable.
Increased neurotic symptomatology was not, however, associated with
greater sleep pattern disturbance.
Subjects who required post-treatment drug withdrawal were on average,
older, had longer histories of insomnia, and took longer to fall
asleep. Between group differences, however, were not significant.
Similarly, there were no significant differences in terms of treatment
response although Tables 19 and 20 suggested that relapse to drug-
taking was greater in the post-treatment compared with the pre-
treatment withdrawal group. Booster therapy for such patients may be a
practical solution and consideration could be given to this in future
studies.
Detailed baseline assessment of daytime and nighttime variables, and
subjective perception of these, would provide the necessary basis upon
which to investigate predictors of complaint. This study did not
provide data for this purpose. Nevertheless, in terms of predicting
outcome from treatment, the study does makes clear the efficacy of
psychological treatments in producing maintained benefit even in
severe and chronic cases of insomnia. The severity of complaint does
not contraindicate psychological management.
A second priority for further study concerns the mechanism(s) by which
230psychological treatments achieve their effects. As outlined in Chapter
2, each treatment has a logical theoretical basis, but also has
inconsistent evidence to support its hypothesised mode of action. This
study did not attempt specifically to examine such aspects of treatment
process. It has been suggested, however, that two theoretical
perspectives might be applicable.
The stimulus control approach as an operant paradigm may operate upon
behaviour patterns via the laws of learning and reinforcement, and so
be effective in habit restructuring. The failure to produce qualitative
(cognitive/attitudinal) change may be due to the "cognitive lag"
phenomenon which has been reported in other parts of the behavioural
literature (Rachman and Hodgson, 1974). It has been suggested that
desynchrony can exist between behavioural and affective components of a
problem such that behaviour change occurs prior to, or in the absence
of subjective change. Alternatively, a re-education process may be
required, ie. didactic treatment. This may contribute, directly at the
informational/cognitive end, to the newly learned repertoire by
modifying attitudes and self-evaluative procedures. Some preliminary
evidence is supportive of the joint use of stimulus control and
didactic methods (Bootzin and Engle-Friedman, in press) and it may
prove a fruitful avenue of research to consider the complementary
nature of these approaches. It appears conceptually sound to regard
stimulus control instructions as a set of cohesive retraining rules
rather than a collection of "ingredients" which require to be
separately evaluated (cf. Zwart and Lisman, 1979).
The other theoretical position proposed embraces both relaxation and
paradoxical treatments in so far as each are recognised anxiety-
reduction procedures. Here improvement is more likely to be associated
with subjective improvement, with the proviso that behaviour change
231(ie. sleep pattern) may occur also, dependent upon the power of the
treatment. Alternatively, behaviour change may be regarded by patients
as unnecessary if anxiety reduction and other subjective improvements
are sufficently extensive. Other forms of anxiety management treatment
would also fall within this second theoretical perspective.
Clearly care must be exercised in future studies to investigate
separately the impact of treatments upon physiological and cognitive
aspects of presentation, although it seems likely that the latter is
the more critical function. Indeed, it has been argued in the past that
all treatments, including stimulus control, achieve their effects
through the elimination of bedtime worrying. Equally, from the operant
perspective, it could be argued that anxiety reduction as such is
unnecessary as long as anxiety does not occur in the bedroom or around
bedtime. Worry may simply be another example of sleep—incompatible
activity. The work of Espie and Lindsay (1987) in using a "worry
control" procedure should be further investigated in this respect.
Thirdly, and from a cost—effective clinical perspective, it would be
useful to compare the efficacy of a stimulus control/didactic
intervention presented as bibliotherapy, with other more labour—
intensive psychological treatments. The GP remains the primary advice—
giver to poor sleepers and such a minimal contact approach might be
applied readily within the constraints of the GP appointments system.
Interestingly, in spite of the availability to GPs of information on
behavioral management approaches for insomnia (eg. Giblin, 1983), it
has been the author's experience that few practise these techniques.
This appears so in spite of the considerable efforts of many
practitioners to reduce considerably the quantity of hypnotics given on
prescription. Perhaps the health education role of the family physician
requires greater emphasis, and also the role of the psychologist as
232error rate. Secondly,
guidelines of O'Brien
Thirdly, the examination of treatment process data has been a
of this study and the available SPSSX MANOVA sub-commands
disseminator of psychological and interpersonal skills (see Espie and
White, 1986a).
Finally, it is noteworthy that the multivariate repeated measures model
applied in this study had both advantages and disadvantages. Firstly,
the MANOVA approach permitted greater confidence in the interpretation
of significant effects because of its conservatism and minimisation of
relatively free from
than that outlined
computation of gain
values rather than
the approach followed, ie. SPSSX using the
and Kaiser (1985), was a straightforward one,
procedural complication, and considerably simpler
in the SPSSX User's Manual. In addition, the
scores allowed for inbuilt covariance of baseline
comparisons of absolute post-treatment scores.
feature
proved
excellent in this respect. The CONSPLUS sub-routine generated an
overall time within treatment group multivariate statistic and sub-
effects for each week of therapy. This analysis proved invaluable in
treatment comparison, given the relatively few significant interaction
main effects which were achieved.
By way of criticism, the main effects achieving significance using
MANOVA were probably fewer than would have been the case with a
univariate approach. There is, therefore, the possibility of missing
potentially important between group differences due to loss of
sensitivity. In this study care was taken, however, to examine
treatment x time data and to highlight potential benefits of one
treatment over another even when between group comparisons failed to
achieve significance. It is clearly important, with whatever analysis
is selected, to make use of statistical tests and the profile of
results obtained to address the salient research questions. A balance
233must be struck between under—interpreting and over—interpreting.
It is also important to recognise that results in terms of clinically
significant outcome do not always parallel those from statistical
testing (cf. Table 28). Further research is required to develop the
range of assessments available to measure individual variability in
response to treatment. One of the outstanding problems inherent in any
group comparison study which derives general rules, is that these are
not necessarily applicable to the individual who presents in the
consulting room for treatment. Indices of clinical change based upon
both inter—subject and intra—subject variability require greater
recognition and further development.APPENDIX A
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236APPENDIX B
Handouts for Each Treatment Condition 
1. Progressive relaxation
2. Stimulus control
3. Paradoxical intention
4. Imagery reliefOVERCOMING INSOMNIA THROUGH PROGRESSIVE RELAXATION TRAINING 
The treatment programme described below has proved to be effective in helping
people to get a better night's sleep.
Most people who Buffer from insomnia either find it hard to get off to sleep
vhen they go to bed, or find their night's sleep is broken by numerous
wakenings. Some people experience both of these difficulties. Very often
the cause of these problems is an inability to relax. It  is certainly true
that peoble who are good at relaxing seldom have difficulty sleeping.
How does relaxation work?
Relaxation is really a skill, and like other skills it requires practise in
order for it to be learnt. The relaxation exercises teach you to recognise
where there is tension in your body and they show you how to relax such tensions
away. You will become aware of the difference between tensed and relaxed
muscles, and you will be Able to choose to relax parts of your body at will.
Thus, since it is impossible to be both relaxed and uptight at the same time,
you will have learnt a way to help yourself relax your body to sleep.
If at present you go to bed feeling anxious and wondering whether or not you
will get a good night's rest, then these relaxation exercises will also help
build your confidence that you can become a "good sleeper".
Here is a list of the muscles in the body that we are interested in relaxing.
Muscles in both arms and bands
Muscles in the neck and shoulder area
Muscles in the face — eyes, forehead, Cheeks, jaw
Muscles in the stomach and abdomen
Muscles in the bad:
Muscles in the feet and legs
In between each set of tension and relaxation exercises you should vnacentrate
on your breathing, to try and keep it regular, slow and comfortable for you.
You will find that this helps you in relaxing. You will, of course, receive a
period of training at the clinic in these procedures, and you may have  a
cassette which you can play at home to help you learn the exercises.
Some points to remember:
1) You must practise. At the moment being relaxed does not come naturally
to you, so you must be prepared to practise. twice a day. Practise once
during the daytime and a second time when in bed at night. You should also
domme of the exercises to help you fall back to sleep again should you
waken up during the night. Remember a relaxation session takes around 20
minutes.
2) Relaxation involves "letting go" so try not to rush through the exercises
or tense muscles too hard so that they become painful or strained. It is
only necessary that you notice the tension in the muscles, and then the
relaxing of the tension as you let go. The general principle is to allow
yourself to relax because you cannot make yourself relax.
) Always make a point of focussing you attention on the changes occurring in
the muscles. Notice the difference between a tensed and relaxed muscles
If you have a relaxation cassette, make sure that you have it within reash
to switch off so that you don't have to get out of bed. You should, of
course, put the light off before you start the exercises.
4) If you are not asleep at the end of the session, then you should sontinue
you should continue exercising and relaxing those parts of your body which
are still tense. The emphasis is on being patient, you will find that
your body relaxes in time.
'IMPORTANT NOTE
The above instructions take time to have an effect on your sleep pattern.
Patience and perseverance are essential. You must not expect to see any
improvements during the first four weeks of the treatment programme, but
by the beginning of the following week you will begin to see dramatic
improvements and you will be relaxing yourself to sleep.OVERCOMING INSOMNIA BY CHANGING YOUR SLEEPING HABITS 
The treatment programme described below has proved to be effective in helping
people to get a better night's sleep and achieve a consistent sleep rhythm.
In order to be a "good sleeper" your bed and bedroom must serve as cues for
successful and enjoyable sleep. At the present time, because of your insomnia,
you probably experience some anxiety and frustration at the thought of going
to bed and thus associate bedtime not with having a good night's sleep, but with
a poor one. These worries themselves, of course, interfere with falling asleep
and contribute to the insomnia problem.
In this treatment programme we want to get you to the stage where failing
asleep quickly is associated with being in bed. We must therefore identify
behaviours which interfere with falling asleep so that we can stop these and,
instead, do things which will help us to fall asleep. We want to strengthen *
bed as a cue for sleep and remove all other activity which we sometimes
associate with bedtime. The only exception to this being sexual activity.
Here is a list of some of the things which people areAn the habit of doing In
bed or in the bedroom.
Eating and drinking
Reading
Watching TV or listening to the radio
Smoking
Thinking About the past day
Planning the following day's activities
Discussing things
Although you may do some of these things because you are not falling over to
sleep, they are all, in fact, unhelpful. They are all incompatible with
falling asleep quickly.
The Treatment Programme:
The following set of Instructions have been shown to bring about improvements
in sleep patterns. You may find some of these instructions uncomfortable or
unpleasant, but the treatment will not work unless you carry them out.
1) Go to your bedroom intending to sleep when you feel sleepy and stick to this
even if it means that you stay up very late.
2) When you go to bed, put the light out, and try to relax. Do not use your
bed for anything except sleep, that is, eating, reading, worrying, and so
on. Sexual activity is the only exception. On eudh occasions the
instructions are to be followed afterwards when you intend to sleep.
3) If you find yourself unable to fall asleep you must not lie there awake.
Get up if you are not asleep within 20 minutes, and go into another room.
This is the most difficult part, asUt is very tempting to lie on for a
while longer. Remember we are trying to associate your bed with falling
asleep quickly.
4) In the other room you should do something relaxing such as reading or
listening to music. Do not do anything energetic. Go back to bed again
only when you feel sleepy.
5) If you still cannot fall asleep repeat step 3. You may have to get up many
times in the one night, especially at first. If you waken later during the
night and do not fall asleep quickly, then you should also repeat step 3.at
this point.
6) Set the alarm for the same time each morning and get up then regardless
of how much sleep you have had. This also is very important as it will
help your body develop a consistent sleep rhythm.
7) Do not sleep during the daytime, not even for a short nap.
IMPORTANT NOTE
The Above instructions take time to have an effect upon your sleep pattern.
Patience and perseverance are essential. You must hot expect to see  any
improvement during the first four weeks of the treatment programme, but by
the beginning of the following week you will begin to see dramatic improve-
ments and you will develop a consistent sleep rhythm.
239OVERCOMING INSOMNIA BY PARADOXICAL INTENTION 
The treatment programme described below has proved to be effective in helping
people to get a better night's sleep.
The Problem 
Many people who suffer from insomnia find that they become anxious and worried
as bedtime draws near. Unpleasant memories of hours spent lying awake or
tossing and turning come to mind, and the worrying prospect is that the same
thing might happen again tonight. It is, therefore, not surprising that all
sorts of things are tried out to combat sleeplessness. Some people take extra
exercise, others a cup of warm milk, or read a boring book; others may try
lying this way or that. It is the insomniac's hope that by doing such things
he can make himself drowsy, and get to sleep.
Unfortunately, it seldom works, and sleeplessness continues, while frustration
grows.
The Treatment Programme 
Paradoxical Intention is a difficult term to understand but the treatment
programme is really very simple. If you ask a good sleeper how he manages
to fall asleep, and stay asleep, you will find that he shrugs his shoulders
and says that it just happens! This is a very important  point — sleep is an
INVOLUNTARY PROCESS. In other words we do not make it happen. It must
happen naturally.
Sleep appears to be a member of a class of behaviours which cannot fully be
placed under voluntary control. That is, although it is possible to arrange
conditions most suitable for sleep (a bed, darkened room, constant temperature),
there is a point beyond which the person cannot exert further control in a
positive direction. You cannot make yourself fall asleep.
'Research has shown that all effort at sleeping actually inhibits sleep — it
stops it happening naturally. When you attempt to directly control an
involuntary process you simply disrupt the process further. Therefore, in
order to overcome the insomnia problem you must stop trying to make yourself
fall asleep. You must stop worrying about getting to sleep.
You can do this by going to bed with the INTENTION of remaining awake. The
paradoxical instruction then is that you should try to lie awake as long  ELS is
possible. As you do this you jive up all effort'at falling asleep, so sleep
will come on NATURALLY. As it does so, however, and you begin to feel drowsy,
you are to resist that drowsiness and try to remain awake — you will not be
able to do this for all that long if you are really tired. The secret is to
stop trying so hard and let it happen. Trying makes Us tense instead of
being relaxed.
Some points to remember 
1) There is now no need to worry at bedtime because your paraskoxical intention
is to stay awake, not to go to sleep. You can go to bed knowing that you
will always succeed at this goal. You can see that the word paradoxical
just means "the opposite" intention to what you might think.
2) Try to stay awake for as long as possible. Perseverance is required,
especially since this programme is not one that is easy to follow.
3) Although you have to try to remain awake, do not move around or
do things deliberately to prevent sleep. The idea is simply
to remain awake, not become highly aroused. You are to resist
falling over but still lie relaxed in bed with the light out.
All these points will be carefully explained to you at the clinic.
IMPORTANT VOTE —
The above instructions take time to have an effect on your sleep pattern.
Patience and perseverance are essential. You must not expect to see
any improvement during the first four weeks of the treatment programme,
but by the beginning of the following week you will begin to see
dramatic improvements, and you will be relaxing yourself to sleep.OVERCOMING INSOMNIA BY IMAGERY RELIEF
The treatment programme described below has proved to be effective in
helping people to get a better night's sleep.
The Problem
Many people who suffer from insomnia find that they become anxious and worried
as bedtime draws near. As the usual routine in the evening progresses and
time moves on towards bedtime, anxiety increases at the thought of possibly
not sleeping. Because of this, you may find yourself unsettled even before
getting into bed, and, therefore, find it difficult to fall over to sleep.
It is really a vicious circle starting with getting ready for going to bed,
being a bit worried, not falling over, and then a dissatisfaction with the
amount of sleep you've had when morning comes. As a result you worry even
more the next evening during the run up to bedtime. This whole process should
be seen as part of the insomnia problem. Evening activities become as much a
part of it as does being in bed itself.
The Treatment Programme 
The purpose of the imagery relief programme is to stop you developing this
ViciOUS circle of anxiety and poor sleep.
The first stage is the construction of a list of bedtime activities. This
list will be made up of the various things: you do in the evening leading up to
bedtime. You will do this at the clinic with the help of the therapist. It
requires careful thought so as to achieve a list of activities in sequence,
which is descriptive of what normally happens in your case. Eighteen items
are included in this list which covers all important events leading up to
bedtime and then being in bed.
The second stage is to develop a set of six mental images which you can
readily call to your imacin-tion. Again the therapist will help you select
these and train you to visualise them.
The third stage involves pairing items from the list with these mental
images. The purpose here is to dislodge the anxiety normally associated with
the various events. With training and practice at the clinic, and at home,
you will then be able to rehearse your bedtime routine in a frame of mind more
compatible with sleep, and, therefore, your sleep pattern will improve.
Some points to remember
1) You must practise. Imagery relief therapy is easier for some people to
learn than for others. Individual abilities to visualise differ, but
few derive benefit without regular practise. You are recommended to
practise twice daily and the average session will last 20 minutes.
2) The beet times for you to practise would be once early in the day, with a
second session immediately after teatime. Always try to have your day's
training completed by early evening.
3) Patience is required. Remember you are learning a skill.
IMPORTANT NOTE 
The above instructions take time to have an effect upon your sleep pattern.
Patience and perseverance are essential. You must not expect to see any
improvement during the first four weeks of the treatment programme, but
by the beginning of the following week you will begin to see dramatic
improvements and you will develop a satisfactory sleep pattern.APPENDIX C
Rating Instrument Derived from Young and Beck's (1980) Co9nitive 
Therapy Rating ScaleINDEPENDENT ASSESSMENTS OF AUDIO TAPES
1. Inier=Tkuarlal EffeLlisenezz
0	
-	
Therapist had poor inter-personal skills.	 Seemed
hostile, demeaning, or in some other way destructive
to the patient.
2	
-	
Therapist did not seem destructive, but had
significant inter-personal problems. At times,
therapist appeared unnecessarily impatient, aloof,
insincere, or had difficulty conveying confidence
and competence.
4	 Therapist displayed a satisfactory degree of warmth,
concern,	 confidence,	 genuineness and
professionalism.	 No significant inter-personal
problems.
6	 Therapist displayed optimal levels of warmth,
concern, confidence, genuineness and
professionalism, appropriate for this particular
patient in this session.
2. LDIlabpriBlism
0	
-	
Therapist did not attempt to set up a collaboration
with patient.
2	
-	
Therapist attempted to collaborate with patient but
had difficulty either defining a problem that the
patient considered important or establishing
rapport.
4	
-	
Therapist was able to collaborate with patient,
focus on a problem that both patient and therapist
considered important, and establish rapport.
6	
-	
Collaboration seemed excellent;	 therapist
encouraged patient as much as possible to take an
active role during the session so that they could
function as a "team".
2433. atratecy fpr
(Note: For this item, focus on the quality of the
therapist's strategy for change, not on how effectively the
strategy was implemented.)
0	
-	
Therapist did not select appropriate techniques.
2	
-	
Therapist selected appropriate techniques; however,
either the overall strategy for bringing about
change seemed vague or did not seem promising in
helping the patient.
4	
-	
Therapist seemed to have a generally coherent
strategy for change that showed reasonable promise
and incorporated appropriate techniques.
6	
-	
Therapist followed a consistent strategy for change
that seemed very promising and incorporated the most
appropriate techniques.
4. 2.41l11.a_tism Di Ta.chnisulaz
(Note: For this item, focus on how skillfully the
techniques were applied, not on how appropriate they were
for the target problem.)
0	 —	 Therapist did not apply any appropriate techniques.
2	
-	
Therapist used appropriate techniques, but there
were significant flaws in the way they were applied.
Therapist applied appropriate techniques with
moderate skill.
6	 Therapist very skillfully and resourcefully applied
appropriate techniques.
All items to be rated on a 7 point scale, i.e.
0	 1	 2	 3	 14	 5	 6
If you believe the therapist falls between two of the descriptors
(0 2 14 6), select the intervening odd number (1 3 5).APPENDIX D
Daily Sleep Questionnaire 
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Sleep, Assessment Device Scoring Sheet 4041(
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Pre—Post Rating Scale Assessment Measures 
1. Zung Anxiety Scale
2. Zung Depression Scale
3. Sleep Behaviour Rating Scale
4. Analogue Rating ScaleC)
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Pleaae indicate how often you do the following things at bedtime and while in your
bedroom by placing an X in the appropriate box.
Complete the form by considering what you would do in an average normal week.
Bedtime Behaviour Never Rarely Sometimes Often Very
Often,
Reading a book or magazine
Watching T,V,
Listening to the radio
Speaking on the telephone
Drinking tea/coffee etc,
Eating
Smoking
Talking about the day past	 •
Talking about thelbllowing day
Thinking about the day past
Thinking about the following day
Thinking pleasant thoughts
Thinking unpleasant thoughts
Drinking alcohol
Please also answer the following
I go for a walk before retiring to bed
I do some other form of exercise near
bedtime
I switch the light off as soon as I
7et into bed
I leave the light on until I am almost
asleepANALOGUE RATING SCALE
Below you will see a list of words which describe how a person feels or acts.
You have to consider each description carefully and decide how true it could be
of you during the Dant .est.
Simply place a cross (X) LlaUbere along the line opposite each description to
indicate how true a description it would be from "not at all" at one end to
"extremely" at the other end. Obviously the closer you put the cross to the
"extremely" end the more true you feel the description is and the closer to the
"not at all" end the less true, and so on.
Go ahead and remember you can put your cross LI nnv noint along the line between
"not at all" and "extremely".
Energetic	 not	 	  extremely
at all
Worrying	 not	 	 extremely
at all
Coping well	 not	 	 extremely
at all
Healthy	 not	 	 extremely
at all
Irritable	 not	 	 extremely
at all
Downhearted/	 not	 	 extremely
sad	 at all
Concentrating not	 	 extremely
well	 at all
Warm and	 not	 	 extremely
affectionate	 at all
Sleeping well not	 	 extremely
at all
Confident	 not	 	 extremely
at all
PLEASE COMPLETE THIS FORM CB MU CHBAPPENDIX G
Credibility Evaluation Questionnaire BORKOVEU AND NAU CEO
• not at all
0	 1	 2
extremely
3
	
4
	
5	 6 
1. How sensible does this treatment
seem to you?
2. How confident are you that this
treatment will work for you?
3. How confident would you be in
recommending this treatment to a
friend who suffers from insomnia?
4. Do you feel satisfied that the
therapist is giving you enough
personal attention?
5. Do you feel that the therapist
is warm and accepting of your
problems?
255APPENDIX H
Additional Tables for Chapter 8
256Variable/
Relaxation
Stimulus
Paradox Placebo
No
Treatment Week Control
SQL mean
Bl 88.0(59.3) 86.8(50.4) 70.3(43.5) 89.5(41.6) 84.5(55.1)
B2 93.1(77.6) 78.6(49.1) 74.5(61.2) 81.6(35.3) 84.6(54.7)
SQL SD
Bl 56.6(37.7) 38.8(19.4) 49.1(32.8) 46.8(27.8) 56.2(45.4)
B2 43.3(33.8) 44.9(28.2) 46.8(33.7) 42.6(29.7) 51.0(28.2)
TOT mean
Bl 5.79(1.12) 6.26(1.59) 5.72(1.18) 5.24(1.15) 5.77(0.89)
B2 5.80(1.20) 5.94(1.38) 6.00(1.36) 5.44(1.15) 5.92(1.29)
TOT SD
Bl 1.32(0.53) 1.16(0.36) 1.25(0.53) 1.20(0.63) 1.35(0.54)
B2 1.50(0.79) 1.18(0.56) 1.41(0.77) 1.26(0.82) 1.15(0.63)
WAKE mean
Bi 1.61(1.28) 0.97(1.14) 1.27(1.05) 1.59(1.22) 1.13(1.32)
82 1.51(1.37) 0.89(0.90) 1.05(0.74) 1.92(1.52) 0.89(0.88)
WAKE SD
Bl 0.96(0.64) 0.68(0.59) 0.81(0.51) 0.94(0.54) 0.72(0.51)
82 0.95(0.78) 0.67(0.59) 0.83(0.43) 0.95(0.82) 0.64(0.62)
TABLE (i) Mean scores (with SD scores bracketted) during the two pre -
treatment baseline weeks (Bl 82) for the DSQ sleep pattern variables 
under each of the experimental conditions in the main study. SQL scores 
are in minutes TOT scores are in hours and WAKE scores are simple 
frequency counts Variable/
Relaxation
Stimulus
Paradox Placebo
No
Treatment Week Control
REPTH
Bl 1.42(1.20) 1.63(0.90) 1.69(0.80) 1.88(1.05) 1.60(0.89)
B2 1.23(1.16) 1.34(0.97) 1.17(0.91) 1.95(0.86) 1.63(1.20)
RESTED
Bl 1.44(0.82) 1.67(0.73) 1.80(0.68) 1.74(0.44) 1.89(0.55)
B2 1.70(0.77) 1.98(0.52) 2.03(0.81) 1.66(0.76) 1.98(0.59)
ENJOY
Bl 1.43(0.82) 2.07(0.74) 1.94(0.87) 1.73(0.55) 2.05(0.58)
B2 1.68(0.75) 2.15(0.73) 2.13(0.83) 1.68(0.74) 2.08(0.40)
IRRIT
Bl 1.29(0.94) 1.68(0.95) 1.39(0.88) 1.46(1.04) 1.39(0.90)
B2 1.13(0.95) 1.74(0.85) 1.30(0.87) 1.46(1.11) 1.47(1.16)
NAPDAY
Bl 8.4(12.0) 5.3(	 8.8) 10.8(20.9) 7.0(	 9.5) 21.5(40.6)
B2 3.4(	 5.6) 3.0(	 6.7) 9.7(14.9) 5.9(10.2) 18.3(24.8)
TABLE (ii) Mean scores (with SD scores bracketted) during the two pre-
treatment baseline weeks (Bl B2) for the DSQ sleep. quality variables 
under each of the experimental conditions in the main study. For
NAPDAY scores are in minutes; for the remaining variables scores refer 
to the 5-point rating scale (see Chapter 7)Treatment Group. Mean SD
Relaxation 10 25.17 2.93
Stimulus control 12 24.40 3.75
Paradoxical intention 11 24.89 3.89
Placebo 11 25.11 4.43
TABLE (iii) Mean and SD scores obtained within each treatment group in
the main study on the Credibility Evaluation Questionnaire (CEQ)0 •
•
4-1
0 •
•
4-1
44-1
cc
•
•••n••
•
4-1
44-1
cc
•
•••n••
•
4-1
1/4.0
1/40
▪•
1/4.0
1/40
•
03
CO
03
CO
nn••••••
1/4.0
•
nn••••••
1/4.0
•
0 0
...1	 01	 ......n
M	 0	 tr) N	 01	 1/40
• • 0
V3
CA•
0
0
i-4•
4.J
C
U) .4-4. —
E co CO
CO
(0 • •
U) r-I 0 1-4 VI ,.... ......•
&I 01 V'
4-1 0
•
r-I
•
LII
C"••• 01
• •
0
••n••••
4-1
4-1
•
0
1.
41
a
•s
Nf
U)
4-)
a)
(o
0)0
44 4-)
4-1
0(0
W
3 .-c
=
2 LI,
C
ro w
Erwl
a
z
4-1
.0
44-44,
(10
ct)
cc
4-1
4-1
Ot
o
LO co.
o
LO	 V,
Ot	 co	 o
o	 o	 1-1
V, o .
1-1
.	 .
CO .... 4..-.. CO....	 4..-..	 ..-.. ..-..
V) cp V)	 cp	 0 0 0 CNJ 0	 CNJ	 4-I 4-I • • •	 •
4-1 4-1 4-1	 4-1	 1-1 1-1
.4.,
Crl Crl	 ON
.....
ON
.4.,	 .....
4-1 4-1
03 03	 0'1 0'1 1/40 1/40
• •
0 0	 0 0 N ...... N......	 ...... ......
•zt.
CO
•zt.	 1/40
CO	 r--1
1/40
r--1
• •
r-1
•	 •
r-1
• •
• CV	 CO	 N
	
CO	 N	 CA	 h	 V,
• •	 •	 •	 •
	0 	 4-1	 0	 4-1
	...-..	 ..-.	 .--..	 ......	 ..-..
	
s l,	 0	 C11	 N	 Cr)
	
c)	 t---	 uo	 cn	 cn • •	 •
	
.-1	 o	 o	 0	 0
-se 'in	 —	 .....	 —	 .....
	
0	 10	 01
	
(N	 VD	 (r)
	
.	 •	 .
0 0 0 .......
1/40
ccr-1
•
1.1)
CO	 r--1
•
.)
C 	 -1
•
4-1
1/40	 •:34
•
41
14 	 :4
•
▪ Co	 CY)
co	 co
0 0 o
kso
co
0
r-/
kso
co
0
r-/
	
.	 •	 •	 •	 •	 VU)
	
r-1	 10	 o	 0	 0	 C (04-i
	
m	 co	 co	 CV	 V'
I-I
•
4-1
•
4-1
• •
E .0
C 11/41-1 to 0 r_1
w
cv)
	
 v	 v	 cn	 vp
U ,-)	 (U
U)
	
,--I	 >4 .•-s .-.i 0
u c
4-1
co
I -I /a)
..... cp
>
	
(0
-t o	 0 4_S .8	 w	 73
	
1...	 ,a C	 w	 1..
	
•ri C	 1... .1-1	 (L1	
4-1 41-1	 N S
	
E 4-1	ICI W	 C)
	
(.1	 04 ••••I 	 O. Z E	 F,
C
	
4..10	 ro C	 r-1	 0 cu
CD 
	  r-1	 0 cu
CD 
260 260.....
	
Cn	 r--I	 lf.)
	rn 	 s	 r-1
• •	 •
r-4
1/40
cc
Cy)
•
Cfl
•
1/40
•
r-4
11)
1/40
L.C1
03
•
r-4
•
In
•
r-4
•41
r-4
	
--.	 ......	 n••n	 .......	 -...
	rn 	 N	 1/40	 .zr	 1--1
	
01	 11• 	 1/40	 CO	 h
• •
0 0 0 0 0
	
CO....•	 .....	 ..-..	 ..n•
	
4-4	 II)	 PI	 1--1	 h
	
CN1	 n--1	 01	 0	 CO
• •	 •	 •	 •
	
N	 N
ee.,	 ,...	 ....,	 /.1	 .,...\
%CI	 h	 CA	 N	 CO ON	 h	 1/40	 CO
• •
0	 0 0 0	 0
	
111	 C''•••	 r-1
	
01	 m	 03
• •	 •	 •	 •
r-1
	
..-..	 ......	 .-...	 ..-...	 .•-n
	
rf	 VI	 N	 0	 03
	
N	 1/40	 1/40	 CO	 h
• •
	
0	 0	 0	 0	 0
	
.....	 .....	 n-..	 .....
	
PI	 43	 Cf1	 N	 LC1
	
CO	 ON	 %--I	 h	 t--4
• •	 •	 •	 •
	
.--.	 .--..	 ...-.	 .-.5	 .--..
	CO 	 N	 r-1	 0	 1/40
	
03	 Cr	 1/40	 1/40	 h
• •
	
0	 0	 0	 0	 0
	
......	 .....	 .......	 -.we	 ....-..
	
r--I	 Cr)	 Ln	 f--i	 co
	
ol	 ..-1	 r-1	 ',CI	 ON
• •	 •	 •	 •
	
N	 r-4
4.1 (13
CI
CiN	 e-4
4-1 .0
0 0 • I co
co	 r0
CD
a
4.3
r-t N	4 r--1 N	 4-1 C11
C
0
	
.01	 .......	 .......	 ......	 .......	 C.) .,..(
	
%ID	 v	 ..-1	 1/40	 1/40	 03 4-1
in
	
In	 h	 s	 ka	 1....-4
• •	 •
	
cz,	 o	 a	 o	 o	 — c
	
..-	 -...	 —	 —	 .....	 o
	In 	 ch	 a	 cn ti
	o3 	 o	 cn 	 in	 r-1	 ,11) • •	 •	 •
	
1.-4	 04	 .-i	 ,--1	 N	 0 C
OW
u) E
4-0
CO
u)
•
	.44
••
0	 0	 itn
	
.......	 ........	 ,....	 C
N	 ,-1	 cn	 ro 	 (34)
oo	 01	 43	 ON	 .0 ,..i .	 •	 •	 •	 C 4-/
	
r-I	 r-I	 .--)	 Pa
Q) 4-1
E 0 .--1
)1:7	 4
0 Z	 I0
CA	 •,-( 0	 4-1	 ';%1 (3
r-4	 X •,-4	 0	 fa	 ...... a)
r-i 0 	 041	 .0	 a)
Z 4...	 'C	 a)	 4-
4.)	 '0 4)	 0	 4-4 4-1	 Nit;
.,-,	 L.. 4-)	 413	 C	
Qii 4.1 0	 to	 4-1	 00
COO	 al..,	 04	 z	 E-)
261	
..--.	 .--...
	
LC)	 N	 CO
	
CT	 CO	 LC) • •	 •
	0 	 0	 0 0
CO
Cr)
	
t--1	 lf)	 Cr) • •	 •	 •
	
......	 .......	 ...,
	
re)	 0
	
01	 01	 h • •
0 0 0
Is--	 .._,	 .....	 .._.
	N 	 k.0	 I's
	
0	 CO	 Cr) • •	 •
	
N	 CV
	CV 	 Cr)	 CO	 CY)
	
03	 t•-•	
•	
Lel
	
•	 •	 •	 •
3 --I	
0
	
CO	 Cr)	 szt,
Cn
	
•	 •	 •	 •	 •
	
—	 ..--..	 .--..	 ..--,
	
01	 N	 CO	 0	 Ln
	
N	 co	 LO	 431	 Is.. • •	 •	 •
0 0 0 0 0
..1C III	 .....	 5.-...	 .....	 .....	 .....,
a)	 up	 r--
a)	 co	 m	 Cr)	 co	 m 3	 .	 .	 .	 .	 .
	r-I 	 N	 r--I	 N
4-I
0
a)	 .—.	 .4-45	 ..-4,	 —..,	 ----..
E	 r-.4	 4-4	 0	 •04	 N
4.1	 CT	 C's	 40	 k0	 431
Ca	 •	 •	 •	 •
a)	 0	 0	 0	 0	 0 )... .C11
El	 lID	 Cs,	 .--.1	 1-1	 M
	
cn	 •zr	 'It	 0)	 N • •	 •	 •
	r-I 	 N	 CV	 r-4	 N
	
.....	 ..--.	 .....	 .--...	 .....
	N 	 CD	 r--I	 cr	 CO
	
L's	r•-•	 CO	 CO	 ID • •	 •	 •
0 0 0 0 0
Cr)	 .....	 N-...
	
cn	 cn	 -zit	 c..44	 ,c3,
	
O	 csi	 0	 %.0	 N • •	 •	 •	 •
	
N	 N	 C,--1	 N
.0...4	 0.....n
CO	 N.
N	 4.0 • •
0 0
(N	 ......	 5-....
CO	 h
CO	 Cr)
• •
r-4	 CV
CO	 r-I	 r-I
CO	 C*--	 Ln
• •
cp	 (:)	 0
•nn••
0 N 0
	
.-.4	 h	 re) • •	 •
	
e-4	 CV
..--..	 ..--.
C".•	•41
4.13	 V)
• •
CD	 0
r-I	 ..-.	 N...
CT	 ON
N	 Cr) • •
C
▪
 r)
0
••••
CO
LC)	 L.0 • •
0 0
111
•
	
N	 l'N	 r--I	 V'
	
4.0	 n,0	 CO	 LC) • •	 •
0 0 0 0
	
.......	 ......	 -....	 5-
L
	
fl	 r--I	 CY)	 0
	LC)	 r-4	 (D	 h
• •	 •
	r--1	 (N	 CV	 r-i
•-I
Iv
c) 0	 I
co	 •f-i 0	 4-1 r-I	 X .1-4	 0	 co '-40	 04-)	 .0	 a)
= i..	 V C	 a)	 I-.
E4-'	 co w	 c.)	 4.1 4..)
---i z	 ;... .1-1	 as	 c
-I-JO	 ca 0	 4-1	 OW
CD C.)	 04 ',4	 al	 Z E
2621-4
••n••n
•r4
•,{
>(U
V
	
a)	 v	 cn	 -44	 to
	
CD	 ,--1	 r---	 a)	 a) • S	 .	 .	 . 	o 	 co	 o	 V 03	 .......•	 ......	 ..-...	 ......	 0
	
N	 N	 to	 •41	 co	 ..-L
	
a)	 -4,	 o	 r-i	 -I	 1.- .---.1 ,..4.
	
.--L	 ,
•
--1
• ,.. 	o 	 i	 au NI •
onA
—
03
cc ,
0
•
cn
...--
--L
	
.--1	
-..
03
In
0
••-•
In
	
cn
•	 •	 •
co
r-1 CD
4-1
03 4-1
C ea
E U
a) 4
:.. al
	
N--.	 .......	 —	 ....-•	 ..(
	
,--i	 NI	 N	 .41	 ).... Q)
	
03	 C\1	 0	 e-I	 (D
	
0	 '-4C/3 • •	 •	 •
	
r-1	 r-1	 )4 ......
a)
a)
	en 	 co	 Le)	 N	 00	 C.) Q
	
0	 0	 00	 N	 10	 113 •,-1
	
r-4	 _-4 0	 ,-i	 o	 W a • •	 •	 •
0
• •
	
,4	 .__,
. •
._.1
•
V 4.1
.1j)
1: a)
m ..c
	
....-	 ........	 —	 -...	 ....-
	
ccm	 .:L4	 to	 ,--
	
co	 1
	
m	 r--1	 .v	 .---1
E-1 C
	
en	 oo	 N ,--1
.--1
N-
	
o	
l's
0
a)
co
a)
o 
	
.	 •	 .	 N 0
. • 
„.
.
	
to	 to	 co	 a)
	
r-I	 ro	 i---	 en	 m	 ,-.1 Cll • .	 •	 •	 •	 .0 a)
	
r-i	 o	 1--1	 r-i	 CD 1-•
•r4 0
$.1 C.)
(13 Cl)
	
`V	 en	 N	 cnto>
	
co	 on	 N	 o
cn .4n
o - 5
cN .4.
.- . o'
to
00 _5__ _5__ n
co
CA
.--1 	5. 	 -•
N
• 0
2 't
w cn
1
	
.	 .	 .
	
.....	 ..._...	 .......	 __.	 .......	
4_, 01
0 E
..-L
	
co	 ,-I	 .-.1	 r-i
	
N.	co	 .4,	 In	 szt,	 4-I
I-1 o o s-L r-L
-..C
V -Li
.
a) • •	 .	 •	 •	 I
	
n--1	 N	 cn	 N	 r-i
a) to .--1• Le) N o m
	
.	 en en
•
t.-- 4-1 	m
•	
4. al •r9 I
	
r-1	 r_i
	
1-1	 n-i	 li	 —Ne cn
U C
eis 0
)•• .1-4 	a 	 r-i	 .--1	 Ln	 co	 .J 	co 	 co	 co	 ,--1	 a)	 ..... .,..(
• S	 .	 •	 •	 V
	
c)	 0	 0	 r-i	 o	 cri C
cu 0
	
to	 co	 N	 r--	 to	 1-0
	
N	 .zr	 cn	 0 • •	 •	 •	 •	 c..) 4 	o 	 r-i	 .--1	 ,-)	 ,--1	 tn c
a)
8 5
	
r-4	 en	 CNJ	 •:r	 CO	 no 	cn 	 co	 c0	 o	 cr, 	 VU • •	 •	 •	 •	 C L-
	
o	 o	 o	 r-L	 0	 ets 4-1
	
......	 ......	 ....-	 .....	 ..-•
	
r-i	 o	 m	 to	 en	 0 I W
	
N	 N.	 M	 .4,	 v
,--i
	
1-4	 r-1 r-1 n 1 Z
'T
	
• • •	 •	 •	 ip
0
.--1
113
0 C	 1
VI	 ...-S 0.1-1
= r--1	 X ••••S	 8	 ca
'-10	 0	
.
4	 13)
= f....	 qu c	 a)	 $...
E .L.1	(OW	 C.)	 4)41
--L C	 1-41	 so	 C 4)0 (D C r-1	 OW U)(..)	 al ..-C	 tai	 Z E
	co 	
.
	
CD	 Ln
0 H
	
01	
N
	
0	
1-4
	
03	
.0 CU
4-JO
a) 1,-4
	
..--..	 ......	 .-..5-.......
• •	 •	 •	 •	 (II
	
co	 ,--1	 0	 r-1	 0	 4-1
	
k0.......	 ......	 ..-....	 ........	 ...-.,	 0
	
C•3	 t--1	 cn	 N	 N.
	c 	 . ) ,--1 ,-1 r-1 a) 1:1
a) n:s
	
N.	 m .	 o •	 • m	 (NI . • -se •-t
263(r.1
W
CQ
OD
	
..,..	 ..---.	 ..-..	 ...-..	 ..--.
	CV 	 CD	 t--I	 in	 r-I
	
.	 •	 •	 •	 •
	03 	 01/40	 r-I
	
n-•1	 01
tr)
c:).1
1-1
	
...^.	 ,...	 I%	 .."1	 0...n
	VD 	 I'`..	 CO	 Ill	 0n
	
.	 •	 •	 •	 •
	I' s	CT	 N
	
r-I	 Crl
	
N	 CO	 N	 N	 Ln
• •	 •
	VD 	 N
N
n•••n	 0.•••••.	 ...1
L.r)	 r")	 0 • •
.--I	 0	 .41.
- Cr)
..
▪
 ..	 ....
•
 .	 ......
III	 Cr)	 1/44D • •	 •
CTL	 r-I
N
	0 	 c--1
• •	 •
	1/40 	 LI1	 N
fr)
	
.....	 ....	 ......
	
vo	 CO	 N
• •	 •
	
NI.	 01
•-.1	 8-1
	
(--	 VI	 In • •	 •	 •
	01 	 v4	 r-.1	 N
	
C`4	 r-I
Cr)	 —	 ......	 ......• 	 —
	
In	 co	 Ill	 CO • •	 •
	
1---1	 N	 4.0
1`.1
• •
1/40
—.. ....
N 01
• •
0
N
VO ....., ......
,--I CTI . •
0
0'.... ,...
CO ,4
• •
•:r
111 ...-.• ....
WI 03 •
WI 0
Cr) o
4-)
(ip
a)
E-1
-cr
•
C.1
N
.....
L.C1
•
0
.._..
N • •
CD 0
• •	 •
	
CO	 r--
	
r--I	 r-I
	
N •....,	.....
	
.:34	 Ill	 01
• •	 •
	
r•••	 CO
03• •
tr.)
‘-)
	1/40	 .4,	 o • .	 •
	
o	 in	 l0	 1-1
,--1
.--i	 ......	 —	 .....	 .......
	
o	 up	 o	 v) • •	 •
	
s	 co	 s
	r-f 	 LO • •	 •	 •	 •
co
	r-I 	 I n ON
• •	 •	 •	 •
•zr	 c»
r-f
r--1
fli
u c	 I
U7	 ,-s 0	 4J
	r-I 	 X ,,,,(CI (CI
'-4 0	 o 4-)	 .8	 Q)
	
1....	 ro c	 w	 $...
	
E 4-3	 (c) a)	 u	 4.1 4.4
	
H-I C	 I, 4-1	 (a	 C
	
-I) 0	 fa c	 r-4 	 OW
	
(CC.)	 fai *r4	 04	 Z E
264APPENDIX I
Additional Tables for Chapter 9
265Treatment/ Baseline Final Therapy	 Follow Up
Variable	 Mean	 Week	 6 Week	 3 Month	 6 Month 17 Month
RELAXATION (n= 14	
13	 11	 8	 10	 9 )
SQL mean
SQL SD
TOT mean
TOT SD
WAKE mean
WAKE SD
REPTH
RESTED
ENJOY
IRRIT
NAPDAY
90.5(57.8)
50.0(32.6)
5.79(0.99)
1.41(0.52)
1.56(1.30)
0.96(0.66)
1.33(1.14)
1.57(0.70)
1.55(0.67)
1.21(0.91)
5.9( 8.1)
57.4(25.0)
37.4(30.8)
6.41(0.93)
1.32(0.83)
1.23(1.01)
0.75(0.50)
1.05(0.94)
2.21(0.95)
2.13(0.95)
0.92(1.09)
9.3(18.1)
48.1(31.1) 45.3(22.8) 37.5(27.9) 45.1(24.5)
27.9(21.9) 30.2(30.4) 16.3(21.6) 30.6(29.4)
6.73(1.07) 6.65(1.31) 6.81(0.80) 6.61(1.35)
1.02(0.65) 1.07(0.67) 0.92(0.69) 1.45(0.93)
0.81(0.58) 0.80(0.95) 0.57(0.50) 1.00(1.09)
0.58(0.32) 0.68(0.40) 0.51(0.36) 0.73(0.66)
1.05(1.08) 0.79(1.06) 0.90(0.85) 1.14(1.05)
2.32(0.72) 2.34(1.02) 2.21(1.03) 2.32(0.68)
2.37(0.67) 2.24(0.99) 2.24(0.91) 2.24(0.68)
0.75(0.86) 0.53(0.84) 0.98(0.89) 0.67(0.70)
18.3(44.4) 0.5( 1.4) 23.4(56.0) 8.0(14.4)
STIMULUS
CONTROL	 (n= 14	
12	 10	 7	 6	 9)
SQL mean
SQL SD
TOT mean
TOT SD
NAM mean
WAKE SD
REPTH
RESTED
ENJOY
IRRIT
NAPDAY
82.7(48.5)
41.9(21.0)
6.10(1.44)
1.17(0.41)
0.93(0.97)
0.67(0.48)
1.49(0.83)
1.83(0.65)
2.11(1.08)
1.71(0.83)
4.1( 5.3)
31.1(27.1)
19.0(18.2)
6.56(1.14)
1.07(0.70)
0.44(0.90)
0.16(0.22)
1.20(0.86)
2.15(0.52)
2.52(0.82)
1.42(1.14)
0.0( 0.0)
25.6(13.9) 29.9(29.6) 37.3(32.1) 57.3(44.2)
15.9(19.5) 19.0(27.2) 22.3(38.7) 32.0(34.1)
7.05(1.13) 7.05(0.84) 6.98(0.66) 6.76(1.09)
1.06(0.31) 0.66(0.48) 1.05(1.01) 1.05(0.90)
0.55(0.87) 0.65(1.07) 0.79(0.83) 0.63(0.87)
0.34(0.40) 0.54(0.77) 0.29(0.24) 0.35(0.39)
0.70(0.43) 0.26(0.43) 1.55(1.02) 1.84(1.13)
2.38(0.72) 2.26(0.74) 2.33(0.84) 2.22(0.90)
2.66(0.70) 2.64(0.74) 2.39(0.82) 2.57(0.68)
0.93(0.92) 1.13(1.10) 1.67(1.07) 1.68(0.92)
0.8( 1.6) 0.0( 0.0) 2.5( 6.1) 3.3( 8.6)
PARADOX	 (n= 15	
13	 12	 10	 8	 12 )
SQL mean
SQL SD
TOT mean
TOT SD
WAKE mean
WAKE SD
REPTH
RESTED
ENJOY
IRRIT
NAPDAY
72.4(49.9)
47.9(27.2)
5.86(1.23)
1.33(0.49)
1.16(0.86)
0.82(0.44)
1.43(0.43)
1.92(0.67)
2.03(0.81)
1.33(0.82)
10.3(17.3)
35.8(39.3)
14.2(15.8)
6.54(0.77)
0.78(0.35)
0.53(0.42)
0.61(0.42)
1.10(1.04)
2.33(0.66)
2.36(0.66)
1.06(0.79)
3.3( 6.1)
36.4(29.9) 28.7(40.7) 40.7(41.4) 37.9(24.7)
21.8(12.1) 14.7(11.1) 23.9(21.5) 23.7(22.4)
7.00(0.94) 7.10(0.79) 7.14(0.49) 6.83(0.95)
0.94(0.36) 1.22(0.51) 0.98(0.37) 1.08(0.63)
0.62(0.63) 0.43(0.47) 0.73(0.79) 0.51(0.35)
0.62(0.57) 0.59(0.55) 0.78(0.65) 0.76(0.78)
0.98(0.58) 1.00(0.72) 0.97(0.55) 1.52(0.85)
2.37(0.64) 2.50(0.58) 2.61(0.80) 2.30(0.66)
2.51(0.61) 2.59(0.53) 2.70(0.88) 2.43(0.76)
0.90(0.88) 0.97(0.80) 1.11(0.94) 1.10(0.91)
7.4(10.0) 2.7( 4.8) 5.9(11.5) 5.3( 6.2)
TABLE (ix) Mean and SD scores (bracketted) for each of the DSQ variables at
baseline final therapy week and at each follow—up assessment. Results are
presented separately for each of the three active treatment conditions Pre—treatment df F Ratio F Prob Significance
Measure Level
ZAS (4,61) 1.245 0.302 NS
ZDS (4,62) 0.578 0.680 NS
SBRS (4,61) 1.451 0.228 NS
ARS (4,62) 0.430 0.787 NS
ARS	 1 (4,62) 0.501 0.735 NS
ABS	 2 (4,62) 0.407 0.803 NS
ABS	 3 (4,58) 0.845 0.502 NS
ABS	 4 (4,62) 1.130 0.351 NS
ABS	 5 (4,62) 0.583 0.676 NS
ABS	 6 (4,62) 0.080 0.988 NS
ABS	 7 (4,62) 0.545 0.704 NS
ABS	 8 (4,61) 0.453 0.770 NS
ABS	 9 (4,62) 0.800 0.530 NS
ABS 10 (4,62) 0.180 0.948 NS
TABLE (x) ONEWAY ANOVAs across the five experimental groups in the
main study on each rating scale assessment measures at pre—treatment Pre-treatment Male Female T - df Prob Sig Level
Measure
ZAS 37.3 39.3 -0.72 64 0.475 NS
ZEIS 41.6 43.0 -0.44 65 0.662 NS
SBRS 44.6 46.0 -0.57 64 0.573 NS
ARS 51.2 50.9 0.07 65 0.942 NS
ARS	 1 4.18 4.50 -0.46 65 0.646 NS
ARS	 2 5.25 5.40 -0.20 65 0.844 NS
ARS	 3 5.43 5.34 0.12 61 0.908 NS
ARS	 4 5.75 5.78 -0.05 65 0.963 NS
ARS	 5 4.29 4.18 0.13 65 0.901 NS
ARS	 6 4.30 4.02 0.32 65 0.750 NS
ARS	 7 4.30 4.84 -0.74 65 0.404 NS
ARS	 8 5.78 5.68 0.14 64 0.889 NS
ARS	 9 2.40 2.00 0.72 65 0.477 NS
ARS 10 4.52 4.50 0.03 65 0.974 NS
TABLE (xi) Independent T-TESTS of sex differences on each of the
rating scale assessment measures at pre-treatment Treatment/	 pre	 post SE diff	 T	 df	 Prob Sig Level 
Variable 
RELAXATION
ABS 1	 4.88	 5.58	 0.52	 -1.34	 12	 .206	 NS
ABS 2	 5.83	 4.56	 0.42	 3.04	 12	 .010	 **
ARS 3	 4.55	 6.35	 0.64	 -2.82	 12	 .016	 *
ABS 4	 6.70	 6.88	 0.44	 -0.40	 12	 .697	 NS
ARS 5	 3.76	 3.59	 0.73	 0.23	 12	 .820	 NS
ABS 6	 4.26	 4.23	 1.42	 0.02	 12	 .983	 NS
ARS 7	 3.98	 5.64	 0.35	 -4.77	 12	 .000	 ***
ARS 8	 6.95	 7.36	 0.37	 -1.07	 12	 .306	 NS
ABS 9	 2.65	 5.81	 0.76	 -4.19	 12	 .001	 **
ABS 10	 4.27	 5.32	 0.62	 -1.68	 12	 .119	 NS
STIMULUS CONTROL
ABS 1	 3.92	 4.37	 0.77	 -0.58	 12	 .571	 NS
ABS 2	 4.99	 4.29	 0.95	 0.74	 11	 .476	 NS
ABS 3	 6.10	 5.73	 0.54	 0.69	 10	 .508	 NS
ABS 4	 5.26	 5.62	 0.79	 -0.45	 12	 .661	 NS
ABS 5	 5.45	 4.32	 1.14	 1.00	 12	 .336	 NS
ABS 6	 4.21	 2.85	 0.93	 1.47	 12	 .167	 NS
ABS 7	 4.67	 4.71	 0.68	 -0.06	 12	 .956	 NS
ARS 8	 5.32	 6.17	 0.56	 -1.52	 12	 .155	 NS
ABS 9	 1.92	 4.74	 0.73	 -3.88	 12	 .002	 **
ARS 10	 5.08	 4.86	 0.80	 0.27	 12	 .793	 NS
PARADOX
ARS 1	 4.51	 4.63	 0.49	 -0.60	 13	 .840	 NS
ARS 2	 4.45	 3.65	 0.60	 1.34	 13	 .202	 NS
ARS 3	 6.00	 6.49	 0.49	 -1.00	 12	 .337	 NS
ABS 4	 6.04	 6.92	 0.70	 -1.26	 13	 .229	 NS
ABS 5	 3.62	 3.36	 0.82	 0.31	 13	 .769	 NS
ARS 6	 4.22	 3.05	 0.83	 1.42	 13	 .179	 NS
ABS 7	 5.36	 5.87	 0.64	 -0.81	 13	 .434	 NS
ABS 8	 5.57	 5.78	 0.70	 -0.30	 12	 .771	 NS
ABS 9	 2.59	 5.76	 0.73	 -4.34	 13	 .001	 ***
ARS 10	 4.53	 6.26	 0.65	 -2.68	 13	 .019	 *
PLACEBO
ABS 1	 4.63	 4.71	 0.68	 -0.14	 10	 .894	 NS
ABS 2	 5.09	 3.94	 0.71	 1.62	 10	 .139	 NS
ABS 3	 6.07	 5.72	 0.98	 0.26	 9	 .800	 NS
ABS 4	 6.14	 6.87	 0.68	 -1.07	 10	 .312	 NS
ABS 5	 3.59	 2.77	 1.02	 0.80	 10	 .442	 NS
ABS 6	 2.95	 2.50	 0.88	 0.51	 10	 .622	 NS
ARS 7	 5.44	 6.03	 0.58	 -1.02	 10	 .336	 NS
ABS 8	 7.05	 6.19	 0.78	 1.11	 10	 .296	 NS
ABS 9	 1.36	 4.49	 1.27	 -2.46	 10	 .036	 *
ABS 10	 4.92	 5.50	 1.08	 -0.54	 10	 .605	 NS
WAITING LIST
ABS 1	 5.05	 4.62	 0.19	 2.25	 12	 .048	 *
ABS 2	 5.37	 5.39	 0.54	 -0.03	 12	 .974	 NS
ABS 3	 5.47	 5.23	 0.52	 0.46	 10	 .656	 NS
ABS 4	 5.57	 5.83	 0.42	 -0.61	 12	 .556	 NS
ABS 5	 3.90	 4.18	 0.95	 -0.30	 12	 .773	 NS
ABS 6	 4.57	 4.17	 0.64	 0.63	 12	 .546	 NS
ABS 7	 5.00	 4.78	 0.28	 0.78	 12	 .452	 NS
ABS 8	 6.08	 5.57	 0.29	 1.75	 12	 .111	 NS
ABS 9	 2.40	 1.56	 0.56	 1.49	 12	 .167	 NS
ABS 10	 4.77	 4.13	 0.70	 0.77	 12	 .461	 NS
TABLE (xii) Paired TL-TESTs on pre. and post-treatment Analogue Rating 
kg@ immamonts presented separately for each experimental condition
269Sleep Behaviour
2-tailed Prob Sig Level Rating Scale
Item	 1 -2.37 .018 *
Item	 2 -1.60 .109 NS
Item	 3 -1.83 .068 NS
Item	 4 -1.34 .180 NS
Item	 5 -1.60 .109 NS
Item	 6 -1.10 .273 NS
Item	 7 -0.36 .715 NS
Item	 8 -0.94 .345 NS
Item	 9 -0.24 .813 NS
Item 10 -0.63 .529 NS
Item 11 -0.51 .612 NS
Item 12 -0.91 .361 NS
Item 13 -1.48 .138 NS
Item 14 -1.34 .180 NS
Item 15 -1.60 .109 NS
Item 16 -0.73 .465 NS
Item 17 -2.01 .028 *
Item 18 -2.01 .028 *
TABLE (xiii) WILCOXON tests on pre and post-treatment scores for each
item of the Sleep Behaviour Rating Scale for subjects in the stimulus 
control group (n = 11; 3 cases with missing data) * E <  •05Variable	 df	 F Ratio F Prob	 Pair Scheffe Range. Planned t
.05	 .10	 .01
ZAS	 (4,57)	 0.970	 0.432
ZES	 (4,57)	 3.994	 0.006	 1 v 5
2 v5
SBRS	 (4,57)	 3.158	 0.021	 2 v 4
2 v3
2 v5
2 vi
ARS	 (4,59)	 2.020	 0.104
ARS 1	 (4,59)	 1.129	 0.352
ARS 2	 (4,58)	 0.556	 0.670
ARS 3	 (4,53)	 2.259	 0.076
ARS 4	 (4,59)	 0.246	 0.911
ARS 5	 (4,59)	 0.348	 0.844
ABS 6	 (4,59)	 0.331	 0.856
ABS 7	 (4,59)	 1.794	 0.143
ABS 8	 (4,58)	 1.440	 0.233
ABS 9	 (4,59)	 4.320	 0.004	 1 V 5
3 V 5
4 V 5
2 V 5
ARS 10	 (4,59)	 1.534	 0.205
* *	 *
* *	 *
* *	 *
*	 *
TABLE (xiv) ONEWAY ANOVAs on pre—post change scores for each of the
rating scale assessments across the experimental conditions 
(Relaxation=1,	 stimulus control=2,	 paradox=3, placebo=4, no
treatment=5). Results of range tests are also presented AGE -DURATION MEDPAST ZASPRE ZDSPRE
SOL8 .1162 .1739 .1629 -.0420 -.0069
SOLSDB .1239 .0652 -.0303 .1014 .1026
TOTS -.1928 -.1105 .0059 .0875 .1502
TOTSDB -.2417 -.1773 -.2955* .0852 .2299
WAKES .1426 .1195 .0107 -.1853 -.2164
WAKESDB -.0961 -.0659 -.3040* .0336 .0215
REPTHB -.0877 -.0111 -.0358 .4444** .3108*
RESTEDB .2103 .1989 .2856* -.2036 -.3228*
ENJOYS .0732 .1037 .2169 -.1098 -.1987
IRRITB -.2817* -.2470 -.3590* .6502** .6413**
NAPDAYB -.0605 -.0071 -.0274 .0377 -.0502
SOLCH .1150 .0450 .0156 -.1208 .0889
SOLSDCH -.0532 -.0618 -.1432 .1411 .1637
TOTCH -.1063 -.0588 .0691 .1976 .0802
TOTSDCH -.1345 -.0988 -.0883 .0575 .1506
WAKECH .0622 -.0629 -.1466 -.0007 -.0082
WAKESDCH -.0700 -.2052 -.3377* .2139 .1859
REPTHCH .0924 -.3021* -.3571* .1976 .2991*
RESTCH -.1964 -.0146 .1210 .0361 -.0363
ENJCH -.2120 .0675 .1851 .0225 -.0545
IRRITCH .0632 .0274 -.1264 .2228 .1704
NAPCH -.2071 -.2605 -.1226 -.0523 -.0973
ZASCH .2091 .0356 -.0599 .3497* .2735
ZDSCH .0348 -.1414 -.2205 .1862 .3491*
-* - SIGNIF. LE .01	 ** - SIGNIF. LE .001
TABLE (xv) Predictor variables and their relationship
with baseline and change score (outcome) measures.
PEARSON co-efficients and probability value are
presented1.28	 42	 0.206 1.22	 21.37	 0.204
0.75	 87	 0.451 0.74	 20.82	 0.467
0.43 17.20	 0.542
1.26 0.431 1.45	 42	 0.151
1.26 4.643 0.29	 67	 '0.656
SOLCN
CROuP 1	 14	 20.2214	 71.821	 10.445
CROP 2	 25	 25.1127	 43.144	 6.087
-0.21 40.1•	 0.772
3.24 0.015 0.12	 17	 0.811
	
79704 CROP 
1	 14	 -0.2575	 0.517	 0.131
	
CRCuP 2	 55	 -0.2121	 0.560	 0.122
•	
1070004
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0.470
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1.04 1.000
CROUP 2	 41	 11.3112	 11.424	 1.215
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SOLD
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61001
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•
e
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1.117'01	 -
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3.16 0.024
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DAMN
CROUP 1	 14	 4.1784	 4.043	 2.140
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1.20 0.427
7
TABLE (xvi) Independent sample T-TESTs on drug 
status for demographic variables and baseline and
change score (outcome) DSQ measures 
273APPENDIX J
Sleep Disturbance Questionnaire 
274SUEZ DISTURPANcF OWSTIMNAIRE
Please put a X in the appropriate box, depending upon how 1zue you feel each of
the following statements is for your tvpiral sleep pattern.
On the nights when I don't sleep well the problem seems to be that:-
Never
True
Seldom
True
Sometimes
True
Often
True
Very
Often
True
1. I can't get into a comfortable
position in bed.
2. My mind keeps turning things over.
3. I can't get my sleep pattern into
a proper routine.
4. I get too "worked up" at not
sleeping.
5. I find it hard to physically "let go"
and relax my body.
6.
•
My thinking takes a long time to
"unwind".
7. I don't feel tired enough at bedtime.
8. I try too hard to get to sleep.
9. My body is full of tension.
10. I am unable to empty my mind.
11. I spend time reading/watching TV
in bed when I should be sleeping.
.
12. I worry that I won't cope tomorrow
if I don't sleep well.
_
Which .0.oe of the above statements is most relevant to you.	 No.
Are there any other factors associated with your poor sleep pattern? If so,
please write a short note in this space.
275APPENDIX X
Additional Tables for Chapter 10
276Factor Eigenvalue % Variance Cumulative %
1 4.780 39.7 39.7
2 2.162 18.0 57.7
3 1.278 10.7 68.3
4 .995 8.3 76.6
5 .685 5.7 82.3
6 .551 4.6 86.9
7 .540 4.5 91.4
8 .444 3.7 95.1
9 .207 1.7 96.8
10 .173 1.4 98.3
11 .124 1.0 99.3
12 .081 0.7 100.0
TABLE (xvii) Complete factor extraction table for the Sleep
Disturbance Questionnaire under Principal Components AnalysisVariable df F Ratio F Prob Pair	 Scheffe Range
.05	 .10
SOL mean (3,80) 0.036 0.990
SOL SD (3,80) 2.334 0.080
TOT mean (3,80) 5.080 0.003 1 v 2
4 v2
TOT SD (3,80) 0.016 0.956
WAKE mean (3,80) 1.494 0.223
WAKE SD (3,80) 1.791 0.156
REPTH (3,80) 1.077 0.364
RESTED (3,80) 0.592 0.622
ENJOY (3,80) 0.903 0.443
IRRIT (3,80) 0.106 0.956
NAPDAY (3,80) 2.717 0.051 4 v 1
TABLE (xviii) ONEWAY ANOVAs on baseline mean scores for each of the
DSQ variables across random therapy (1), tailored therapy (2), placebo 
(3) and no treatment (4) conditions. The results of range testing are
also presented a)
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279Variable p post SE diff T df Prob Sig Level
ARS	 1 3.79 4.50 0.48 -1.47 10 0.179 NS
ARS	 2 5.26 4.96 0.39 0.77 10 0.462 NS
?RS	 3 4.77 5.43 0.89 -0.51 10 0.621 NS
ARS	 4 6.72 6.68 0.87 0.05 10 0.960 NS
ARS	 5 4.34 4.65 0.59 -0.53 10 0.613 NS
ABS	 6 4.56 3.55 0.92 1.11 9 0.305 NS
ABS	 7 3.69 3.79 0.72 -0.14 10 0.892 NS
ABS	 8 7.33 5.73 1.01 1.49 8 0.188 NS
ABS	 9 1.70 5.34 1.06 -3.45 10 0.009 **
ABS 10 4.13 4.84 0.72 -0.98 10 0.354 NS
TABLE (xx) Mean scores for the pre and post-treatment ABS items and
results of paired T-TEST comparisons for the tailored therapy group
(* .la< .01)APPENDIX L
Additional Tables for Chapter 11
281Treatment/ Baseline Treatment Week
Subject mean SQL 1 2
RELAXATION
1 37 43 56
2 76 86 90
3 166 239 * 101
4 136 34 122
5 89 59 64
6 143 75 93
7 226 247 154
8 76 89 43
9 70 131* 88
10 26 31 29
11 57 66 39
12 75 43 30
13 24 19 20
14 65 56 54
STIMULUS CONTROL
1 128 41 43
2 80 44 34
3 67 45 32
4 35 39 16
5 32 9 11
6 129 66 86
7 73 33 61
8 41 31 51
9 51 30 28
10 88 56 47
11 66 23 14
12 208 99 73
13 112 86 69
14 48 16 19
PARADOX
1 48 36 26
2 77 47 51
3 94 90 63
4 226 214 326
5 32 69* 49
6 104 154 * 146
7 25 26 27
8 42 49 11
9 31 5 14
10 71 26 13
11 87 73 90
12 26 59 g 28
13 75 103* 50
14 76 109* 89
15 71 61 47
TABLE (xxi) SQL mean scores at baseline and during the first two weeks
of treatment for each of the active treatments in the main study._ Items
marked * indicate increments of 33% or greater over baseline valueTreatment/	 Baseline Final	 Absolute	 Reduction	 Reduction
Subject	 SQL SQL	 Reduction	 >-= 30' >= 50%
RELAXATION
1	 37 42
2	 76 68
3	 166 59
4	 136 76
5	 89 68
6	 143 47
7	 226 120
8	 76 48
9	 70 79
10	 26 35
11	 57 47
12	 75 26
13	 24 41
14	 65 45
STIMULUS CONTROL
1	 128 28
2	 80 12
3	 67 34
4	 35 20
5	 32 7
6	 129 103
7	 73 15
8	 41 19
9	 51 27
10	 88 39
21	 66 14
12	 208 47
13	 112 39
14	 48 14
PARADOX
1	 48 6
,	 2	 77 28
3	 94 43
4	 226 121
5	 32 12
6	 104 118
7	 25 29
8	 42 8
9	 31 13
10	 71 8
11	 87 51
12	 26 15
13	 75 75
14	 76 60
15	 71 43
TAILORED THERAPY
1	 132 79
2	 104 144
3	 31 77
4	 64 128
5	 86 14
6	 21 21
7	 143 69
8	 139 60
9	 34 5
10	 31 19
11	 45 19
12	 178 29
13	 98 30
14	 94 84
TABLE	 (,mit)	 SOL	 mean scores at baseline and	 the	 final week of
treatment for each of the active treatment conditions. The clinical
significance of therapy—induced change is indicated in terms of the
three criteria . absolute SOL reduction (ie. greater than 1 min), SOL
reduction greater than 30 rain, and 50% SQL reduction REFERENCES
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